University of Tennessee, Knoxville

TRACE: Tennessee Research and Creative
Exchange
Doctoral Dissertations

Graduate School

8-2015

Synthesis, Characterization and Evaluation of Lectin-Binding
Properties of 1,2-cis-Glycosides
Bo Meng
University of Tennessee - Knoxville, bmeng@vols.utk.edu

Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss
Part of the Organic Chemistry Commons

Recommended Citation
Meng, Bo, "Synthesis, Characterization and Evaluation of Lectin-Binding Properties of 1,2-cis-Glycosides. "
PhD diss., University of Tennessee, 2015.
https://trace.tennessee.edu/utk_graddiss/3447

This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee
Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized
administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact
trace@utk.edu.

To the Graduate Council:
I am submitting herewith a dissertation written by Bo Meng entitled "Synthesis, Characterization
and Evaluation of Lectin-Binding Properties of 1,2-cis-Glycosides." I have examined the final
electronic copy of this dissertation for form and content and recommend that it be accepted in
partial fulfillment of the requirements for the degree of Doctor of Philosophy, with a major in
Chemistry.
David C. Baker, Major Professor
We have read this dissertation and recommend its acceptance:
Michael D. Best, Mark Dadmun, Paul D. Frymier
Accepted for the Council:
Carolyn R. Hodges
Vice Provost and Dean of the Graduate School
(Original signatures are on file with official student records.)

Synthesis, Characterization and Evaluation of
Lectin-Binding Properties of 1,2-cis-Glycosides

A Dissertation Presented for the
Doctor of Philosophy
Degree
The University of Tennessee, Knoxville

Bo Meng
August 2015

Acknowledgements
At the preface of my dissertation, I would like to express my sincere
acknowledgements to all the persons for their care, help, and support to me during the
past five years, not only in science but also in life.
I gratefully thank my advisor, Professor David C. Baker, for his guidance,
supervision, encouragement and full support throughout my graduate study and for
providing me such a great platform to grow in the field of organic and carbohydrate
chemistry.
I would like to thank Professor Michael D. Best and his group members for the
instruction, suggestion and help in carbohydrate microarray studies.
I would also like to thank Professor Mark Dadmun and Professor Paul D.
Frymier, who served on my committee, for the time, comments and suggestions they
dedicated to my dissertation.
Best regards to all my friends at UT: Dr. Xiaojun Wang, Dr. Zhenqian Zhu, Dr.
Kathrin Tscherch, Dr. Costyl Njiojob, Dr. Irene Abia, Dr. Chad LeCroix, Yundi Gan,
Robert Simion, Andrew Moss, and Haiying Li, to name a few, for helping and
accompanying me during the past years.
Lastly, I give very special thanks to my parents, my mother Cailing Ma and my
father Xiansheng Meng for their love, care, understanding, and support. I exclusively
dedicate this dissertation to my family.
Bo Meng

ii

Abstract
This dissertation presents a state-of-the-art research of 1,2-cis-glycosides,
including synthetic methodology development, combinatorial total synthesis of
galactoside ligands, construction of glycomicroarray surfaces, and quantitative evaluation
of carbohydrate–lectin binding properties.
In Chapter 1, as a general introduction, various strategies that have been
developed for the stereoselective construction of 1,2-cis-O-glycosidic bond are reviewed.
1,2-cis-O-Glycoside structural units are ubiquitous in nature, and they are extensively
involved in numerous biological activities. The systematic identification and evaluation
of the roles of carbohydrates usually relies on practical synthetic approaches to afford
pure carbohydrates in considerable quantities. Further development of general and
efficient approaches to achieve the intrinsic organizational diversity of carbohydrates is
still urged in order to meet the substantial carbohydrates in demand for biological,
medicinal, and therapeutic studies.
In Chapter 2, I report a 1,2-cis-glycosidation protocol that makes use of
unprotected phenyl 1-thioglycosyl donors. Glycosylation of various functionalized
alcohols was accomplished in moderate to high yield and selectivity to give the 1,2-cisglycosides. In order to quickly optimize glycosylation conditions, a flow injection
analysis method was established that enabled rapid and quantitative evaluation of yield
on small scale. This methodology, together with nuclear magnetic resonance
spectroscopy, allowed for rapid evaluation of the overall reactions.
In Chapter 3, I describe the synthesis of alpha-linked propargyl terminated
galactosides with various spatial presentations, which are set to be applied in the
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construction of synthetic carbohydrate microarrays to mimic featured carbohydrate
presentations on a cell surface. Through the routes, glycosyl acceptors were obtained via
flexible and efficient regioselective protection strategies, and they were glycosylated with
an alpha-directing glycosyl donor to have the alpha-linked galactosides in exclusive
stereoselective and satisfactory yield.
In Chapter 4, the establishment of a synthetic carbohydrate microarray is
described. The carbohydrate surface was interrogated by a fluorescence-labeled lectin to
quantitatively analyze the carbohydrate-binding affinities and dissociation constants. This
study will add new dimensions to our understanding of the effects of spatial arrangement
of carbohydrate ligands in carbohydrate–lectin binding, and shed light on elucidating the
structure–affinity relationship of carbohydrate recognition with receptors.
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Chapter 1 1,2-cis-Glycosylation in Carbohydrate Chemistry:
An Overview

1

Abstract
Oligosaccharides and glycoconjugates containing 1,2-cis-glycoside structural
units are ubiquitous in nature with numerous biological roles. An increasing
understanding of the biological roles has led to a significant demand for these
carbohydrates for biological, medicinal, and therapeutic studies. Therefore, considerable
effort has been devoted to develop efficient and general strategies for the synthesis of
glycosides with 1,2-cis-stereocontrol. The scope of this overview is on the recent
advances that have been developed to address the challenge of stereoselective 1,2-cis-Oglycosylation. Glycosyl donors with diverse leaving groups, protecting groups, and their
corresponding activation conditions are presented, and the subtle influences of these
factors on glycosylation outcomes are also compiled and discussed.
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1.1 Background
As one of the essential components in living systems, carbohydrates, including
natural glycosides, oligosaccharides, polysaccharides and glycocalyx, are ubiquitous in
nature. Tons of carbohydrates are produced by plants and microorganisms on a yearly
basis through the photosynthesis process. Cellulose, which is a structural polysaccharide
with β-1,4-linkage, is the most abundant chemical substance on the planet. Carbohydrates
perform numerous biological roles and sustain the metabolism in living systems. In the
past, the functionalities ascribed to carbohydrates were limited to energy storage and
skeletal components. However, with the first isolation and identification of a
carbohydrate-binding protein, their diverse roles in biological systems sparked great
interest and a multitude of efforts, which resulted in the emerging of ‘Glycobiology’ as a
science. Nowadays, people realize that carbohydrates are heavily involved in the cellcell
recognition and cellexternal agent interactions. Since cell membranes are covered with a
thick layer of glycoconjugates, they form the basis for molecular interactions at the cell
surface. These interactions mediate cell adhesion, fertilization, cell growth and
differentiation, immunological processes, blood clotting, and hostpathogen interactions,
all of which are critical for proper development and higher order function in living
systems.1, 2
Biologically significant carbohydrates usually exist as complicated oligomers or
polymers, or in conjugation with other biomolecules to form bioconjugates such as
glycolipids, glycoproteins, or glycosylphosphatidylinositol (GPI) anchors.3 In order to
systematically identify and evaluate the roles of carbohydrates, glycobiologists need
access to particular target carbohydrates in sufficient quantities, as isolating these
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molecules from nature in high purity is still difficult due to their low abundance and
heterogeneity. Therefore, developing practical synthetic approaches is an important
method to afford pure carbohydrates in considerable quantities.
The synthesis of glycosides always includes the regioselective and stereoselective
construction of glycosidic bonds between glycosyl donors and acceptors, a process called
glycosylation. Although considerable effort has been expended and progress has been
made in developing efficient glycosylation approaches,4–9 the rapid construction of
complex oligosaccharides or glycoconjugates with specific structures still remains
challenging. Carbohydrate building blocks are present in more than one form (pyranose
and furanose forms), and the variations of their size, configuration, connectivity, and
spatial arrangement leads to diverse structures ranging from monosaccharides to
oligosaccharides to highly branched polysaccharides and glycodendrimers. Each sugar
unit is a unique stereogenic center, and the stereochemical control of the glycosidic
connections requires precise design and prudent manipulation. Furthermore, from the
mechanistic viewpoint, the process also lacks generality and consistency in
rationalization of the glycosylation reactions.10 The glycosylation process usually initiates
from the activation of a donor and via glycosyl oxacarbenium ion formation, which is
reacted or coordinated with a counterion to form a covalent intermediate, or an
equilibrating close-contact and loosely bound ion pair. These covalent intermediates or
ion-pairs react with an acceptor in either SN1-like or SN2-like pathways to afford the
corresponding products. During this process, many factors including donor type,
promoter, protecting group, solvent, concentration, temperature, etc., are capable of
affecting the glycosylation outcomes, and sometimes the combined efforts of several
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factors will dominate the outcomes.11,

12

Therefore, proposing a comprehensive

glycosylation method is a challenging task.
Among the various glycosidic linkages, the O-glycosidic linkage is one of the
representative linkage types based on its high generality and abundance in nature.
Typically, the O-glycosides can be classified into either 1,2-cis- and 1,2-trans-Oglycosides or α- and β-O-glycosides. 1,2-cis-O-Glycosides are generally α-O-glycosides,
but there are exceptions such as α-O-mannosides and α-O-arabinosides, which belong to
1,2-trans-O-glycosides. The α or β designation is based on the stereochemical
relationship between the anomeric center (C-1) and the configuration of the highest
numbered stereogenic center at the hemiacetal stage. If the hydroxyl groups bound to this
center are cis to the substituent at the highest-numbered stereocenter, this anomer is
called the α-anomer, otherwise the one with a trans relationship is called the β-anomer.1
Several typical glycoside configurations are shown in Figure 1.1. Sometimes if the 2hydroxyl group is replaced by hydrogen, such as in 2-deoxyglycosides and sialosides, we
no longer define them as 1,2-cis or 1,2-trans glycosides, and they are referred to as α- and
β-glycosides. Both 1,2-cis and 1,2-trans glycosidic linkages are essential and
indispensable in natural compounds, but the extremely difficult syntheses of 1,2-cis
glycosidic linkages are barriers and could be encountered in many carbohydrate
syntheses. The management of these difficulties is the focus of this review.13
1,2-cis-O-Glycosidic linkages can be found in many oligosaccharides or
glycoconjugates of high biological importance and therapeutic potential. Several typical
naturally occurring oligosaccharides and glycolipids comprising 1,2-cis-O-glycosidic
bonds are displayed in Figure 1.2. For example, glycosphingolipids (GSLs) of the globo
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Figure 1.1 Typical glycoside configurations found in nature.

6

series, which is a current target for tumor-specific antigen, have the α-linked galactosyl
residue.14 Simplexide, another kind of glycolipid of marine origin with immunological
potential, also consists of an α-D-glucosyl-(1→4)-β-D-(1→6)-galactosyl disaccharide
residue.15 The bacterium Azospirillum brasilense SR80 consists of a lipopolysaccharide
with an O-tetrasaccharide repeating unit, which contains a 2-O-(α-L-fucopyranosyl)-α-Dgalactosyl-(1→3)-β-D-galactosyl residue.16 The capsular polysaccharide A of Bacteroides
fragilis NCTC 9343, which has been shown in mediating the formation of intraabdominal abscesses in experimental animal models, is composed of a 1,2-cisglycosaminoglycan motif.17 Clostridium difficile, which triggers nosocomial infections,
has been found to express glycans containing 1,2-cis-linkage on the bacterial cell
surface.18 Several asymmetrically branched N-glycans bearing 1,2-cis-β-D-mannoside
residues are important synthetic targets to represent glycan structures of those found on
human and animal airway epithelia. These are involved in the recognition of influenzavirus hemagglutinins.19
There are several methods that can be applied to govern the stereochemistry of
glycosylation reaction. The most general method is to put specific protecting groups on
glycosyl donors. Various protecting groups have been developed and applied to afford
desired stereochemical glycosides. Generally, they can participate in the formation of the
oxacarbenium ions by either forming a covalent acetal bond, or by molecular interaction
such as hydrogen bonding, or by steric effects to steer a specific nucleophilic attack
pathway. For example, an acyl group on C-2 usually forms an acyloxonium ion with the
anomeric center to reliably achieve 1,2-trans glycosides, which is called neighboringgroup participation (NGP). The NGP concept is also applied to the formation of 1,2-cis
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Figure 1.2 Representative naturally occurring oligosaccharides and glycolipids
comprising 1,2-cis-O-glycosidic bonds (specified in tangerine color).
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glycosidic bonds. Some kind of remote protecting groups, such as picolinoyl and 2quinolinecarbonyl groups,20,
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have been demonstrated to guide the 1,2-cis

stereoselectivity of glycosylation via hydrogen-bonding effects. Moreover, several bulky
cyclic protecting groups, including di-tert-butylsilylene (DTBS)22 and benzylidene,23 are
powerful 1,2-cis-directing groups, which have been extensively applied in the
construction of the α-linkage in galactosides and the β-linkage in mannosides. Besides
using an effective protecting group, the application of nucleophilic ether solvents, such as
diethyl ether, dioxane, and tetrahydrofuran, are also highly regarded to facilitate the 1,2cis-stereoselectivity of glycosylation under different glycosylation conditions.24,
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Recently, I reported a straightforward 1,2-cis-alkyl glycosylation strategy by utilizing
unprotected thiophenol glycosyl donors, which were glycosylated with a variety of
reactive acceptors to make the corresponding 1,2-cis-O-glycosides in moderate to high
yield and selectivity (see Chapter 2).26
This overview focuses on the advances that have been developed to rise to the
challenge of stereoselective glycosylation, especially of the 1,2-cis-O-glycosylation. The
aim of this perspective is to overview (i) the application of diverse glycosyl donors and
activation conditions on 1,2-cis-O-glycosylation, (ii) the influence of various protecting
groups on 1,2-cis-O-glycosylation, and (iii) outlook of the 1,2-cis-O-glycosylation
methods.
1.2. Glycosyl Donors and Their Applications in 1,2-cis-Glycosylations
1.2.1 Glycosyl halides
In 1901, glycosyl chlorides and glycosyl bromides were first introduced as
glycosylation agents by Wilhelm Koenigs and Eduard Knorr,27 and this classical method
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is still widely used nowadays in the stereospecific synthesis of glycosides. Heavy metal
salts, such as Ag2O, Ag2CO3, AgOTf, AgClO4, HgBr2, Hg(CN)2, HgO or CdCO3 usually
serve as promoters in this reaction.1 Another benefit of using metal carbonates and oxides
as activators is they are also acid scavengers, which can neutralize the acid released in the
glycosylation reaction. Sometimes organic bases, for example s-collidine, lutidine,
tetramethylurea, and the sterically hindered 2,6-di-tert-butyl-4-methylpyridine (DTBMP)
and 2,4,6-tri-tert-butylpyrimidine (TTBP) also perform the same function.2
Besides a leaving group, the halide ion is also used as a stereodirecting agent.
Lemieux introduced halide-ion catalyzed glycosylation (Scheme 1.1a), which is to
combine promoters such as Et4NBr or Bu4NBr with Hünig’s base to yield high
stereoselectivity of 1,2-cis glycosides.28, 29 During this process, the generated bromide ion
(Br−) performs as a nucleophile to convert α-glucosyl bromide 1 into β form 2, which was
glycosylated with an acceptor to give 1,2-cis-α-glucoside 3. However, the Lemieux
glycosylation often takes long reaction times (>2 days), and only applies to reactive
glycosyl halides and acceptors. Fortunately, these drawbacks can be avoided by using
alternate glycosyl donors, to generate glycosyl halides in situ, such as to activate
thioglycoside donors by CuBr2−Bu4NBr30 or DMTST−Bu4NBr,31 to progress through
glycosyl halide intermediates.
Although these were the only donor choices for a long period of time, glycosyl
halides are now losing their prevalence in glycosylation reactions. They suffer from two
weaknesses: first, equimolar amount of poisonous, costly and often moisture- and lightsensitive heavy metal reagents are utilized as promoters; second, the lability of glycosyl
halides obstructs chemical manipulation on the other functional without impairing the
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Scheme 1.1 Stereoselective glycosylation by glycosyl halide donors.
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activity of the very sensitive anomeric halides. These drawbacks can be circumvented by
either applying benzyl or silyl protecting groups on glycosyl halide donors, or by using
more stable donors such as thioglysides as effective stereospecific glycosylation methods
that have been developed.
Although glycosyl iodides were first prepared many years ago,32 their utility as
glycosyl donors has not been fully explored until recent decades, which is due to their
instability and high reactivity. The halide ion-catalyzed glycosylation method paves way
for their in situ preparation, and they have showed delightful properties in reaction rate,
efficiency, and stereoselectivity.33–35 Most reported glycosylation reactions by glycosyl
iodide donors are equipped with arming (activating) protecting groups, usually O-benzyl,
O-trimethylsilyl,

or other electron-donating groups.36 The direct nucleophilic

displacement of an anomeric iodide by an acceptor via an SN2 process could achieve a
straightforward synthesis of a 1,2-cis glycosyl linkage, which avoids the introduction of
stereodirecting groups that require further removal. For example, benzylated glycosyl
acetate 4 can be activated by iodotrimethylsilane (TMSI) to yield the α-glycosyl iodide 5.
Without isolation, α-glycosyl iodide is activated by TBAI and Hünig’s base to produce βglycosyl iodide 6 in situ, and subsequent axial attack on the anomeric center affords the
α-glycoside 7 in high stereoselectivity (Scheme 1.1b).37, 38 Besides the benzyl protecting
group, the trimethyl silylated glycosyl iodide 8 can also be synthesized and applied in
constructing the biologically active α-D-cholesterylglycoside 10 in high 1,2-cis selectivity
(Scheme 1.1c).39 Because of their high reactivity and instability, methods are needed to
generate glycosyl iodides in situ, and further improvements are expected to increase their
stability and develop other activation conditions for a broader usage.
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1.2.2 Glycosyl imidates
In glycosyl imidates, the anomeric oxygen atom is derivatized to a labile leaving
group, which can be readily removed by Lewis acid activators such as TMSOTf or
BF3·OEt2. Sinaÿ prepared the first β-O-glycosyl acetimidates by treating benzylated
glycosyl chlorides 11 with N-methylacetamide,40 and applied them in the construction of
the blood group B determinant. The acetimidates 12 and 13 were each glycosylated with
glycosyl acceptors 16 and 14, respectively, by the promotion of pTsOH, and 1,2-cis
glycoside 17 was thus synthesized in excellent stereoselectivity (Scheme 1.2).41, 42
In the 1980s, Schmidt reported O-glycosyl trichloroacetimidates and O-glycosyl
trifluoroacetimidates as advanced imidate donors with better general applicability.43 After
that, a series of N-substituted O-glycosyl trihaloacetimidates was synthesized from the
corresponding

glycosyl

hemiacetals

and

trihaloacetonitrile

or

N-substituted

trihaloacetimidoyl halides in a basic medium.44 Generally, trichloroacetimidate donors
are more competent than trifluoroacetimidate donors with respect to reactivity and
reaction

yield,

while

in

some

specific

cases45,

46

O-glycosyl

N-phenyl-

trifluoroacetimidates are more reactive. There are several factors including the existence
of a substituent, the basicity and/or the size of the leaving group, and its conformational
change synergistically determining the donor efficiency.47
The glycosylations with trichloroacetimidates are usually carried out under acidic
conditions, and various Lewis acids have been tested and demonstrated, ranging from
typically used TMSOTf and BF3·OEt2,43 to Sm(OTf)348 and Yb(OTf)349 for the specific
activation of armed and disarmed O-glycosyl donors, respectively. The activation of Naryl-trifluoroacetimidates needs more forceful conditions, and successful activation
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Scheme 1.2 Application of glycosyl acetimidate donors in the synthesis of blood group B
determinant.
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systems include Bi(OTf)3, I2/Et3SiH, and TMSB(C6F5)4.46, 50 For the purpose of reaching
desired 1,2-cis-stereoselectivity, the glycosylation conditions need to be precisely
controlled, usually assisted by the use of non-participating protecting groups (benzyl
group), nonpolar solvents, mild Lewis acid catalysts (BF3·OEt2), and low reaction
temperatures. Such conditions favor the SN2 processes, and β-trichloroacetimidate will
preferentially provide α-glycosides. If more powerful conditions were applied, such as
using strong acid catalysts (TMSOTf, TfOH), higher temperature and more polar
solvents, both α- and β-trichloroacetimidates would generate the thermodynamically
stable products, which are the α-glycosides in general. Besides the glycosylation
conditions, the nature of the counter anion of the Lewis acid also has an influence on the
stereoselectivity. For example, in some specific cases HClO4 favors the formation of αglycosides, while HB(C6F5)4 does not; yet the reason behind these observations has not
been explained.51
The O-glycosyl trihaloacetimidate donors have been extensively employed in the
synthesis of 1,2-cis-O-glycosides. Benzylated O-galactosyl trichloroacetimidate 18 was
glycosylated with the acceptor 19 to exclusively furnish the α-(1→4)-linked trisaccharide
20, for the synthesis of oligosaccharide moieties 21 of a globotriaosylceramide (Scheme
1.3a).52 They were also used in the stereoselective construction of α-(1→6)-linked
saccharides such as verbascose, raffinose or sucrose (Scheme 1.3b).53 Benzylated Oglucosyl trichloroacetimidates also displayed comparable properties. The glycosylations
can be successfully realized with either 2-, 3-, 4- or 6-OH on glycosyl acceptors in the
presence of TMSOTf at low reaction temperature, in order to obtain predominantly αlinked oligosaccharides.54 Besides, it has also been reported that N-phenyl-
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Scheme 1.3 Synthesis of 1,2-cis-O-glycosides with glycosyl trihaloacetimidate donors.
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trifluoroacetimidate 24b, in some specific cases, is superior to trichloroacetimidate 24a,
such as achieving higher yield and better stereoselectivity in the β-mannosylation
reactions (Scheme 1.3c).55
The disadvantages of this method still exist: the high reactivity and lability of
glycosyl trichloroacetimidates can give rise to side reactions during glycosylations; the
donor may decompose during long-time storage; the rearrangement of the donor may
occur to produce the non-reactive glycosyl trichloroacetamide. All these will lead to low
glycosylation yields, side products, and challenges in purification. Moreover, the
structural characterization of donors could be complicated by their invertomers, and
further aggravated by the splitting of the carbon signals by adjacent fluorine.4–9
1.2.3 Glycosyl phosphates and phosphites
The first synthesis of glycosyl diphenyl phosphates as effective glycosyl donors
was reported in 1989.56 After that, many glycosyl donors bearing phosphorus leaving
groups were developed by adopting different substituents on the phosphorus atom.57, 58 In
most circumstances, both α- and β-glycosyl phosphate donors are easy to prepare, store,
and manipulate; yet the glycosylation properties were found inferior to the corresponding
O-glycosyl trichloroacetimidates. The traditional reaction method was to use TMSOTf as
the promoter in at least a stoichiometric amount, which is due to the formation of an
equal amount of silyl phosphate to be the driving force of glycosylation. Recently,
perchloric acid was employed in only a catalytic amount as an efficient activator, and
enhanced α-selectivity was obtained.59
Likewise, the glycosyl phosphate and phosphite donors are capable of forming
1,2-cis-α-O-glycosidic linkages. For instance, benzylated glucosyl diphenyl phosphates
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Scheme 1.4 Glycoside syntheses with glycosyl phosphates (a, b) and glycosyl phosphite
(d) as donors, and rationalization of the high α-selectivity upon the activation of HClO4
(c).
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27 (mixed isomers with high α) was reported as the donor to glycosylate with glycosyl
acceptor 28 to provide glycoside 29 in good yields and α-selectivity upon activation with
catalytic amount of TMSClO4 or HClO4 in a dioxane/Et2O mixed solvent (Scheme
1.4a).60 This strategy has also been practiced in the preparation of α-galactosylceramide
KRN 7000, a ligand for natural killer T cells activation on antigen-presenting cells.
Benzylated galactosyl diphenyl phosphate 30 was coupled with the ceramide acceptor 31
under a catalytic amount of HClO4 in dioxane, and the glycoside 32 was formed in
respectable yield and α-selectivity (Scheme 1.4b).59 It is believed that during the
glycosylation process a contact ion pair (CIP) 35 is formed with an oxocarbenium ion and
a perchlorate counter ion after the cleavage of the phosphate group, and ethereal solvent
facilitates the formation of solvent-separated ion pair (SSIP) 36, which favors the axial
addition of acceptors from the α-face due to the kinetic anomeric effect (Scheme
1.4c).61, 62
Glycosyl phosphite exhibits the preference in α-glycosylations as well. Glycosyl
diethyl phosphite 38 was reacted with the acceptor 28 to predominantly furnish αglycoside 29 under the activation of 2,6-di-tert-butylpyridinium iodide (DTBPI) and
TBAI. The glycosyl iodides were supposed to be generated as intermediates during the in
situ anomerization process (Scheme 1.4d).63
1.2.4 Thioglycosides
Thioglycosides are amongst the most popular types of glycosyl donors in
oligosaccharide synthesis from their first preparation over a century ago.64
Thioglycosides have many benefits as glycosyl donors, which include long shelf life for
storage, easy accessibility, great stability under various reaction conditions for protecting-
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group operation, favorable state as crystalline, and most importantly, amenability to
desired chemoselective transformations when necessary. Therefore, thioglycosides satisfy
most requirements as ideal glycosyl donors.2, 4-9
Accordingly, a great variety of strategies have been developed for the synthesis of
thioglycosides. The most popular method for thioglycoside preparation is to treat per-Oacetylated carbohydrates with thiols such as thioethanol or thiophenol in the presence of
Lewis acids, usually BF3·OEt2, to predominantly furnish 1,2-trans thioglycosyl donors.65
They have also been prepared by a two-step procedure that involves a nucleophilic
displacement of acetylated glycosyl halides to give the corresponding glycosyl
thioacetates, followed by alkylation/arylation of the in situ generated thiols by selective
S-deacetylation.66 This protocol is quite versatile when different alkyl/aryl thiol
glycosides or S-linked disaccharides need to be synthesized.67 The acetylated
thioglycosides thus prepared can survive in deacylation and many other protecting group
manipulations, whereas glycosyl bromides and glycosyl trichloroacetimidates cannot.
A wide range of activation systems for thioglycoside donors has evolved as well.
The use of iodonium ions generated from N-iodosuccinimide (NIS) with a catalytic dose
of triflic acid (TfOH), which was first reported in 1990, has been regarded as the
preferred method to activate thioglycosides.68 Since then, the activation ability of
iodonium ions on thioglycosides has been demonstrated by many successful applications
with variations, and besides, many other thiophilic promoters have been developed. For
example, the employment of NIS with other types of Lewis acids, including AgOTf,69
TrB(C6F5)4,70 Bi(OTf)3,71 HClO4-silica72 etc., as alternatives to TfOH for the activation of
thioglycosides with comparable effects. Sometimes N-bromosuccinimide (NBS),73
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interhalogen compounds (ICl or IBr),74 or iodine (I2)75 functions similarly as substituent
halo sources. 1-Fluoropyridinium triflates were also reported76 as versatile promoters in
the transformation of thioglycosides to O-glycosides. All these activation systems rely on
the intrinsic soft nucleophilicity and especially the halophilicity of the sulfur atom in the
thioglycosides. The glycosylation process initiates from the activation with soft
electrophilic reagents (halogen in such cases) and the formation of a sulfonium ion,
which is a better leaving group. Cleavage of the sulfonium ion leads to the formation of a
oxocarbenium ion as a common intermediate in glycosylation, and the following
nucleophilic addition by the glycosyl acceptor affords the O-glycoside (Scheme 1.5a).77
Recently another type of soft electrophile, the organo-sulfur compounds, has been
evaluated as valuable promoters for the activation of thioglycosides. Representative
activation systems involve sulfonium triflates such as DMTST,31 MeSOTf,78 or
PhSOTf,79 and sulfinates in combination with Tf2O such as benzenesulfinyl morpholine
(BSM)/Tf2O,80

1-(phenylsulfinyl)piperidine

(BSP)/Tf2O,81

diphenyl

sulfoxide

(Ph2SO)/Tf2O82 or Me2S2/Tf2Ots83. Since the sulfinyl/triflic anhydride systems are able to
preactivate thioglycosides at low temperatures, the thioglycosides can be activated in the
presence of another and be treated as glycosyl acceptors as well. Besides, the relative
stability of thioglycosides facilitates the selective glycosylation of glycosyl imidate
donors. These features have often been applied in the iterative and one-pot synthesis of
complex oligosaccharides (Scheme 1.5b, Scheme 1.6a).4-9
The applications of thioglycosides in 1,2-cis-glycosylation reactions are
frequently reported. For example, stereoselective construction of 1,2-cis-α-O-glycosidic
linkages in some oligosaccharide syntheses was performed by benzylated thiomethyl
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Scheme 1.5 Glycosylation by a thioglycoside via the activation of an electrophile (a), and
selective activation of O-glycosyl trichloroacetimidates in the presence of thioglycoside
donor (b).
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Scheme 1.6 Oligosaccharide and alkyl glycoside syntheses with thioglycosides as donors.
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glycosides in the presence of iodine as an efficient promoter.84 Thiogalactoside was also
reported to be glycosylated with acceptors by using BSM/Tf2O in a preactive one-pot
synthesis fashion, to give the trisaccharide 48 bearing a 1,2-cis linkage as analogue of a
tumor-associated antigen IsoGb3 (Scheme 1.6a).85 The unprotected deoxythioglycoside
49 was coupled with alcohols under the assistance of DDQ and long-wavelength UV
irradiation to effectively give α-O-glycoside 50α as the major product (Scheme 1.6b).
Specifically, p-methoxyboronic acid was demonstrated to temporarily protect the 1,3-diol
(C-4 and C-6 positions) and increase the reaction yields.86 Very recently, a method using
thioglycoside donors was developed for the highly selective O-glycosylation. The
thioglycoside 51 was activated with Ph2SO/Tf2O, followed by TBAI, to possibly generate
a glycosyl iodide intermediate that undergoes stereoselective 1,2-cis-α-glycosylation in
high yield. This method permits iterative oligosaccharide synthesis (Scheme 1.6c) as
well, and shows promise in synthesizing complex α-glycosides with no specialized
protective groups.87
In conclusion, lots of attention and effort have been generated in the preparation
and activation of thioglycosides, and many strategies have been proposed during the past
decade. Since thioglycosides are representative glycosyl donors with many benefits, they
were designed to play a key role in oligosaccharide synthesis. Therefore, advanced
approaches, which emphasize regio- and stereoselective reactions in high yield with easy
isolation of products and minimum protecting group usage and manipulation, are still
desired.
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1.2.5 Other glycosyl donors and activators
The previous sections review the glycosyl donors most typically used in
oligosaccharide synthesis and especially their applications in 1,2-cis-O-glycosylations.
Although these glycosylation strategies have offered significant advances for
chemselective glycosidic bond formation, it is still necessary to evaluate other less
commonly used glycosyl donors. Adopting dissimilar glycosyl donors alters activation
patterns and glycosylation potential, which might be vital to solve a particular
glycosylation problem.
Glycosyl thioimidates, which contain an SCR1=NR2 aglycone, bear properties of
both a thioglycoside and a glycosyl imidate. Glycosyl thioimidates are efficient donors,
and examples such as S-benzoxazolyl (SBox) glycoside88 and S-thiazolinyl (STaz)
glycoside89 have been employed in the 1,2-cis-O-glycosylation with complete
stereoselectivity (Scheme 1.7a). The high stability of glycosyl thioimidates makes them
competent to tolerate harsh reaction conditions that sometimes have to be designated for
the activation of other glycosyl donors, and these properties popularize them in the
synthesis of complex oligosaccharide.90 Recently, benzylated glycosyl boranophosphate
58 was developed with modified reactivity as a glycosyl phosphate analog. The
displacement of the P=O moiety by a PBH3 group enables the donor to be stable in the
presence of Lewis acids, while its specific activation can be easily fulfilled by the trityl
cation (Tr+). A trityl salt such as trityl N,N-bis(trifluoromethanesulfonic)imidate (TrNTf2)
can be used, while the reaction can also be carried out with the O-trityl ether 59 that
serves as both the Tr+ source and the glycosyl acceptor (Scheme 1.7b), which provides
improved O-glycosylation yields and 1,2-cis stereoselectivity as well.91 Moreover, 1,2-
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Scheme 1.7 Stereoselective glycosylation with other typical glycosyl donors.
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orthoesters, which are usually intermediates in glycosylation processes, can also give 1,2cis-glycosides through rearrangement.45, 92, 93 2-Nitroglycals are particularly valuable in
the cis-formation of 2-acetamido galactosides.94 Even if those inactive glycosides such as
methyl glycoside 60 and 1-hydroxy sugars are now used as glycosyl donors under
specific conditions with moderate to high reactivity (Scheme 1.7c).95
1.3. 1,2-cis-Directing Protecting Groups
Nowadays, the role of protecting groups in carbohydrate chemistry is no longer
limited to simply provide blocking of hydroxyl groups, because it has been realized that
protecting groups can have a pronounced impact on the reactivities of both glycosyl
donors and acceptors, as well as on the stereoselectivity of the glycosylation. This section
will focus on the formation of 1,2-cis glycosidic bonds via installation of special
protecting groups that preferentially direct the 1,2-cis-stereoselective. Based on the
directing effects, the protecting groups are typically classified into two major categories,
which are 1,2-cis-directing through electronic effects (Section 1.3.1) and through
torsional effects (Section 1.3.2). Besides, unprotected glycosyl donors and their
applications in 1,2-cis-glycoside synthesis have also been reported (Section 1.3.3).
1.3.1 1,2-cis-Directing protecting groups through electronic effects
Ether protecting groups are often used in the synthesis of 1,2-cis gluco- or
galactosides for the neighboring hydroxyl protection. They are generally treated as
nonparticipating protecting groups, and the 1,2-cis selectivity is achieved by the anomeric
effect. Similarly, results can also be reached by aryl sulfonyl protecting groups,
especially in the construction of β-mannosyl (Scheme 1.8a) and rhamnosyl glycosides.
They are nonparticipating groups, but with strongly electron-withdrawing properties.
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Scheme 1.8 Stereoselective synthesis through electronic effects by a neighboring
protecting group (a). Flattened twist-boat intermediate (b).

Scheme 1.9 Stereoselective glycosylation with (S)-(ethoxycarbonyl)benzyl-protected
glycosyl donor (a), and neighboring-group participation by an (S) auxiliary at C-2 leading
to 1,2-cis stereoselectivity (b).
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When the donor is activated, the strong dipole effect facilitates the formation of a
flattened twist-boat intermediate (Scheme 1.8b), and it is attacked favorably from the β
face to give a 1,2-cis-glycoside.96, 97
A new general strategy was developed for the formation of 1,2-cis-glycosidic
linkages by introducing a neighboring auxiliary group at the 2-O-position, such as (S)ethoxycarbonyl)benzyl chiral substituent depicted in Scheme 1.9a.98 The addition of the
ethoxycarbonyl group from the chiral auxiliary to the anomeric center, which is called
neighboring-group participation, leads to the formation of a stable dioxolenium ion. It is
expected that the (S)-stereochemistry of the phenyl group would occupy the equatorial
face, which prevents unfavorable 1,3-diaxial steric interactions. Therefore, the attack of
the dioxolenium ion by acceptors could only be feasible from the bottom face to give αglycosides (Scheme 1.9b). Instead, β-glycosides can be readily afforded with the help of
an R-configuration auxiliary. Moreover, the introduction of an electron-withdrawing
group at the C-3 position could destabilize the oxacarbenium ion and facilitate the
auxiliary group participation as well as the formation of α-glycosides. However, a
drawback of this strategy is that an auxiliary group has to be installed on the glycosyl
donor and cleaved after glycosylation, which requires relatively harsh conditions and
tedious operations.
Recently, a simplified approach was proposed based on the virtue of a
neighboring auxiliary group towards the preparation of 1,2-cis-glycosides. The glucosyl
1,2-oxathiane ether was made from thioglucoside 69, and its further oxidation gave
glucosyl sulfoxide donor 70 in a bicyclic anomeric sulfonium ion state. Glycosylations of
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Scheme 1.10 Synthesis of 1,4-oxathiane-protected glucosyl donor and its employment in
stereoselective glycosylation.
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the donor with various glycosyl acceptors furnished corresponding disaccharides in high
yields and 1,2-cis stereoselectivity (Scheme 1.10). The new donor is capable of
withstanding many kinds of reaction conditions with respect to protecting group
manipulations, and it has been successfully applied in the synthesis of a branched
glucoside as a polysaccharide derivative isolated form a natural fungi.99
The influence of remote substituents on configuration of the anomeric center
during glycosylations has been exploited in recent years as well. Several kinds of
protecting groups, ranging from commonly used acetyl100 and carbonate101 groups to
deliberately designed picolinyl (Pic)102 and picoloyl (Pico)103 protecting groups, are
carefully studied and determined to be effective in the stereo-formation of glycosidic
bonds. For example, a comparative study100 revealed that when trichloroacetimidate
mannoside donors contain electron-withdrawing substituents such as an acetyl or benzoyl
group at the C-3 position, their glycosylations with primary glycosyl acceptors could
provide the disaccharides in great yields and 1,2-cis-selectivity. However, if the electronwithdrawing substituent at C-3 is changed to benzylsulfonyl, the stereoselectivity of the
corresponding disaccharide would be inverted to 1,2-trans-selectivity. Recently, a
parallel study104 was carried out on the glycosylations of glucosides with both
conformationally restricted and non-restricted glucosyl donors. The results indicated that
when the glucosyl N-phenyltrifluoroacetimidate donors bear acetyl groups at C-3 or C-6,
the glycosylations with acceptors were accomplished in high yields and 1,2-cis
selectivity. When the acetyl group at C-6 was switched to a benzoyl group, a further
selectivity increase was observed. Comparable yields and selectivity were also applied to
the conformationally constrained 4,6-O-benzylidene-protected glucosyl donor. These
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experimental results support the hypothesis that electron-withdrawing or sterically bulky
groups, specifically those at C-6, favor 1,2-cis-glycosylation. The protecting groups
electronically or sterically shield the top face of the pyranose rings, and facilitate the
nucleophilic addition from the opposite face to afford 1,2-cis-glycosides.105
The study of 2-azido-2-deoxy glycosyl donors showed a distinctive relationship
between the remote protecting groups and stereoselectivity of glycosylations.106 It was
observed that acetyl substituents at C-3 and C-6 positions on GlcN3 donors directed αglycosylations, whereas acetyl group at C-4 was more β-directing.107 The application of
2-azidomannouronate ester donor in 1,2-cis-glycosylation was investigated as well.108, 109
The donor could be coupled with a glycosyl acceptor with the activation of Ph2SO and
TfOH at low temperature to give predominantly 1,2-cis-glycosides. The proposed
mechanism states that the oxacarbenium ion is formed as an intermediate in association
with the triflate counterion. Meanwhile, the strong electron-withdrawing carboxylate
group on C-5 dominates a pseudo-axial location and stabilizes the positive charge on the
intermediate, which expedites the following nucleophile attack from the bottom face and
provides 1,2-cis selectivity exclusively.
In addition, an innovative stereodirecting glycosylation strategy, which is defined
as H-bond-mediated aglycone delivery (HAD), has been carefully designed and applied
with the assistance of specific protecting groups such as picolinyl (Pic) and picoloyl
(Pico) groups.20 When incorporating these substituents at C-3 or C-4, a hydrogen bond is
formed between the picolinyl nitrogen with the oxygen of the acceptor at the syn face,
and a high stereoselectivity is achieved. The applicability of this strategy was
demonstrated by many applications. Various glycosyl donors, including 4-O-picoloyl
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glucosyl donor, 3-O-picoloyl mannosyl donor, 5-O-(2-quinolinecarbonyl) arabinosyl
donor, as well as the 6-O-picoloylated 2-deoxy glycosyl donors, all successfully
contributed to 1,2-cis glycosidic bond formation. Besides, it was observed that this
strategy is particularly effective under dilute conditions (5 mM). The use of 4-O-picoloyl
glucosyl donors provides faster and increased 1,2-cis selectivity compared with those
acquired at higher concentration.103
1.3.2 1,2-cis-Directing protecting groups through conformational constraining
effects
Recently, much attention has been paid to the conformationally constrained
glycosyl donors in effective glycosylations. Since the first report110 of the deactivation
effect of a cyclic acetal group on glycoside donors, conformationally restricted protecting
groups have been largely applied101 to modulate the reactivity of donors, especially to
enhance the stereoselectivity and enable orthogonal oligosaccharide syntheses that
involve considerable synthetic challenge. Conformational constraining protecting groups,
which are usually cyclic bifunctional protecting groups, can confine the flexibility of the
sugar ring and lock the donors to certain conformations. When the donors are activated,
glycosyl oxocarbenium ions are generated with face discrimination, which makes them
principally accessible from one side.
The employment of 4,6-O-benzylidene protecting group has been demonstrated as
a successful strategy of β-selective mannosylations (Scheme 1.11a).111–114 Early examples
involve using 4,6-O-benzylidenate sulfoxide donors and thioglycoside donors to directly
form β-mannosidic linkages. It was believed that the benzylidene protecting group
stabilized the generated α-mannosyl triflate intermediates, in which the following
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Scheme 1.11 Application of 4,6-O-benzylidene protecting group in 1,2-cis-glycosylation
reactions.
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additions had to be preferentially carried out from the β face.115 Subsequently, high βselective mannosylations were practiced with other types of mannosyl donors possessing
4,6-O-benzylidene protections, such as TCAI, PTFA, phosphite, iodide and phthalate
donors, and many of which were even activated by non-triflate promoters other than
forming the mannosyl triflate intermediates.55, 116–119 Therefore, it has been rationalized
that the high β-mannosylations are induced by a torsional effect imposed by the
benzylidene group. The stereoselective glycosylation processes proceed via the formation
of a conformationally constrained twist-boat structure intermediate, other than the αmannosyl triflate intermediate. This proposal accounts for the great β-stereoselectivity of
4,6-O-benzylidene 2-deoxy-2-iodoglucosyl donors as well. However, it has to be added
that other factors, including leaving groups, glycosyl acceptors, substituents at the 2-/3position, and activation conditions, can all influence the stereoselectivity outcomes to
different extents.120, 121
Besides its applications in β-mannosylations, the 4,6-O-benzylidene protecting
group was also used in other kinds of glycosyl donors to achieve α-glycosylations. For
instance, 4,6-O-benzylidene-protected thioglucoside donor 78 was glycosylated with
various acceptors to give α-glucosides with excellent selectivities (Scheme 1.11b).122 We
know that during the glycosylation processes, numerous intermediates with different
reactivities and stabilities are likely to exist, and many factors can determine the
compositions and equilibrium proportions. In such circumstances, however, the
conformational constraining effect imposed by the benzylidene group still contributes a
major impact towards the glycosylation pathways, and could be responsible for the
observed stereoselectivities.
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Scheme 1.12 Application of carbonate and oxazolidinone protecting groups in 1,2-cisglycosylation reactions.
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Inspired by the strong stereospecific effect of the 4,6-O-benzylidene group, the
strategy of using a 2,3-O-carbonate group as a conformationally constraining protecting
group has also been established.123 In many cases, 2,3-O-carbonate thioglucosides and
thiogalactosides have been shown to be good α-glycosylating agents, but these reactions
always relied on specific activators and/or solvent systems.124 Although neighboringgroup participation is unavailable due to the incorporated carbonate ring, some kinds of
2,3-O-carbonate donors also present β-stereoselectivity and have been used in the
synthesis of β-glycosides (Scheme 1.12a).125 Fortunately, there is not a huge gap for the
transition from a β- to an α-stereodirecting effect, and the corresponding switching
method has been developed. With the assistance of either a catalytic or stoichiometric
amount of Lewis acid, the β-stereospecificity of 4,6-di-O-benzyl-2,3-O-carbonate
thioglucoside was inverted completely to α-selectivity (Scheme 1.12b).126 Moreover, the
carbonate

group

deactivates

the

glycosyl

donors

both

electronically

and

conformationally. Thus, the disarming effect enables them to serve as acceptors at the
same time in an orthogonal glycosylation synthesis, where chemoselective activations of
other armed glycosyl donors can be performed.
The 2,3-N,O-oxazolidinone group has been used as an α-directing group in
glycosylation reactions as well, specifically in the preparation of α-linked 2-amino-2deoxyglycosides.127 However, side reactions may occur sometimes, and the nitrogen
atom on the oxazolidinone group has the propensity to undergo N-glycosylation or Nsulfenylation. Therefore, a revised method is to use N-acetylated oxazolidinone donors
(Scheme 1.12c).128 The stereospecificity of the donors in glycosylations can also be
adjusted by tuning the reaction conditions such as relative reactivity, configuration of the
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acceptors, and the activation systems. For example, the N-acetylated oxazolidinone
donors were β-stereoselective when applying the NIS/AgOTf activation system; when an
excess amount of AgOTf was used, in situ anomerization would occur to generate α
products. Meanwhile, the torsional oxazolidinone ring played a key role, as an endocyclic
C-1–O-5 bond cleavage pathway was found to be operative.129 The employment of Nbenzyl-2,3-oxazolidinone thioglycosides as glycosyl donors for α-glycosylations was
reported recently, and satisfactory yields and selectivities were observed.130
Silyl groups are among the most frequently used protecting groups in
carbohydrate synthesis based on their high stability and of easy operation. However, it
was until the recent applications of di-tert-butylsilylene (DTBS) protecting group in 1,2cis-galactosylations that their stereodirecting ability had been widely recognized.131,

132

Since then, cyclic bifunctional silyl protecting glycosyl donors had been largely applied
in the stereoselective syntheses of glycosides.133 Compared with mono-substituted silyl
protected donors, cyclic bifunctional silyl protecting groups exhibit stronger governance
on the stereoselectivity of glycosylation through rigidifying the donor ring conformation
and imposing steric hindrance during glycosylation. For example, the 1,1,3,3tetraisopropyldisiloxane-protected thiofructofuranoside 87 was synthesized as a
stereospecific donor (Scheme 1.13a).134 The highly bulky silyl group blocks the α-face of
the donor to guarantee a completely β-glycosylation with the glycosyl acceptor.
The employment of DTBS-protected donors is becoming a popular method for the
construction of 1,2-cis glycosidic bonds, especially in the syntheses of α-galactosides. It
has been demonstrated that DTBS-protected galactosyl donors are able to glycosylate
various acceptors to get the corresponding α-galactosides exclusively. Even if
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Scheme 1.13 Application of cyclic silyl protecting groups in directing 1,2-cisglycosylation reactions.
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neighboring participating groups such as benzoyl (Bz) or 2,2,2-trichlorethoxycarbonyl
(Troc) were installed at C-2 (Scheme 1.13b), high α-selectivities were also observed,
which revealed the convincing effect of DTBS group.22,131 132A plausible mechanism has
been proposed to account for the powerful α-directing effect of DTBS group. As for the
galactopyranoside, it has been demonstrated that the axially oriented oxygen at C-4
contributes electrons to stabilize the generated oxocarbenium ion during the glycosylation
process, which is called “through-space electron donation”.135 This effect steadies the
intermediate and prevents the neighboring groups with moderate nucleophilicity from
participating. Meanwhile, the bulky tert-butylsilylene group entails a closer positioning to
the anomeric center, and prevents the nucleophilic acceptors to add from the β-side.133
Besides its applications in galactosylations, the DTBS group was also incorporated into
arabinofuranoside to obtain a conformationally constrained donor to control the anomeric
configuration. Glycosylations were performed to have expected β-selectivity with many
acceptors, which claimed its potential in the construction of β-arabinoside domains from
lipoarabinomannan and mycobacterial arabinogalactan (Scheme 1.13c).136, 137
1.3.3 Protective group free glycosylations
Generally, a well-established glycosyl donor should contain the following
properties, which are, (a) easy accessibility; (b) high generality for various alcohols and
glycosyl acceptors; (c) applicability with alternative reaction conditions or catalysts; (d)
high efficiency on both yield and stereoselectivity. Adopting unprotected glycosyl donors
directly into the glycosylations is an appealing strategy. Unprotected glycosyl donors
often hold higher reactivities, and their usage avoids the cumbersome protection and
deprotection processes. Despite the tremendous growth of glycosylation strategies over
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the past century, the original Fischer glycosidation method is still the most utilized
method for glycosylations with simple alcohols. Fischer glycosidation refers to the
reaction of a cyclic hemiacetal (a free sugar) with an alcohol to form a glycoside by the
catalysis of an acid, which named after Emil Hermann Fischer who devloped this method
a century ago (Scheme 1.14a).138 The Fischer glycosidation involves an equilibrium
process, and usually it is shifted by the treatment of an excess amount of alcohol, acid
catalyst, high temperature and long reaction times. This strategy often provides a mixture
of stereoisomeric products, of which the alpha anomer is normally the major product, as
it is the most thermodynamically stable product owing to the anomeric effect. Up to now,
the traditional Fischer glycosidation has been enhanced by exploiting different kinds of
acid catalysts139 and reaction conditions, such as microwave irradiation140 and
ultrasonication.141 However, since free carbohydrates have limited solubility in alcohols,
it usually requires harsh conditions (e.g., high temperature, microwave, ultrasonication)
to push the reaction, which results in decomposition of the products, encroachment of
side products, and tedious separation processes.

Scheme 1.14 Glycosylation by unprotected glycosides.
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Some

kinds

of

unprotected

glycosyl

donors,

such

as

glycosyl

trichloroacetimidates and 3-methoxy-2-pyridyloxy (MOP) glycosyl donors, were applied
into α-stereodiecting glycosylations.142 However, drawbacks including low stability and
limited generality, impair their versatility. Later, advanced unprotected glycosyl donors
were prepared to rise to the challenges. The glycosylations using unprotected alkynyl
glycosyl donors under the activation of gold(III) have been reported (Scheme 1.14b).143
Several terminal alkynyl glycosides were glycosylated with various primary alcohols in
excess amount under reflux in acetonitrile and 5% AuCl3. The 2-butynyl glycosides were
most reactive, giving good yields with moderate to high α-selectivities. The secondary
alcohols were also tested but showed reduced efficiency.
A rencent study investigated the photoinduced O-glycosylation of unprotected
deoxythioglycosides (Scheme 1.6b). It was revealed that glycosylations could be
performed with alcohols in the presence of DDQ and long-wavelength UV irradiation to
give respectable yields and α-selectivities. It has also been demonstrated that pmethoxyboronic acid could temporarily protect the 1,3-diols (C-4 and C-6 positions) to
prevent self-coupling of the donor or formation of a 1,6-anhydroglycoside.86
1.4. Conclusions and Outlook
The advances of chemical glycosylation strategies summarized herein have
significantly enriched our tactics to build various glycosidic linkages and access complex
oligosaccharides and glycoconjugates of great biological importance. Nevertheless, it is
still too early to claim that all roughness associated with glycosidic bond formation has
been smoothed. Carbohydrates are amongst the most complicated biomolecule systems in
nature, and a variety of aspects, including the glycosyl donor type, protecting groups,
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activator/catalyst, and reaction conditions, are influential or decisive to the glycosylation
outcomes. Even for the construction of a simple oligosaccharide molecule, a carefully
designed synthetic route and a meticulous experimental operation are often required to
obtain the target molecule in high yield and selectivity. Therefore, development of
general, efficient, and flexible strategies to achieve the intrinsic organizational diversity
of carbohydrates is still imperative.
How do we reach this ultimate goal? From my perspective, a continuous
screening of alternative glycosyl donors and protecting groups may not spark
fundamental advancement of the current approaches for glycosylations. Instead, more
concerns should be put into the discovery of glycosylation mechanistic principles and the
driving forces behind these reactions. There has been proposed many sorts of
glycosylation pathways and intermediates, such as generations of oxacarbenium triflate
ion-pair and solvent separated ion-pair, conformation-dependent reactivity, H-bonding
stereodirecting effects, and so forth, but none of these can be completely demonstrated. A
comprehensive understanding of glycosylation mechanisms will be beneficial for further
advances in glycosylations and to generate innovations, such as the development of
“enzyme-like catalysts”. The enzyme-like catalyst will not only have comparable
properties as enzymes such as transglycosidases or glycosyl transferases with high
selectivities and a minimum of protections, but these reagents also exhibit superior
glycosylation performance with respect to stability and efficiency, and availability in
industrial production. It could specifically detect the target glycosides, and provide the
platform and the activation required. It is inspiring that some preliminary attempts have
been performed to obtain glycosides in great regio- and stereoselectivity.144, 145
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Chapter 2 1,2-cis Alkyl Glycosides: Straightforward
Glycosylation from Unprotected 1-Thioglycosyl Donors
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Abstract
A 1,2-cis-alkyl glycosidation protocol that makes use of unprotected phenyl 1thioglycosyl donors is reported. Glycosylation of various functionalized alcohols was
accomplished in moderate to high yield and selectivity to give the 1,2-cis-glycosides. In
order to quickly develop optimum glycosylation conditions, an FIA (flow injection
analysis)–ESI-TOF-MS method was developed that enabled rapid and quantitative
evaluation of yield on small scale. This methodology, coupled with NMR spectroscopy,
allowed for rapid evaluation of the overall reactions.
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2.1 Background
As

essential

components

in

the

cell

membrane,

carbohydrates

and

glycoconjugates serve many protective, stabilizing, organizational, barrier, and
recognition functions.1 The chemical synthesis of these glycoconjugates, including
proteoglycans, glycolipids, and glycoproteins, is in great demand for biological studies of
their functions as cell-wall components that are collectively termed the glycocalyx.
Anomerically pure alkyl glycosides serving as fundamental building blocks are in
demand to achieve the stereoselective synthesis of these cell-wall structures. Some alkyl
glycosides, such as propargyl2 and allyl3 glycosides are simple approaches for the
construction of microarrays4, 5 and glycodendrimers.6
Generally, 1,2-trans-alkyl glycosidation can be reliably achieved via neighboringgroup participation of a C-2 acyl group on a glycosyl donor, while stereochemical control
for 1,2-cis-alkyl glycosidation can be challenging.7 The conventional Fischer
glycosidation reaction, a straightforward way to afford short-chain, uncomplicated,
thermodynamically favored 1,2-cis alkyl glycosides, has been improved by using various
acid catalysts,8–10 microwave irradiation,11 ultrasonication,12 and ionic liquids.13 Since
free sugars have limited solubility in longer-chain alcohols (acceptors), harsh conditions
(e.g., high temperature, microwave, ultrasonication) are often required to push the
reaction, which results in decomposition of the products,8 formation of various side
products,

time-consuming

separation

processes,

and

low

yields

and

poor

stereoselectivities. Ether protecting groups, most often the benzyl group, are routinely
used for protecting free hydroxyl groups in the synthesis of 1,2-cis-glycosides,14 but
benzyl deprotection by H2/Pd will destroy a number of groups (alkene, alkyne, nitro,
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halogen) on functionalized alkyl glycosides.15 The elegant intramolecular aglycon
delivery (IAD) approach offers a stereospecific 1,2-cis-glycosidic synthesis, albeit from
selectively protected intermediates.16–19
In principle, many of these issues can be circumvented through conversion of an
unprotected glycosyl donor directly into the desired 1,2-cis alkyl glycosides.
Glycosylation by an unprotected sugar donor has several practical values: 20 the often
tedious protection and deprotection process can be avoided;21 unprotected donors possess
higher reactivity compared to O-acyl-protected donors, and the better solubility of
unprotected donors in short-chain alcohols (acceptors) enables glycosylation at lower
temperatures, which reduces the formation of by-products.
Mamidyala and Finn have reported glycosylation using unprotected alkynyl
donors and AuCl3 as an effective activator.22,

23

Very recently, Nitz and co-workers

reported glycosidation in relatively good yields using a protecting-group-free protocol
with 1-p-toluenesulfonyl hydrazide and glycosyl chloride donors; however, anomeric
selectivities were generally lacking.24 Among the various classes of glycosyl donors,
phenyl 1-thioglycosyl compounds have been regarded as ideal choices for donor
precursors (including precursors for light-induced glycosidation21) because they are
stable, easily synthesized, and for the most part, crystalline.25 Herein, I report a 1,2-cisalkyl glycosidation protocol that makes use of unprotected phenyl 1-thioglycosyl
donors.21
2.2 Glycosidations
Phenyl 1-thio-β-D-galactopyranoside (1a)26 and propargyl alcohol (2a) were
selected as the unprotected glycosyl donor and acceptor, respectively, for the model
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glycosylation reaction (Table 2.1). Initially, the reaction was carried out between 1a and
dry 2a (40 equiv) under the activation of N-iodosuccinimide (NIS)/trimethylsilyl triflate
(TMSOTf). The desired product was obtained in respectable yield and stereoselectivity
(Table 2.1, entry 1). TLC analysis of the crude product showed only the desired α,β
isomers. Further experiments revealed other Lewis acids, BF3·OEt27 and TfOH27, that
used for 1,2-cis-glycosidations, provided similar yields and stereoselectivities, while
H2SO4·SiO29 gave a lower yield (a result also reported from another laboratory28) but
higher stereoselectivity (entries 2−4). I surmise that the results may be due to the
heterogeneity of the H2SO4·SiO2 catalyst. The bisulfate counterion would be trapped in
the silica gel matrix, leading to the formation of a loosely solvent-separated ion pair
(SSIP) between the bisulfate counterion and the oxocarbenium ion, suggesting a
unimolecular (SN1) favored transition state and better α selectivity due to the anomeric
effect.29–31 I also examined the activation by Lewis acids and N-bromosuccinimide
(NBS). As anticipated, relatively lower yields and stereoselectivities were observed
(entries 5 and 6), which could be attributed to the diminished electrophilic properties of
the bromonium ion. Moreover, experimentation showed that glycosylation was most
favored when the amount of alcohol was in the range of 40–60 equiv (entries 1–3 and 9
vs. entries 7–8 and 10). Experiments further demonstrated neither TMSOTf nor NIS
alone was able to trigger the glycosylation reaction (entries 11 and 12).
2.3 Rapid High-Throughput Screening of Reactions
In order to rapidly evaluate and optimize glycosylation conditions for a number of
reactions, I adapted the concept of high-throughput screening using mass spectrometry
similar to that reported by Ito and co-workers, who employed MALDI-TOF-MS.32, 33
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Table 2.1 Optimization of reaction conditionsa

Entry

Lewis acid

Halogen
source

1
2
3
4
5
6
7
8
9
10
11
12

TMSOTf
BF3∙OEt2
TfOH
H2SO4∙SiO2
TMSOTf
BF3∙OEt2
TMOSTf
TMSOTf
TMSOTf
TMSOTf
TMSOTf
None

NIS
NIS
NIS
NIS
NBS
NBS
NIS
NIS
NIS
NIS
None
NIS

a

Propargyl
alcohol
(mol equiv)
40
40
40
40
40
40
20
30
60
100
40
40

Yield (%)b

α:βc

75
74
76
52
59
38
50
53
76
58
0
0

10:1
10:1
9:1
15:1
5:1
5:1
7:1
10:1
10:1
11:1
-

The reaction was conducted using 0.37 mmol of 1a, 1.03 mmol of NIS/NBS, and

0.07 mmol of Lewis acid. bThe yield was determined after acetylation by FIA–ESI-TOFMS. cThe anomeric ratio was determined by integration of H-1 in the 1H NMR spectrum
of the crude product.
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In the reactions with small molecules, I used a coupled flow-injection system with ESITOF-MS (FIA–ESI-TOF-MS) that enabled quantitative evaluation of glycosylation yield
with products of MW <500 amu. Furthermore, the method provided a more accurate
estimation of yield in two ways: (1) An average value from a certain volume of sample
(e.g., 2.5 μL with our flow-injection equipment) was evaluated rather than a tiny spot
excited by the laser on MALDI. (2) Integration of the ion intensity peaks was used to
calculate yield instead of the m/z peak height as in the MALDI method.32, 33
In order to provide an internal standard for the FIA–ESI-TOF-MS studies,
propargyl α-D-galactopyranoside (3a, Scheme 2.1) was acetylated with Ac2O-d6 to afford
the per-deuterated glycoside 4. While it is known that the ionizing properties of
deuterated and nondeuterated glycosides are nearly identical,32 the fact was confirmed in
this study specifically for these compounds. The FIA–ESI-TOF-MS responses were
found essentially the same for either the 1H- or 2H-labeled compounds, thus facilitating a
relatively uncomplicated rapid analysis of the reactions.

Scheme 2.1 Synthesis of deuterated glycoside substrate as the internal standard.
2.3.1 Flow-injection–ESI-TOF-MS (FIA–ESI-TOF-MS) instrumentation
The QStar Elite mass spectrometer was outfitted with a flow-injection analysis
(FIA) device to provide rapid and effective injection of multiple samples for ESI-TOFMS analysis. A picture of the FIA equipment is shown in Figure 2.1.
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Figure 2.1 Flow-injection device outfitted on QStar Elite TOF-MS instrument. A:
Dionex Ultimate fully integrated micro-, capillary-, and nano-HPLC system (Sunnyvale,
CA, USA), B: 6-Port manual injection valve (Rheodyne, Rohnert Park, CA), and C: AB
Sciex QSTAR Elite triple quadrupole time-of-flight (QTOF) mass spectrometer
(Concord, Ontario, Canada) with an ESI ion source.
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FIA–ESI-TOF-MS conditions
• FIA flow
– Solvent: MeOH
– Flow rate: 120 μL/min
• Manual injection
– Sample concentration: 10 μg/mL; 25 μL diluted to 1.00 mL with MeOH for injection
– Loop volume: 2.5 μL
– Syringe size: 250 μL
– Injections at 2-min intervals; 10 times each
2.3.2 High-throughput screening/reaction optimization by flow-injection analysis–
ESI-TOF-MS (FIA–ESI-TOF-MS)
Before the screening for glycosylation conditions, I carefully examined whether
the ionizing properties of deuterated and nondeuterated glycoside isomers are identical.
To establish a quantitative calibration curve, deuterium-labeled glycoside solution [10
μg/mL, propargyl 2,3,4,6-tetra-O-(acetyl-d3)-α-D-galactopyranoside (4)] and non-labeled
glycoside solution [propargyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4a)] were
prepared separately, mixed in five concentration ratios, and diluted to the same volume
by MeOH to afford five standards (Table 2.2). A six-port manual injection valve was
installed between the LC pump and the ESI-QTOF instrument. MeOH was chosen as the
FIA solvent. Each sample was injected into the six-port manual injection valve with a
2.5-μL sample loop and analyzed by ESI-QTOF-MS for 10 replicates. Non-labeled
glycoside ([MH+Na]+ ion) and labeled ([MD+Na]+ ion) were observed at m/z 409 and m/z
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[C ]

PA

Table 2.2 Comparison of [CH] a and PAH b
D

Standard

[CH ] a
[CD ]

[PAH ] b

1

0.2

0.2061

0.0095

2

0.4

0.3955

0.0094

3

1

0.9946

0.0158

4

2.5

2.5619

0.0354

5

5

5.2201

0.4221

entry

a

D

[PAD ]

deviation

Concentration ratios of non-labeled standards/labeled standards. b Peak area ratios using

isotope-diluted FIA–ESI-TOF-MS.
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Figure 2.2 ESI-TOF-MS of product 4a ([MH+Na)+] ion at m/z 409) and internal standard
(deuterated) 4 ([MD+Na)+] ion at m/z 421).
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Figure 2.3 Relationship between concentration ratios of standards ([𝐂𝐇]) and peak area
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𝐃

73

421, respectively (Figure 2.2). Integration of peak areas under extracted peak profiles at
m/z 409 and m/z 421 were performed, and peak area ratios were calculated for each entry.
The results indicated that the ionizing properties of the deuterated and nondeuterated
glycoside isomers are almost identical, which enables quantification of the nondeuterated
glycoside when deuterated glycoside is added as an internal standard (Figure 2.3).
For a general analytical method, the internal standard was dissolved in CH2Cl2 to
afford a 10 μg/mL solution. The crude product (non-labeled glycoside) was also
dissolved in CH2Cl2 to get an estimated 10 μg/mL solution. Samples (20 μL) of both
labeled and non-labeled solutions were mixed and diluted with MeOH to get a 1 mL of
solution. The solution was injected into the six-port injection valve, and the injection was
repeated 10 times at 2-min intervals. The peaks of labeled ([MD+Na]+ ion at m/z 421) and
non-labeled ([MH+Na]+ ion at m/z 409) glycoside were observed (Figure 2.2). After
analyzing the ratio of the two peak areas, the concentration of the non-labeled glycoside
solution was obtained.
2.3.3 Optimization studies and scope of the reaction
Optimization studies were conducted as in the following paragraphs in which
several solvents and solvent mixtures were examined. The conditions were those of Table
2.1, with variations. The effect of N,N-dimethylformamide (DMF) in the solvent on
stereoselective α-glycosylation has been well documented,34 and I anticipated that adding
a catalytic amount of DMF might promote the formation of the 1,2-cis-glycosidic bond.
After screening with added DMF, other solvents, including CH2Cl2, THF and Et2O (0.2
equiv), were examined; however, no obvious improvement in yield or α selectivity was
observed with any of these additives, and a further increase of the amount of solvent

74

added (6 equiv) led to a decrease in stereoselectivity and yield, which indicates that a neat
alcohol environment is essential for optimum glycosylation under these conditions.
With the appropriate conditions for 1,2-cis-alkyl glycosidation in hand, I
investigated the scope of the reaction with several unprotected glycosyl donors and
alcohols bearing various functional groups. (See Table 2.3.) The stereoselectivity of
glycosylation with unprotected

D-glucose, D-mannose

and disaccharide donors and

propargyl alcohol spanned from modest to high (Table 2.3, entries 1, 9−12). It is
noteworthy that the major product from phenyl 1-thio-α-D-mannoside is the β (cis)
anomer (Table 2.3, entry 10) that is formed. Glycosylation with various functionalized
alcohols was accomplished without difficulty (Table 2.3, entries 2−8). A variety of
groups on alcohols were tolerated to provide the corresponding 1,2-cis-substituted-alkyl
glycosides. These results indicate the generality and applicability of the present
glycosylation method.
2.4 Proposed Mechanism
A mechanistic explanation of the observed results from these glycosylations is no
doubt complex, as numerous alcohol–substrate–Lewis acid reagent associations
(including H-bonding interactions) are possible and difficult to sort out. I presume the
role of NIS/TMSOTf is critical for the activation of related systems.35,

36

Perhaps

noteworthy is the fact (Table 2.3, entry 13) that a 2-deoxy-1-thioglycoside (1f), an analog
of 1a, gives a significantly diminished α selectivity of only 1.7:1, possibly indicating a
special role for the 2-OH group that might coordinate with the reagent alcohol and
account for the generally higher cis-selectivities in the other examples. The role of such
H-bonding in stereoselection in glycosylation has been addressed in many articles.37-41
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Table 2.3 Scope of the reactiona
Entry

Donor

Acceptor

Product

1

% Yieldb

α:βc

75

10:1

2d

1a

62

10:1

3

1a

71

7:1

4

1a

93e

5:1f

5g

1a

85

5:1

6d

1a

56

3:1

7d

1a

42

> 20:1

8d

1a

72

3:1

9

2a

79

7:1

10

2a

81

1:2

11

2a

69

8:1

12

2a

57

12:1

13

2a

67

1.7:1
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a

For details of the synthetic procedures, see the Experimental Section.

b

Isolated yield

after acetylation of the products to give 4a–4m except for 3d. c The anomeric ratio was
determined by integrating the 1H NMR spectrum of the crude product. d The reaction was
performed at −10 °C.

e

Isolated yield without acetylation.

f

The anomeric ratio was

determined from isolated products. g The reaction was performed at 0 °C.

Scheme 2.2 Plausible mechanism.
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A mechanism for the 1,2-cis-glycosylation (Scheme 2.2) is proposed based on the
analysis above. Upon the activation of the iodonium ion28 generated by NIS/TMSOTf,
the phenyl 1-thioglycoside is converted to an oxocarbenium ion, which traps the triflate
counterion to form an oxocarbenium–triflate ion pair.29 The generally good solubility of
the unprotected donors in alcohols (acceptors) indicates H-bond formation, one of which
will coordinate the 2-OH with the oxygen of the alcohol, increasing its nucleophilicity30
and steering the nucleophilic attack for cis selectivity via a five-membered ring transition
state. A final deprotonation step achieves the 1,2-cis glycosides, which is in accordance
with the fact that only catalytic amount of Lewis acid is needed.
2.5 Experimental Section
2.5.1 General methods
All chemicals were purchased as reagent grade and used without further
purification, unless otherwise noted. Alcohols that were opened and stored for a period of
time were pre-dried by Drierite® (anhyd calcium sulfate). Reagent grade dichloromethane
(CH2Cl2), diethyl ether (Et2O), tetrahydrofuran (THF), methanol (MeOH), N,Ndimethylformamide (DMF) and toluene were obtained from the Pure-Solv (Innovation
Technologies) solvent system that uses alumina columns except for DMF, which was
dried over a column of 5 Ǻ molecular sieves. Pyridine was distilled over CaH 2 prior to
use. All reactions were performed under anhydrous conditions unless otherwise noted.
Reactions were monitored by thin-layer chromatography (TLC) on silica gel precoated
aluminum plates. Zones were detected by UV irradiation using a 254 nm lamp and/or by
heat/charring with p-anisaldehyde–sulfuric acid development reagent.42 Column
chromatography was performed on silica gel (40−63 μm). Optical rotation values were
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obtained at the sodium D line using a Perkin–Elmer 241 polarimeter. 1H (500 MHz) and
13

C NMR (125 MHz) spectra were recorded at room temperature with a Varian Inova 500

MHz instrument. Chemical shifts are reported in δ-units (ppm) relative to the residual 1H
CDCl3 at δ 7.26 ppm and 13C at δ 77.16 ppm. All two-dimensional experiments (gCOSY,
gHSQC and gHMBC) were recorded on the same instrument using Varian protocols.
Mass spectrometric analysis was performed on a QSTAR Elite quadrupole time-of-flight
(QTOF) mass spectrometer with an ESI source.
2.5.2 General synthetic procedures
(1). Synthesis of the phenyl thioglycoside donors 1a–1f26
The selected free sugar (5.0 g, 27.8 mmol for D-galactose, 1.0 g, 5.6 mmol for Dglucose, D-mannose and 2-deoxy-D-galactose, and 1.0 g, 2.9 mmol for disaccharide) was
suspended in a mixture of NaOAc (2.50 g, 30.5 mmol for D-galactose, 0.50 g, 6.1 mmol
for other sugars) and Ac2O (25 mL, 262.3 mmol for D-galactose, 5 mL, 52.5 mmol for
other sugars), and the mixture was heated under an N2 atmosphere to 70 °C. After 24 h,
the yellow solution was cooled to room temperature, poured onto ice and quenched with
satd aq NaHCO3. The aqueous phase was extracted with CH2Cl2 (3 × 50 mL). The
organic extract was washed successively with water and brine, dried over anhyd Na2SO4,
and concentrated to afford the per-acetylated sugar as a solid that was used directly
without further purification.
Thiophenol (3.60 mL, 35.2 mmol for the per-acetylated D-galactose; amounts for
the other sugars were adjusted correspondingly) was then added to a solution of peracetylated sugar (10.6 g, 27.1 mmol) in dry CH2Cl2 (20 mL) at 0 °C, and the mixture
were stirred for 30 min. Then BF3·Et2O (10.3 mL, 81.3 mmol) was slowly injected into
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the mixture, which was allowed to warm to room temperature. After 5 h, the mixture was
diluted by CH2Cl2, washed with satd aq NaHCO3 and brine, dried over anhyd Na2SO4,
concentrated in vacuo, and purified by column chromatography (hexanes–EtOAc 5:1,
hexanes–EtOAc 2.5:1 for the disaccharides) to afford the per-acetylated phenyl
thioglycoside as a colorless syrup.
The per-acetylated phenyl thioglycoside (22.5 mmol for per-acetylated phenyl 1thio-D-galactoside, amounts for other sugars were reduced correspondingly) was then
dissolved in dry MeOH (20 mL), followed by the addition of a small amount of NaOMe
to afford pH 9. After 2 h the solution was quenched by the addition of Amberlite ® IR 120
(H+) resin. The resin was filtered off, and the solvent was removed in vacuo to afford the
unprotected phenyl thioglycoside donor as a white powdery solid.
Literature reports for the phenyl thioglycosides 1a–c and 1e are as follows:
phenyl 1-thio-β-D-galactopyranoside (1a),26 phenyl 1-thio-β-D-glucopyranoside (1b),43
phenyl 1-thio-α-D-mannopyranoside (1c),44 and phenyl β-D-galactopyranosyl-(1,4)-1thio-β-D-glucopyranoside

(1e).45

Phenyl

α-D-galactopyranosyl-(1,6)-1-thio-β-D-

glucopyranoside (1dβ), a new compound, was prepared as in the foregoing paragraphs
and is characterized NMR spectroscopy and high-resolution MS in the following
paragraph.

Scheme 2.3 Synthesis of phenyl α-D-galactopyranosyl-(1,6)-1-thio-β-D-glucopyranoside
(1dβ).
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1

H NMR (500 MHz, CD3OD): δ 7.56–7.54 (m, 2H), 7.36–7.33 (m, 2H), 7.29–

7.26 (m, 1H), 4.89 (d, J = 3.5 Hz, 1H, H-1’), 4.70 (d, J = 9.8 Hz, 1H, H-1), 3.92 (dd, J =
10.8, 6.1 Hz, 1H), 3.88 (ddd, J = 6.6, 5.6, 1.4 Hz, 1H), 3.83 (m, 1H), 3.80–3.73 (m, 3H),
3.70 (m, 2H), 3.59–3.56 (m, 1H), 3.43 (t, J = 8.8 Hz, 1H), 3.37 (m, 1H), 3.27 (dd, J = 9.8,
8.6 Hz, 1H).

13

C NMR (125 MHz, CD3OD): δ 135.29, 132.15, 130.01, 128.26, 100.10,

89.04, 80.29, 79.65, 73.92, 72.11, 71.53, 71.49, 71.12, 70.38, 67.94, 62.84. HRESIMS:
(m/z) (M+Na)+ calcd for C29H38O18Na+ 457.1144; found 457.1146.
(2). Glycosylation to give glycosides 3a–3m.
Phenyl 1-thiogalactoside donor 1a (100 mg, 0.37 mmol) was dissolved in
propargyl alcohol (2a, 0.87 mL, 0.82 g, 14.71 mmol), followed by the addition of preactivated powdered 4 Å molecular sieves (150 mg), and stirring was continued for 1 h
under nitrogen at room temperature. Then the mixture was cooled to −30 °C, and NIS
(232 mg, 1.03 mmol) and TMSOTf (13.3 μL, 0.074 mmol) were added, which made a
black (maroon with most other alcohols) solution. After 2 h, satd aq Na2S2O3 was added
to quench the reaction, and the dark color faded. The mixture was then filtered through
Celite®, and the solution was concentrated in vacuo to give crude 3a. Other alcohols were
reacted in a similar manner to give glycosides 3b–3m.
(3). Acetylation of alkyl glycosides to give per-acetylated glycosides 4a–4c and 4e–
4m
The residue from the foregoing step (3a) was dissolved in dry pyridine (10 mL),
and 4-(dimethylamino)pyridine (DMAP, catalytic amt.) and Ac2O (1 mL, 10.6 mmol)
were added with stirring overnight at room temperature. After concentrating the mixture,
the residue was partitioned between EtOAc and water, and the organic layer was washed
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with satd aq NaHCO3 and brine, dried over anhyd Na2SO4, and concentrated in vacuo to
afford the crude product 4a. In a similar manner compounds 4b–4c, 4e–4m were
prepared.
2.5.3 Experimental data for compounds 3d, 4, 4a–4c and 4e–4m

Scheme 2.4 Synthesis of propargyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4a).
The compound was synthesized according to the general glycosylation and
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel
chromatography (5:1 to 4:1, hexanes–EtOAc) to give 4a (106.7 mg, 75.1%, α/β = 10:1)
as a mixture of isomers. 4aα: Rf 0.23 (2.5:1, hexanes–EtOAc). [α]D20 +148.5 (c 1.00,
CHCl3). 1H NMR (500 MHz, CDCl3): δ 5.46 (1H, dd, J = 3.4, 1.4 Hz, H-4), 5.36 (1H, dd,
J = 10.9, 3.4 Hz, H-3), 5.32 (1H, d, J = 3.6 Hz, H-1), 5.17 (1H, dd, J = 10.9, 3.7 Hz, H2), 4.27 (2H, dd, J = 2.4, 1.0 Hz, CH2−C≡CH), 4.25 (1H, m, H-5), 4.11-4.09 (2H, m, H6a, H-6b), 2.45 (1H, t, J = 2.4 Hz, CH2−C≡CH), 2.14, 2.08, 2.04, 1.98 (12H, 4s,
4×COCH3). 13C NMR (125 MHz, CDCl3): δ: 170.50, 170.48, 170.29, 170.05 (4×COCH3)
95.08 (C-1), 78.39 (CH2−C≡CH), 75.32 (CH2−C≡CH), 68.11 (C-4), 67.88 (C-2), 67.53
(C-3), 66.94 (C-5), 61.63 (C-6), 55.43 (CH2−C≡CH), 20.91, 20.83, 20.78, 20.77
(4×COCH3). HRESIMS: (m/z) calcd for C17H22O10Na+ (M+Na)+ 409.1111; found
409.1114. Compound 4a has been reported (NMR spectral data match those above) from
the silica gel/H2SO4 glycosidation of the free sugar, a process I was unable to duplicate in
yield and purity.9 A similar problem has been reported by at least one other laboratory.28
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Scheme 2.5 Synthesis of propargyl 2,3,4,6-tetra-O-(acetyl-d3)-α-D-galactopyranoside (4).
Compound 3a (64.3 mg, 0.295 mmol) was dissolved in dry pyridine (10 mL), and
DMAP (catalytic amt.) and Ac2O-d6 (0.56 mL, 5.92 mmol) was added with stirring
overnight at room temperature. After concentration, the residue was partitioned between
CH2Cl2/water, and the organic layer was washed with satd aq NaHCO3 and brine, dried
over anhyd Na2SO4 and concentrated in vacuo. The crude product was purified by silica
gel chromatography (4:1 hexanes–EtOAc) to give 4 (106.1 mg, 90.4%) as a colorless
syrup. Rf 0.23 (2.5:1, hexanes–EtOAc). [α]D21 +148.2 (c 1.00, CHCl3). 1H NMR (500
MHz, CDCl3): δ 5.46 (1H, dd, J = 3.4, 1.4 Hz, H-4), 5.36 (1H, dd, J = 10.9, 3.3 Hz, H-3),
5.31 (1H, d, J = 3.8 Hz, H-1), 5.16 (1H, dd, J = 10.9, 3.7 Hz, H-2), 4.26 (2H, dd, J = 2.4,
1.1 Hz, CH2−C≡CH), 4.25 (1H, m, H-5), 4.10 (2H, m, H-6a, H-6b), 2.45 (1H, t, J = 2.4
Hz, CH2−C≡CH).

13

C NMR (125 MHz, CDCl3): δ 170.49 (×2), 170.30, 170.05

(4×COCH3) 95.06 (C-1), 78.38 (CH2−C≡CH), 75.31 (CH2−C≡CH), 68.06 (C-4), 67.83
(C-2), 67.48 (C-3), 66.93 (C-5), 61.58 (C-6), 55.42 (CH2−C≡CH). HRESIMS: (m/z)
calcd for C17H10D12O10Na+ (M+Na)+ 421.2050; found 421.2048.

Scheme 2.6 Synthesis of 3-(trimethylsilyl) propargyl 2,3,4,6-tetra-O-acetyl-α-Dgalactopyranoside (4b).
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The compound was synthesized according to the general glycosylation and
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel
chromatography (5:1 to 4.5:1, hexanes–EtOAc) to give 4b (104.9 mg, 62.2%, α/β = 10:1)
as a mixture of anomers. 4bα: Rf 0.37 (2.5:1, hexanes–EtOAc). [α]D20 144.4 (c 1.00,
CHCl3). 1H NMR (500, CDCl3 MHz): δ 5.46 (1H, dd, J = 3.4, 1.3 Hz, H-4), 5.38 (1H, dd,
J = 10.9, 3.4 Hz, H-3), 5.34 (1H, d, J = 3.7 Hz, H-1), 5.16 (1H, dd, J = 10.9, 3.7 Hz, H2), 4.26 (3H, m, CH2−C≡CH, H-5), 4.14-4.05 (2H, m, H-6a, H-6b), 2.14, 2.09, 2.04, 1.99
(12H, 4s, 4×COCH3), 0.17 (9H, s, −Si(CH3)3). 13C NMR (125 MHz, CDCl3): δ 170.51,
170.36, 170.34, 170.11 (4×COCH3), 99.92 (CH2−C≡C−TMS), 94.71 (C-1), 92.52
(CH2−C≡C−TMS), 68.11 (C-4), 67.93 (C-2), 67.56 (C-3), 66.84 (C-5), 61.58 (C-6),
56.05 (CH2−C≡C−TMS), 20.93, 20.83, 20.81, 20.79 (4×COCH3), -0.16 (−Si(CH3)3).
HRESIMS: (m/z) calcd for C20H30O10SiNa+ (M+Na)+ 481.1506; found 481.1507.

Scheme 2.7 Synthesis of allyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4c).
The compound was synthesized according to the general glycosylation and
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel
chromatography (5:1 to 4:1, hexanes–EtOAc) to give 4c (101. 2 mg, 70.9%, α/β = 7:1) as
a mixture of anomers. 4cα: Rf 0.29 (2.5:1, hexanes–EtOAc). [α]D20 +163.0 (c 1.00,
CHCl3). 1H NMR (500 MHz, CDCl3): δ 5.87 (1H, dddd, J = 17.2, 10.4, 6.1, 5.2 Hz,
CH2CH=CH2) 5.45 (1H, dd, J = 3.4, 1.3 Hz, H-4), 5.38 (1H, dd, J = 12.0, 3.4 Hz, H-3),
5.31 (1H, dq, J = 17.2, 1.6 Hz, CH2CH=CH2), 5.22 (1H, dq, J = 10.4, 1.3 Hz,
CH2CH=CH2), 5.15 (1H, d, J = 3.8 Hz, H-1), 5.12 (1H, m, H-2), 4.24 (1H, m, H-5), 4.18
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(1H, ddt, 13.1, 5.2, 1.4 Hz, H-6a/H-6b), 4.09 (2H, m, CH2CH=CH2), 4.02 (1H, ddt, 13.1,
6.1, 1.4 Hz, H-6a/H-6b), 2.13, 2.07, 2.04, 1.97 (12H, 4s, 4×COCH3). 13C NMR (125 MHz,
CDCl3): δ 170.50, 170.48, 170.33, 170.09 (4×COCH3), 133.34 (CH2CH=CH2), 118.12
(CH2CH=CH2), 95.47 (C-1), 68.90 (C-6), 68.25 (C-4), 68.21 (C-2), 67.73 (C-3), 66.49
(C-5), 61.86 (CH2CH=CH2), 20.91, 20.81, 20.78, 20.77 (4×COCH3). HRESIMS: (m/z)
calcd for C17H24O10Na+ (M+Na)+411.1267; found 411.1267. The β anomer of compound
4c has been characterized.46

Scheme 2.8 Synthesis of 2-nitroethyl α-D-galactopyranoside (3d).
The compound was synthesized according to the general glycosylation procedures
B.2 above (The compound partially decomposed when subjected to the acetylation
conditions). The crude product was purified by silica gel chromatography (15:1 to 7:1,
EtOAc–MeOH) to give 3d (86.6 mg, 93.0%, α/β = 5:1) as a mixture of anomers. 3dα: Rf
0.43 (3:1, EtOAc–MeOH). [α]D20 +24.7 (c 1.00, CH3OH). 1H NMR (500 MHz, CD3OD):
δ 4.94 (1H, d, J = 3.9 Hz, H-1), 4.78 (2H, m, OCH2CH2NO2), 4.33 (1H, ddd, J = 11.9,
5.8, 4.6 Hz, OCH2CH2NO2), 4.04 (1H, ddd, J = 11.9, 5.8, 4.6 Hz, OCH2CH2NO2), 3.96
(1H, dd, J = 3.3, 1.2 Hz, H-4), 3.85 (1H, m, H-5), 3.82 (1H, m, H-2), 3.79–3.72 (3H, m,
H-3, H-6a, H-6b). 13C NMR (125 MHz, CD3OD): δ 100.91 (C-1), 75.87 (OCH2CH2NO2),
72.60 (C-5), 71.24 (C-3), 71.05 (C-4), 69.90 (C-2), 65.06 (OCH2CH2NO2), 62.69 (C-6).
HRESIMS: (m/z) calcd for C8H15O8NNa+ (M+Na)+ 276.0695; found 276.0694.
Compound 3d has been reported.47 Partial characterization was by
spectroscopy (reported only seven peaks) in DMSO-d6.
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13

C NMR

Scheme

2.9

Synthesis

of

1,3-dichloro-2-propyl

2,3,4,6-tetra-O-acetyl-α-D-

galactopyranoside (4e).
The compound was synthesized according to the general glycosylation and
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel
chromatography (5:1 to 4:1, hexanes–EtOAc) to give 4e (143.1 mg, 84.9%, α/β = 5:1) as
a mixture of anomers.

4eα: Rf 0.38 (2:1, hexanes–EtOAc). [α]D22 +154.3 (c 1.00,

CHCl3). 1H NMR (500 MHz, CDCl3): δ 5.48 (1H, dd, J = 3.4, 1.3 Hz, H-4), 5.36 (1H, d,
J = 3.9 Hz, H-1), 5.34 (1H, dd, J = 11.0, 3.4 Hz, H-3), 5.08 (1H, dd, J = 11.0, 3.9 Hz, H2), 4.45 (1H, ddd, J = 6.9, 5.6, 1.1 Hz, H-5), 4.10 (2H, m, H-6a, H-6b), 4.00 (1H, m,
CH(CH2Cl)2), 3.74 (2H, d, J = 5.1 Hz, CH(CH2Cl)2), 3.66 (2H, m, CH(CH2Cl)2), 2.14,
2.08, 2.05, 2.00 (12H, 4s, 4×COCH3).

13

C NMR (125 MHz, CDCl3): δ 170.77, 170.49,

170.26, 170.07 (4×COCH3), 96.87 (C-1), 78.97 (CH(CH2Cl)2), 68.14 (C-2, C-4), 67.44
(C-3), 67.34 (C-5), 62.14 (C-6), 44.16, 43.59 (CH(CH2Cl)2), 20.93, 20.80, 20.79, 20.75
(4×COCH3). HRESIMS: (m/z) calcd for C17H24O10Cl2Na+ (M+Na)+ 481.0644; found
481.0645, 483.0619, 485.0626 (ratio of molecular ion isotopic peak heights ≈ 9:6:1).

Scheme 2.10 Synthesis of 3-bromopropyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside
(4f).
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The compound was synthesized according to the general glycosylation and
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel
chromatography (5:1 to 4.5:1, hexanes–EtOAc) to give 4f (96.5 mg, 56.0%, α/β = 3:1) as
a mixture of anomers. 4fα: Rf 0.37 (2:1, hexanes–EtOAc). [α]D20 +98.6 (c 1.00, CHCl3).
1

H NMR (500 MHz, CDCl3): δ 5.45 (1H, dd, J = 3.4, 1.4 Hz, H-4), 5.34–5.31 (1H, m, H-

3), 5.13 (1H, m, H-2), 5.12 (1H, d, J = 3.7 Hz, H-1), 4.23 (1H, m, H-5), 4.10 (2H, m, H6a, H-6b), 3.87 (1H, ddd, J = 9.9, 6.0, 5.0 Hz, one of OCH2CH2CH2Br), 3.58–3.49 (3H,
m, the other OCH2CH2CH2Br and two OCH2CH2CH2Br), 2.17–2.10 (5H, m,
OCH2CH2CH2Br, COCH3), 2.08, 2.04, 1.98 (9H, 3s, 3 × COCH3). 13C NMR (125 MHz,
CDCl3): δ 170.56, 170.49, 170.35, 170.20 (4 × COCH3), 96.63 (C-1), 68.26 (C-2), 68.19
(C-4), 67.69 (C-3), 66.56 (C-5), 65.96 (OCH2CH2CH2Br), 61.91 (C-6), 32.15
(OCH2CH2CH2Br), 30.17 (OCH2CH2CH2Br), 20.93, 20.86, 20.81, 20.78 (4×COCH3).
HRESIMS: (m/z) calcd for C17H25O10BrNa+ (M+Na)+ 491.0529, 493.0511; found
491.0526, 493.0502 (ratio of molecular ion isotopic peak heights ≈ 1:1). Compound 4f
has been reported.48 NMR spectral data match those above.

Scheme 2.11 Synthesis of 5-hexynyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4g).
The compound was synthesized according to the general glycosylation and
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel
chromatography (5:1 to 4.5:1, hexanes–EtOAc) to give 4g (66.3 mg, 42.1%, α/β > 20:1)
as a colorless syrup. 4gα: Rf 0.38 (2:1, hexanes–EtOAc). [α]D20 +139.1 (c 1.00, CHCl3).
1

H NMR (500 MHz, CDCl3): δ 5.45 (1H, dd, J = 3.4, 1.3 Hz, H-4), 5.36–5.32 (1H, m, H87

3), 5.12 (1H, m, H-2), 5.10 (1H, d, J = 3.4 Hz, H-1), 4.21 (1H, m, H-5), 4.10 (2H, m, H6a, H-6b), 3.73 (1H, dt, J = 9.9, 6.1 Hz, one of OCH2CH2CH2CH2−C≡CH 3.45 (1H, dt, J
= 9.9, 6.3 Hz, the other one of OCH2CH2CH2CH2−C≡CH), 2.23 (2H, tdd, J = 6.9, 2.7,
0.7 Hz, OCH2CH2CH2CH2− C≡CH), 2.14, 2.07, 2.04, 1.98 (12H, 4s, 4×COCH3), 1.95
(1H,

t,

J

=

2.6

Hz,

OCH2CH2CH2CH2−C≡CH),

1.75

–

1.69

OCH2CH2CH2CH2−C≡CH), 1.64–1.59 (2H, m, OCH2CH2CH2CH2−C≡CH).

(2H,
13

m,

C NMR

(125 MHz, CDCl3): δ 170.56, 170.54, 170.37, 170.17 (4×COCH3), 96.29 (C-1), 84.10
(OCH2CH2CH2CH2−C≡CH), 68.85 (OCH2CH2CH2CH2−C≡CH), 68.36 (C-2), 68.26 (C4), 68.16 (OCH2CH2CH2CH2−C≡CH), 67.80 (C-3), 66.39 (C-5), 61.96 (C-6), 28.45
(OCH2CH2CH2CH2−C≡CH), 25.21 (OCH2CH2CH2CH2−C≡CH), 20.93, 20.84, 20.81,
20.79 (4×COCH3), 18.23 (OCH2CH2CH2CH2−C≡CH). HRESIMS: (m/z) calcd for
C20H28O10Na+ (M+Na)+ 451.1580; found 451.1580.

Scheme 2.12 Synthesis of benzyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4h).
The compound was synthesized according to the general glycosylation and
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel
chromatography (5:1 to 4.5:1, hexanes–EtOAc) to give 4h (116.5 mg, 72.3%, α/β = 3:1)
as a mixture of anomers. 4hα: Rf 0.40 (2:1, hexanes–EtOAc). [α]D21 +126.8 (c 1.00,
CHCl3). 1H NMR (500 MHz, CDCl3): δ 7.37–7.31 (5H, m, Harom), 5.46 (1H, dd, J = 3.5,
1.3 Hz, H-4), 5.40 (1H, dd, J = 10.7, 3.4 Hz, H-3), 5.18 (1H, d, J = 3.7 Hz, H-1), 5.14
(1H, dd, J = 10.7, 3.7 Hz, H-2), 4.74–4.53 (2H, dd, J = 96.5, 12.1 Hz, CH2Ph), 4.27 (1H,
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td, J = 6.7, 1.4 Hz, H-5), 4.08 (2H, qd, J = 11.2, 6.6 Hz, H-6a, H-6b), 2.13, 2.05, 2.03,
1.98 (12H, 4s, 4×COCH3).

13

C NMR (125 MHz, CDCl3): δ 170.50, 170.40, 170.33,

170.11 (4×COCH3), 136.90, 128.65, 128.24, 128.01 (Carom), 95.52 (C-1), 70.09 (CH2Ph),
68.23 (C-4), 68.20 (C-2), 67.78 (C-3), 66.63 (C-5), 61.81 (C-6), 20.86, 20.84, 20.79,
20.77 (4×COCH3). HRESIMS: (m/z) calcd for C21H26O10Na+ (M+Na)+ 461.1424; found
461.1426.

Compound 4h has been used in experiments apparently without

characterization.49 The β anomer is characterized in another paper.50

Scheme 2.13 Synthesis of propargyl 2,3,4,6-tetra-O-acetyl-α-D-glucopyranoside (4i).
The compound was synthesized according to the general glycosylation and
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel
chromatography (5:1 to 4:1, hexanes–EtOAc) to give 4i (112.8 mg, 79.4%, α/β = 7:1) as
a mixture of anomers. 4iα: Rf 0.35 (2:1, hexanes–EtOAc). [α]D21 +163.6 (c 1.00, CHCl3).
1

H NMR (500 MHz, CDCl3): δ 5.48 (1H, m, H-3), 5.28 (1H, d, J = 3.8 Hz, H-1), 5.08

(1H, dd, J = 10.1, 9.4 Hz, H-4), 4.91 (1H, dd, J = 10.3, 3.8 Hz, H-2), 4.27 (2H, d, J = 2.4
Hz, CH2−C≡CH), 4.25-4.10 (2H, m, H-6a, H-6b), 4.04 (1H, m, H-5), 2.44 (1H, t, J = 2.4
Hz, CH2−C≡CH), 2.08, 2.07, 2.02, 2.00 (12H, 4s, 4×COCH3).

13

C NMR (125 MHz,

CDCl3): δ 170.75, 170.22, 170.14, 169.66 (4×COCH3) 94.69 (C-1), 78.28 (CH2−C≡CH),
75.41 (CH2−C≡CH), 70.56 (C-2), 70.04 (C-3), 68.52 (C-4), 67.94 (C-5), 61.82 (C-6),
55.52 (CH2−C≡CH), 20.84, 20.79, 20.78, 20.72 (4×COCH3). HRESIMS: (m/z) calcd for
C17H22O12Na+ (M+Na)+ 409.1111; found 409.1112. Compound 4i has been reported.46
The NMR data match those reported above.
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Scheme 2.14 Synthesis of propargyl 2,3,4,6-tetra-O-acetyl-β-D-mannopyranoside (4j).
The compound was synthesized according to the general glycosylation and
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel
chromatography (4:1 to 2.5:1, hexanes–EtOAc) to give 4j (115.6 mg, 81.4%, α/β = 1:2)
as a mixture of anomers. 4jβ: Rf 0.18 (2:1, hexanes–EtOAc). [α]D20 −82.8 (c 1.00,
CHCl3). 1H NMR (500 MHz, CDCl3): δ 5.48 (1H, dd, J = 3.3, 1.1 Hz, H-2), 5.26 (1H, t, J
= 9.9 Hz, H-4), 5.09 (1H, dd, J = 10.0, 3.3 Hz, H-3), 4.94 (1H, d, J = 1.1 Hz, H-1), 4.38
(2H, m, CH2−C≡CH), 4.31 (1H, dd, J = 12.3, 5.3 Hz, H-6a), 4.16 (1H, dd, J = 12.3, 2.5
Hz, H-6b), 3.69 (1H, ddd, J = 9.9, 5.3, 2.6 Hz, H-5), 2.48 (1H, t, J = 2.4 Hz,
CH2−C≡CH), 2.17, 2.08, 2.03, 1.98 (12H, 4s, 4×COCH3). 13C NMR (125 MHz, CDCl3):
δ 170.79, 170.36, 170.10, 169.68 (4×COCH3), 95.76 (C-1, JC1-H1 = 158.76 Hz), 77.94
(CH2−C≡CH), 76.09 (CH2−C≡CH), 72.66 (C-5), 71.21 (C-3), 68.85 (C-2), 66.08 (C-4),
62.45 (C-6), 55.91 (CH2−C≡CH), 20.95, 20.88, 20.81, 20.69 (4×COCH3). HRESIMS:
(m/z) calcd for C17H22O12Na+ (M+Na)+ 409.1111; found 409.1111. The JC1−H1 cited
above is in line with that generally expected for a β-D-mannopyranoside.51 A recent
example is that of Demchenko and co-workers.52
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Scheme 2.15 Synthesis of propargyl 6-O-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)2,3,4-tri-O-acetyl-α-D-glucopyranoside (4k).
The compound was synthesized according to the general glycosylation and
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel
chromatography (2:1, hexanes–EtOAc) to give 4k (172.1 mg, 69.4%, α/β = 8:1) as a
mixture of anomers. 4kα: Rf 0.29 (1:1, hexanes–EtOAc). [α]D20 +166.2 (c 1.00, CHCl3).
1

H NMR (500 MHz, CDCl3): δ 5.48 (1H, dd, J = 10.3, 9.3 Hz, H-3), 5.45 (1H, dd, J =

3.4, 1.3 Hz, H-4’), 5.34 (1H, dd, J = 10.8, 3.3 Hz, H-3’), 5.24 (1H, d, J = 3.7 Hz, H-1),
5.16 (1H, d, J = 3.7 Hz, H-1’), 5.11 (1H, dd, J = 10.8, 3.6 Hz, H-2’), 5.05 (1H, dd, J =
10.2, 9.3 Hz, H-4), 4.85 (1H, dd, J = 10.3, 3.8 Hz, H-2), 4.28 (2H, dd, J = 2.5, 0.7 Hz,
CH2−C≡CH), 4.25 (1H, m, H-5’), 4.07 (2H, m, H-6’a,b), 4.02 (1H, m, H-5), 3.72 (1H, dd,
J = 11.3, 5.4 Hz, H-6a), 3.55 (1H, dd, J = 11.3, 2.4 Hz, H-6b), 2.49 (1H, t, J = 2.4 Hz,
CH2−C≡CH), 2.13, 2.11, 2.07, 2.04, 2.03, 2.00, 1.97 (21H, 7s, 7×COCH3).

13

C NMR

(125 MHz, CDCl3): δ 170.66, 170.52, 170.32, 170.27, 170.19, 170.00, 169.64
(7×COCH3), 96.39 (C-1’), 94.49 (C-1), 78.31 (CH2−C≡CH), 75.57 (CH2−C≡CH), 70.63
(C-2), 70.09 (C-3), 69.16 (C-4), 68.93 (C-5), 68.27 (C-4’), 68.25 (C-2’), 67.60 (C-3’),
66.58 (C-5’), 66.31 (C-6), 61.90 (C-6’), 55.51 (CH2−C≡CH), 20.94, 20.86, 20.82, 20.81
(×2), 20.79, 20.78 (7×COCH3). HRESIMS: (m/z) calcd for C29H38O18Na+ (M+Na)+
697.1956; found 697.1956.
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Scheme 2.16 Synthesis of propargyl 4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)2,3,6-tri-O-acetyl-α-D-glucopyranoside (4l).
The compound was synthesized according to the general glycosylation and
acetylation procedures B.2 and B.3, above. The crude product was purified by silica gel
chromatography (2:1 to 1.5:1, hexanes–EtOAc) to give 4l (140.6 mg, 56.7%, α/β = 12:1)
as a mixture of anomers. 4lα: Rf 0.22 (1:1, hexanes–EtOAc). [α]D22 +59.7 (c 1.00,
CHCl3). 1H NMR (500 MHz, CDCl3): δ 5.47 (1H, dd, J = 10.3, 9.2 Hz, H-3), 5.34 (1H,
dd, J = 3.6, 1.2 Hz, H-4’), 5.20 (1H, d, J = 3.8 Hz, H-1), 5.10 (1H, dd, J = 10.4, 7.9 Hz,
H-2’), 4.95 (1H, dd, J = 10.4, 3.5 Hz, H-3’), 4.83 (1H, dd, J = 10.3, 3.8 Hz, H-2), 4.48
(1H, d, J = 7.9 Hz, H-1’), 4.45 (1H, dd, J = 12.0, 2.1 Hz, H-6a), 4.25 (2H, dd, J = 3.3, 2.4
Hz, CH2−C≡CH), 4.14 (2H, m, H-6b, H-6’a), 4.07 (1H, dd, J = 11.1, 7.5 Hz, H-6’b), 3.96
(1H, m, H-5), 3.86 (1H, ddd, J = 7.5, 6.3, 1.2 Hz, H-5’), 3.76 (1H, dd, J = 10.1, 9.2 Hz,
H-4), 2.43 (1H, t, J = 2.4 Hz, CH2−C≡CH), 2.14, 2.12, 2.06, 2.05, 2.04, 2.04, 1.95 (21H,
7s, 7×COCH3). 13C NMR (125 MHz, CDCl3): δ 170.50, 170.48, 170.47, 170.30, 170.21,
169.59, 169.13 (7×COCH3), 101.16 (C-1’), 94.41 (C-1), 78.30 (CH2−C≡CH), 76.42 (C4), 75.37 (CH2−C≡CH), 71.19 (C-3’), 70.79 (C-2), 70.77 (C-5’), 69.76 (C-3), 69.27 (C2’), 68.85 (C-5), 66.74 (C-4’), 61.86 (C-6), 60.94 (C-6’), 55.30 (CH2−C≡CH), 21.00
(×2), 20.84, 20.78 (×2), 20.77, 20.64 (7×COCH3). HRESIMS: (m/z) calcd for
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C29H38O18Na+ (M+Na)+ 697.1956; found 697.1956. Compound 4l has been reported.12
However, the NMR data differ from those I report and assign above. Our assignments are
based on 2D NMR data. See the NMR spectra in the Supplementary Information section.

Scheme

2.17

Synthesis

of

propargyl

3,4,6-tri-O-acetyl-2-deoxy-α,β-D-lyxo-

hexopyranoside (4m).
In addition, the thiophenyl glycoside (donor) of 2-deoxy-D-lyxo-hexopyranose
(phenyl 2-deoxy-1-thio-β-D-lyxo-hexopyranoside, 1f) was also synthesized and applied in
this glycosylation reaction to afford propargyl 3,4,6-tri-O-acetyl-2-deoxy-α,β-D-lyxohexopyranoside (alias: “propargyl 3,4,6-tri-O-acetyl-2-deoxy-α,β-D-galactopyranoside,”
4m).53 However, a moderate yield (67%) and low stereoselectivity (α:β = 1.7:1) were
achieved. The acetylated mixture 4m was not further separated into its anomers.
2.6 Conclusions
In summary, a facile and general strategy for the direct construction of 1,2-cis
alkyl glycosides has been developed. Glycosylations between several unprotected phenyl
1-thioglycosyl donors and alcohols bearing various functional groups proceed smoothly
to give satisfying yields and 1,2-cis selectivity. Use of an FIA–ESI-TOF-MS/NMR
protocol facilitated rapid and efficient optimization of conditions. I anticipate that the
synthetic procedures described herein will find application in a number of areas where
1,2-cis selectivity in glycosylated products is required.

93

References
1.

Varki, A.; Cummings, R. D.; Esko, J. D.; Freeze, H. H.; Stanley, P.; Bertozzi, C.

R.; Hart, G. W.; Etzler, M. E. Essentials of Glycobiology. 2nd ed.; Cold Spring Harbor
Laboratory Press: Cold Spring Harbor, NY, 2009.
2.

Zhao, J.; Liu, Y.; Park, H.-J.; Boggs, J. M.; Basu, A. Carbohydrate-coated

fluorescent silica nanoparticles as probes for the galactose/3-sulfogalactose carbohydratecarbohydrate interaction using model systems and cellular binding studies. Bioconjugate
Chem. 2012, 23, 1166-1173.
3.

Perez, M.; Munoz, F. J.; Munoz, E.; Fernandez, M.; Sinisterra, J. V.; Hernaiz, M.

J. Synthesis of novel glycoconjugates and evaluation as inhibitors against betaglucosidase from almond. J. Mol. Catal. B: Enzym. 2008, 52-53, 153-157.
4.

Horlacher, T.; Seeberger, P. H. Carbohydrate arrays as tools for research and

diagnostics. Chem. Soc. Rev. 2008, 37, 1414-1422.
5.

Park, S.; Lee, M.-R.; Shin, I. Carbohydrate microarrays as powerful tools in

studies of carbohydrate-mediated biological processes. Chem. Commun. 2008, 43894399.
6.

Wang, C.; Sanders, B.; Baker, D. C. Synthesis of a glycodendrimer incorporating

multiple mannosides on a glucoside core. Can. J. Chem. 2011, 89, 959-963.
7.

Geng, Y.; Qin, Q.; Ye, X.-S. Lewis acids as alpha-directing additives in

glycosylations by using 2,3-O-carbonate-protected glucose and galactose thioglycoside
donors based on preactivation protocol. J. Org. Chem. 2012, 77, 5255-5270.
8.

Guchhait, G.; Misra, A. K. Efficient glycosylation of unprotected sugars using

sulfamic acid: A mild eco-friendly catalyst. Catal. Commun. 2011, 14, 52-57.

94

9.

Roy, B.; Mukhopadhyay, B. Sulfuric acid immobilized on silica: an excellent

catalyst for Fischer type glycosylation. Tetrahedron Lett. 2007, 48, 3783-3787.
10.

Smith, E. A.; Thomas, W. D.; Kiessling, L. L.; Corn, R. M. Surface plasmon

resonance imaging studies of protein-carbohydrate interactions. J. Am. Chem. Soc. 2003,
125, 6140-6148.
11.

Bornaghi, L. F.; Poulsen, S. A. Microwave-accelerated Fischer glycosylation.

Tetrahedron Lett. 2005, 46, 3485-3488.
12.

Shaikh, N.; Russo, L.; Cipolla, L.; Nicotra, F. Ultrasonic assisted Fischer

glycosylation: generating diversity for glycochemistry. Mol. Diversity 2011, 15, 341-345.
13.

Auge, J.; Sizun, G. Ionic liquid promoted atom economic glycosylation under

Lewis acid catalysis. Green Chem. 2009, 11, 1179-1183.
14.

Premathilake, H. D.; Demchenko, A. V. Superarmed and superdisarmed building

blocks in expeditious oligosaccharide synthesis. Top. Curr. Chem. 2011, 301, 189-221.
15.

Rodebaugh, R.; Debenham, J. S.; FraserReid, B. Debenzylation of complex

oligosaccharides using ferric chloride. Tetrahedron Lett. 1996, 37, 5477-5478.
16.

Attolino, E.; Rising, T. W. D. F.; Heidecke, C. D.; Fairbanks, A. J. Propargyl

mediated intramolecular aglycon delivery (IAD): Applications to the synthesis of core Nglycan oligosaccharides. Tetrahedron: Asymmetry 2007, 18, 1721-1734.
17.

Carmona, A. T.; Moreno-Vargas, A. J.; Robina, I. Glycosylation methods in

oligosaccharide synthesis. Part 1. Curr. Org. Synth. 2008, 5, 33-60.
18.

Cumpstey, I. Intramolecular aglycon delivery. Carbohydr. Res. 2008, 343, 1553-

1573.

95

19.

Ishiwata, A.; Lee, Y. J.; Ito, Y. Recent advances in stereoselective glycosylation

through intramolecular aglycon delivery. Org. Biomol. Chem. 2010, 8, 3596-3608.
20.

Hanessian, S.; Lou, B. L. Stereocontrolled glycosyl transfer reactions with

unprotected glycosyl donors. Chem. Rev. 2000, 100, 4443-4463.
21.

Nakanishi, M.; Takahashi, D.; Toshima, K. Light-induced O-glycosylation of

unprotected deoxythioglycosyl donors. Org. Biomol. Chem. 2013, 11, 5079-5082.
22.

Mamidyala, S. K.; Finn, M. G. Glycosylation using unprotected alkynyl donors. J.

Org. Chem. 2009, 74, 8417-8420.
23.

Mamidyala, S. K.; Finn, M. G. Glycosylation using unprotected alkynyl donors.

[Erratum to document cited in CA151:528993]. J. Org. Chem. 2010, 75, 1329.
24.

Williams, R. J.; Paul, C. E.; Nitz, M. Protecting-group-free O-glysosidation using

p-toluenesulfonohydrazide and glycosyl chloride donors. Carbohydr. Res. 2014, 386, 7377.
25.

Tatai, J.; Fugedi, P. A new, powerful glycosylation method: Activation of

thioglycosides with dimethyl disulfide-triflic anhydride. Org. Lett. 2007, 9, 4647-4650.
26.

Janczuk, A. J.; Zhang, W.; Andreana, P. R.; Warrick, J.; Wang, P. G. The

synthesis of deoxy-alpha-Gal epitope derivatives for the evaluation of an anti-alpha-Gal
antibody binding. Carbohydr. Res. 2002, 337, 1247-1259.
27.

Shirahata, T.; Kojima, A.; Teruya, S.; Matsuo, J.-i.; Yokoyama, M.; Unagiike, S.;

Sunazuka, T.; Makino, K.; Kaji, E.; Omura, S.; Kobayashi, Y. Sequential one-pot
glycosylation with glycosyl N-trichloroacetylcarbamate and trichloroacetate including
dehydrative approach using 1-hydroxy sugars. Tetrahedron 2011, 67, 6482-6496.

96

28.

Yeoh, K. K.; Butters, T. D.; Wilkinson, B. L.; Fairbanks, A. J. Probing

replacement of pyrophosphate via click chemistry; synthesis of UDP-sugar analogues as
potential glycosyl transferase inhibitors. Carbohydr. Res. 2009, 344, 586-591.
29.

Crich, D. Mechanism of a chemical glycosylation reaction. Acc. Chem. Res. 2010,

43, 1144-1153.
30.

Huang, M.; Garrett, G. E.; Birlirakis, N.; Bohe, L.; Pratt, D. A.; Crich, D.

Dissecting the mechanisms of a class of chemical glycosylation using primary C-13
kinetic isotope effects. Nat. Chem. 2012, 4, 663-667.
31.

Walvoort, M. T. C.; Dinkelaar, J.; van den Bos, L. J.; Lodder, G.; Overkleeft, H.

S.; Codee, J. D. C.; van der Marel, G. A. The impact of oxacarbenium ion conformers on
the stereochemical outcome of glycosylations. Carbohydr. Res. 2010, 345, 1252-1263.
32.

Ishiwata, A.; Ito, Y. High throughput screening of O-glycosylation conditions.

Tetrahedron Lett. 2005, 46, 3521-3524.
33.

Ishiwata, A.; Munemura, Y.; Ito, Y. Synergistic solvent effect in 1,2-cis-glycoside

formation. Tetrahedron 2008, 64, 92-102.
34.

Lu,

S.-R.;

Lai,

Y.-H.;

Chen,

J.-H.;

Liu,

C.-Y.;

Mong,

K.-K.

T.

Dimethylformamide: An unusual glycosylation modulator. Angew. Chem., Int. Ed. 2011,
50, 7315-7320.
35.

Chang, S. S.; Lin, C. C.; Li, Y. K.; Mong, K. K. T. A straightforward alpha-

selective aromatic glycosylation and its application for stereospecific synthesis of 4methylumbelliferyl alpha-T-antigen. Carbohydr. Res. 2009, 344, 432-438.
36.

Veeneman, G. H.; Vanleeuwen, S. H.; Vanboom, J. H. Iodonium ion promoted

reactions at the anomeric centre. II An efficient thioglycoside mediated approach toward

97

the formation of 1,2-trans linked glycosides and glycosidic esters. Tetrahedron Lett.
1990, 31, 1331-1334.
37.

Di Bussolo, V.; Fiasella, A.; Romano, M. R.; Favero, L.; Pineschi, M.; Crotti, P.

Stereoselective synthesis of 2,3-unsaturated-aza-O-glycosides via new diastereoisomeric
N-Cbz-imino glycal-derived allyl epoxidest. Org. Lett. 2007, 9, 4479-4482.
38.

Ding, F. Q.; William, R.; Wang, S. M.; Gorityala, B. K.; Liu, X. W. Ready access

to 3-amino-2,3-dideoxysugars via regio- and stereo-selective tandem hydroaminationglycosylation of glycals. Org. Biomol. Chem. 2011, 9, 3929-3939.
39.

Lawandi, J.; Rocheleau, S.; Moitessier, N. Directing/protecting groups mediate

highly regioselective glycosylation of monoprotected acceptors. Tetrahedron 2011, 67,
8411-8420.
40.

Walvoort, M. T. C.; van der Marel, G. A.; Overkleeft, H. S.; Codee, J. D. C. On

the reactivity and selectivity of donor glycosides in glycochemistry and glycobiology:
Trapped covalent intermediates. Chem. Sci. 2013, 4, 897-906.
41.

Yasomanee, J. P.; Demchenko, A. V. Effect of remote picolinyl and picoloyl

substituents on the stereoselectivity of chemical glycosylation. J. Am. Chem. Soc. 2012,
134, 20097-20102.
42.

Schaumberg, J. P.; Hokanson, G. C.; French, J. C.; Smal, E.; Baker, D. C. 2'-

Chloropentostatin, a new inhibitor of adenosine deaminase. J. Org. Chem. 1985, 50,
1651-1656.
43.

Cheng, M. S.; Wang, Q. L.; Tian, Q.; Song, H. Y.; Liu, Y. X.; Li, Q.; Xu, X.;

Miao, H. D.; Yao, X. S.; Yang, Z. Total synthesis of methyl protodioscin: A potent agent
with antitumor activity. J. Org. Chem. 2003, 68, 3658-3662.

98

44.

Ekholm, F. S.; Polakova, M.; Pawlowicz, A. J.; Leino, R. Synthesis of divalent

2,2'-linked mannose derivatives by homo-dimerization. Synthesis 2009, 567-576.
45.

Nagao, Y.; Nekado, T.; Ikeda, K.; Achiwa, K. Synthesis of ganglioside GM3 and

GM4 analogs having mimics of ceramide moieties and their binding activities with
influenza virus A. Chem. Pharm. Bull. 1995, 43, 1536-1542.
46.

Kopitzki, S.; Jensen, K. J.; Thiem, J. Synthesis of benzaldehyde-functionalized

glycans: A novel approach towards Glyco-SAMs as a tool for surface plasmon resonance
studies. Chem. - Eur. J. 2010, 16, 7017-7029.
47.

Casali, M.; Tarantini, L.; Riva, S.; Hunkova, Z.; Weignerova, L.; Kren, V.

Exploitation of a library of α-galactosidases for the synthesis of building blocks for
glycopolymers. Biotechnol. Bioeng. 2002, 77, 105-110.
48.

Abe, H.; Murayama, D.; Kayamori, F.; Inouye, M. Saccharide-linked

ethynylpyridine oligomers: Primary structures encode chiral helices. Macromolecules
2008, 41, 6903-6909.
49.

Moen, A. R.; Anthonsen, T. Screening of the regioselectivity of acetyl xylan

esterase from Bacillus pumilus as a catalyst for the deacetylation of glycoside acetates.
Biocatal. Biotransform. 2009, 27, 226-236.
50.

Pakulski, Z. Glycosylation in ionic liquids. Synthesis 2003, 2074-2078.

51.

Bock, K.; Pedersen, C. A study of

13

CH coupling constants in hexopyranoses. J.

Chem. Soc., Perkin Trans 2 1974, 293-299.
52.

Pistorio, S. G.; Yasomanee, J. P.; Demchenko, A. V. Hydrogen-bond-mediated

aglycone delivery: Focus on beta-mannosylation. Org. Lett. 2014, 16, 716-719.

99

53.

Babu, B. S.; Balasubramanian, K. K. Contrasting behavior of tri-O-acetyl-D-

glucal and tri-O-acetyl-D-galactal towards alcohols and phenols in lithium perchloratediethyl ether medium. Carbohydr. Lett. 1999, 3, 339-342.

100

Chapter 3 Convergent Synthesis of Diversely Presented
Galactoside Ligands
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Abstract
In order to construct a synthetic carbohydrate microarray to imitate featured
carbohydrate presentations on cell surface, I have developed straightforward synthetic
routes for the preparation of α-linked propargyl terminated galactosides with various
spatial presentations. Through the routes, glycosyl acceptors were obtained via flexible
and efficient regioselective protection strategies, which were followed by glycosylations
with 4,6-di-tert-butylsilylene protected thiogalactoside donor to get the α-linked
galactosides in exclusive stereoselective and satisfied yield. These galactoside ligands
could be readily immobilized on the azide-functionalized surface.
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3.1 Background
Cell

membranes

are

extensively

covered

with

oligosaccharides

and

glycoconjugates, which have been determined to be crucial in mediating many biological
processes, such as cell adhesion, cell recognition, ion conductivity and cell signaling. 1
The carbohydrate landscape provides an ideal basis for these biological functions, which
are based on their highly branched structures and varied linkage types. Moreover,
carbohydrates can modify the intrinsic properties of proteins to which they are attached
by altering the stability, protease resistance, quaternary structure, and dynamics
involved.2 However, explaining the mechanisms involved is still challenging.
Fortunately, the accumulation of experience in both carbohydrate synthesis3,

4

and

glycomicroarray construction5, 6 enables us to explore the mechanisms systematically.
Our goal is to emulate this cell membrane landscape by construction of
microarrays with a collection of diversely presented carbohydrate ligands. Glycoclusters
with capped-galactose will be assembled in a modular fashion and immobilized on glass
surfaces at defined densities to control molecular presentation. The compounds
synthesized will be new glycoclusters of α-galactose units that mimic features of
carbohydrates on cell surfaces. The significance of α-galactosides has been well
documented, as they are extensively involved in many biological recognition processes,
such as being ABO histo-blood antigens,7, 8 Chagas disease antigens,9 and precursors of
Fabry disease symptoms pathogenesis.10 Recently, Commins and co-workers reported the
anaphylaxis to mammalian red meat that is caused by the serum anti-α-Gal IgE antibodies
to the oligosaccharides with the Gal-α-(1,3)-Gal structure.11 They demonstrated that IgE
antibodies were produced in patients after tick bites (such as by the tick Amblyomma
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americanum). These patients are then experienced severe hypersensitivity reactions after
taking mammalian red meat or an mAb cetuximab cancer drug, which contain Gal-α(1,3)-Gal oligosaccharides.12
As the type of linkage from a sugar cap on an oligosaccharide to the neighboring
sugar residue is a major distinguishing feature among natural galactans, I want to
systematically investigate the influence of linkage type and size of α-linked galactosides
on their binding with receptors, and get more insights in elucidating the recognition
mechanism and developing novel diagnostic methods and therapies. This chapter will
primarily focus on the synthesis of α-linked galactoside ligands. Six propargyl-terminated
galactose derivatives will be synthesized with totally 1,2-cis-α-O-glycosidic linkages. I
synthesized a collection of galactoside ligands (α-linked 1,2-, 1,3-, 1,4- and 1,6- galactose
disaccharides, as well as mono- and α-linked trisaccharide, as displayed in Figure 3.1,
compounds 1–6). The installed propargyl terminus of galactosides enables rapid and
efficient incorporation with an azide-terminated cluster via “click chemistry”,13 which
allows a quantitative introduction of glycosyl groups onto carbohydrate microarray
surface. Furthermore, a previous study conducted in our lab revealed that the α-linked
mannose disaccharide presented highest binding affinity with Con A lectin compared
with mono- and trisaccharide.14 Therefore, I intentionally designed the following
galactoside candidates.
Herein, I will take advantage of combinatorial synthesis for the construction of
the propargyl galactoside ligands. Combinatorial synthesis is an efficient means of
making several compounds simultaneously from different combinations of modular
building blocks.15, 16 It is specifically favorable in the preparation of a series of
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Figure 3.1 Structures of defined α-linked galactosides with propargyl terminus to be
incorporated into carbohydrate microarrays.
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oligosaccharides, which can be efficiently achieved through the combinations of different
glycosyl donors and acceptors. In most cases, the benzyl ether protecting group is a
popular choice in 1,2-cis-glycosylation reactions based on the virtue of non-participation
during glycosylations, but debenzylation always needs H2/Pd system that would destroy
the propargyl terminus. Therefore, the selection of a protecting group that favors 1,2-cisglycosylation and tolerates propargyl group as well is a main challenge.
In 2003, Kiso et al. first reported17 the employment of di-tert-butylsilylene
(DTBS) protecting group in presence of C-2 benzoyl participating groups in α-selective
galactosylation. The cyclic bifunctional silyl protecting groups present strong power in
controlling the α-stereoselectivity of glycosylation. Accordingly, the 2,3-di-O-benzoyl4,6-O-di-tert-butylsilanediyl protected galactosyl donors have been prepared and used in
many α-galactosylations.18 The highly bulky silyl group blocks the β-face of the donor to
guarantee a completely α-glycosylation with the glycosyl acceptor.19 This type of donor
shows great accessibility, compatibility, and most importantly, high tolerance with
sensitive groups such as alkene, alkyne, nitro and halogen. The deprotection of silyl and
benzoyl group can be performed at mild conditions without impairing the anomeric
functional groups, which satisfies our requirements in the synthesis of α-linked propargyl
galactoside ligands.
Combinatorial synthesis was performed to afford the α-linked galactose ligands
1–6 from different combinations of glycosyl donor and acceptors. Propargyl α-Dgalactoside 1 was synthesized according to the method described in Chapter 2, through
the glycosylation of unprotected 1-thiogalactosyl donor with propargyl alcohol.20 It was
then regioselectively protected by different strategies21–23 with modifications to afford
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four galactose acceptors 7–9 and 11 with propargyl terminus, which are 2, 3, 4, 6 –OH
free respectively. For the synthesis of the acceptors 7 and 8, I developed a concise
method. The galactoside 1 was protected with the bifunctional silyl-protecting group to
have the compound with the 4 and 6 –OH blocked, and it was treated with an equimolar
benzoyl chloride. As the reactivities of 2 and 3 –OH of galactose are similar, it gave both
acceptors 7 and 8 at the same time. To the best of our knowledge, these synthetic
approaches used minimal steps and protecting group manipulations (Scheme 3.1).

Scheme 3.1 Synthesis of the glycosylation acceptors 7–9 and 11. Reagents and
conditions: (a) DTBS(OTf)2, DMF, –40 °C, 83%; (b) BzCl, Pyridine, 47% for 7, 30% for
8; (c) BzCl, Pyridine, –30 °C, 48%; (d) TBDMSCl, Imidazole, Pyridine, 65%; (e) BzCl,
Pyridine, DMAP, 63%; (f) TBAF, AcOH, THF, 84%.
The synthesized glycosyl acceptors were glycosylated with the α-directing
glycosyl donor 1217 upon the activation with trifluoromethanesulfonic acid (TfOH) and
N-iodosuccinimide (NIS). Expected α-configurations were achieved in moderate to high
yield (Scheme 3.2). It is noteworthy that acceptors 7–9 and 11, yet having similar
structures, possess different reactivity towards the glycosylation with donor 7.
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Accordingly, besides the conventional glycosylation procedure (with acceptor 11), an
inverse-addition (I-A) procedure24 (with acceptors 7–9) was also applied to achieve more
effective glycosylation and to optimize the yield. I speculate that the I-A procedure favors
the formation of oxocarbenium ion due to kinetic anomeric effect and through-space
electron donation effect,19 which enables weakly nucleophilic acceptors (such as these
secondary alcohols) to attack it through SN1 process. Removal of the silyl and benzoyl
groups furnished the α-linked disaccharides 2-5 (Scheme 3.3).

Scheme 3.2 Synthesis of disaccharides 13–16. Reagents and conditions: (g) NIS, TfOH,
CH2Cl2, –40 °C to rt, I-A procedure, 53–80%; (h) NIS, TfOH, CH2Cl2, 0 °C, 64%.
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Scheme 3.3 Deprotection of disaccharides 13–16 to afford 2–5. Reagents and conditions:
(i) TBAF, AcOH; (j) NaOMe, MeOH, 72–84% over two steps.

Scheme 3.4 Synthesis of trisaccharide 6. Reagents and conditions: (d) TBDMSCl,
Imidazole, Pyridine; (e) BzCl, Pyridine, DMAP; (f) TBAF, AcOH, THF; (h) NIS, TfOH,
CH2Cl2, 0 °C; (i) TBAF, AcOH; (j) NaOMe, MeOH; (k) Ac2O, DMAP, Pyridine, 11%
over 8 steps.
The synthesis of trisaccharide 6 was in a similar fashion with disaccharide 5, as
they shared the same Gal-α-(1,6)-Gal structure. Regioselective protection of disaccharide
5 gave the acceptor 17, which was then glycosylated with donor 12 to construct 18 with
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the α-1-6-linkage at the top. Deprotection of 18 afforded the trisaccharide 6, which was
acetylated again for a further purification and better characterization. Final deprotection
by sodium methoxide gave defined trisaccharide 6 in high purity (Scheme 3.4).
3.2 Experimental Section
3.2.1 General methods
All chemicals were purchased as reagent grade and used without further
purification, unless otherwise noted. Reagent grade dichloromethane (CH2Cl2), diethyl
ether (Et2O), tetrahydrofuran (THF), methanol (MeOH), N,N-dimethylformamide (DMF)
and toluene were obtained from the Pure-Solv (Innovation Technologies) solvent system
that uses alumina columns except for DMF, which was dried over a column of 5 Ǻ
molecular sieves. Pyridine was distilled over CaH2 prior to use. All reactions were
performed under anhydrous conditions unless otherwise noted. Reactions were monitored
by thin-layer chomatography (TLC) on silica gel precoated aluminum plates. Zones were
detected by UV irradiation using a 254 nm lamp and/or by heat/charring with panisaldehyde–sulfuric acid development reagent. Column chomatography was performed
on silica gel (40−63 μm). Optical rotation values were obtained at the sodium D line
using a Perkin–Elmer 241 polarimeter. 1H (500 MHz) and 13C NMR (125 MHz) spectra
were recorded at room temperature with a Varian Inova 500 MHz instrument. Chemical
shifts are reported in δ-units (ppm) relative to the residual 1H CDCl3 at δ 7.26 ppm and
13

C at δ 77.16 ppm. All two-dimensional experiments (gCOSY, gHSQC and gHMBC)

were recorded on the same instrument using Varian protocols. Mass spectrometric
analysis was performed on a QSTAR Elite quadrupole time-of-flight (QTOF) mass
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spectrometer with an ESI source. MALDI-TOF mass spectra were obtained on a
Voyager-DE PRO BioSpectrometry workstation.
3.2.2. Synthesis of carbohydrate ligands
(1) Synthesis of the phenyl thioglycoside donor.

Scheme 3.5 Synthesis of phenyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-galactopyranoside 21.
Thiophenol (2.78 mL, 27.2 mmol) was added to a solution of compound 20 (8.15
g, 20.9 mmol) in dry CH2Cl2 at 0 °C and the mixture was stirred for 30 min. Then
BF3·Et2O (7.95 mL, 62.7 mmol) was slowly injected to the mixture, which was allowed
to warm to room temperature. After 5 hours, the mixture was diluted by CH2Cl2, washed
with sat NaHCO3 and brine, dried over Na2SO4, concentrated in vacuo, and purified by
column chromatography (Hexane–EtOAc 6:1) to afford compound 21 as colorless syrup
(7.56 g, 82.2%). Rf = 0.39 (2.5:1, hexane–EtOAc). [α]D23 = + 3.6 (c = 1.00, CHCl3). 1H
NMR (500 MHz, Chloroform-d) δ 7.50 (m, 2H, Ar-H), 7.30 (m, 3H, Ar-H), 5.41 (dd, J =
3.4, 1.1 Hz, 1H, H-4), 5.23 (m, 1H, H-2), 5.06 (dd, J = 10.0, 3.4 Hz, 1H, H-3), 4.73 (d, J
= 10.0 Hz, 1H, H-1), 4.18 (m, 1H, H-6a), 4.11 (m, 1H, H-6b), 3.94 (ddd, J = 7.1, 6.2, 1.1
Hz, 1H, H-5), 2.10, 2.08, 2.03, 1.96 (4s, 12H, 4×COCH3).

13

C NMR (126 MHz,

Chloroform-d) δ 170.35, 170.18, 170.02, 169.42, 132.58, 132.49, 128.91, 128.17, 86.56,
74.45, 72.03, 67.31, 67.28, 61.68, 20.86, 20.68, 20.65, 20.60.
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Scheme 3.6 Synthesis of phenyl 1-thio-β-D-galactopyranoside 22.
Compound 21 (5.85 g, 13.3 mmol) was dissolved in dry MeOH (50 mL),
followed by adding NaOMe in small amount to afford pH 9. After 2 h the solution was
quenched by Amberlite® IR 120 (H+). The resin was filtered off and the solvent was
removed in vacuo to afford a white powdery solid 22 (3.53 g, 97.6%). Rf = 0.53 (4:1,
EtOAc–MeOH). m.p. 106 – 108 °C. [α]D21 = - 48.4 (c = 0.93, CH3OH). 1H NMR (500
MHz, Methanol-d) δ 7.58 (m, 2H, Ar-H), 7.31 (m, 2H, Ar-H), 7.25 (m, 1H, Ar-H), 4.63
(d, J = 9.7 Hz, 1H, H-1), 3.93 (dd, J = 3.4, 1.0 Hz, 1H), 3.80 (m, 1H), 3.74 (m, 1H), 3.64
(t, J = 9.4 Hz, 1H), 3.59 (ddd, J = 6.6, 5.3, 1.1 Hz, 1H), 3.54 (dd, J = 9.2, 3.3 Hz, 1H).
13

C NMR (126 MHz, Methanol-d) δ 136.00, 132.05, 129.82, 127.97, 90.22, 80.55, 76.29,

70.98, 70.38, 62.59.

Scheme

3.7

Synthesis

of

phenyl

4,6-O-di-tert-butylsilanediyl-1-thio-β-D-

galactopyranoside 23.
Compound 22 (3.53 g, 13.0 mmol) was dissolved in dry DMF (40 mL) and cooled
to -40 °C. Di-tert-butylsilyl bis(trifluoromethanesulfonate) (4.02 mL, 12.3 mmol) was
added dropwise to the mixture, which was stirred for 30 min, followed by addition of
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pyridine (3.2 mL). The reaction mixture was stirred for another 15 min, then diluted with
diethyl ether, washed by water (200 mL) and brine (100 mL) and dried over anhydrous
Na2SO4. The organic layer was concentrated in vacuo and purified by column
chromatography (DCM/Acetone 15:1 to 10:1) to afford compound 23 (4.83 g, 90.2%) as
colorless syrup. Rf = 0.56 (10:1, DCM–Acetone). [α]D22 = -78.0 (c = 1.00, CHCl3). 1H
NMR (500 MHz, Chloroform-d) δ 7.57 (m, 2H, Ar-H), 7.30 (m, 3H, Ar-H), 4.57 (d, J =
9.8, 1H, H-1), 4.45 (dd, J = 3.5, 1.1 Hz 1H), 4.27 (m, 2H), 3.76 (td, J = 9.4, 2.5 Hz, 1H),
3.55 (ddd, J = 10.5, 8.9, 3.5 Hz, 1H), 3.48 (m, 1H), 2.81 – 2.70 (br, 2s, 2H, OH), 1.06 (s,
9H), 1.05 (s, 9H). 13C NMR (126 MHz, Chloroform-d) δ 133.27, 132.77, 129.07, 128.02
(Ar-C), 89.21 (C-1), 75.37, 75.27, 72.67, 70.83, 67.22, 27.69, 27.55, 23.47, 20.79.

Scheme 3.8 Synthesis of phenyl 2,3-di-O-benzoyl-4,6-O-di-tert-butylsilanediyl-1-thio-βD-galactopyranoside

12.

Compound 23 (4.28 g, 10.39 mmol) was dissolved in dry pyridine (30 mL),
followed by adding benzoyl chloride (2.90 mL, 24.96 mmol) at room temperature. The
reaction mixture was stirring for 3 hours, which was then quenched by EtOH (5 mL) and
concentrated in high vacuo. The residue was diluted by EtOAc (60 mL), washed with 1N
HCl (50 mL), sat. aq. NaHCO3 (60 mL) and brine (50 mL). The aqueous layer was
extracted with EtOAc (60 mL), and the combined organics were dried over anhydrous
Na2SO4. After concentration, the crude product was purified by silica gel
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chromatography (10:1, hexane–EtOAc) to give 12 (5.69 g, 88.3%) as a white solid. Rf =
0.32 (6:1, hexane–EtOAc). m.p. 72 – 74 °C. [α]D22 = +136.9 (c = 1.03, CHCl3). 1H NMR
(500 MHz, Chloroform-d) δ 7.99 (ddd, J = 8.5, 5.0, 1.3 Hz, 4H, Ar-H), 7.49 (m, 4H, ArH), 7.38 (m, 4H, Ar-H), 7.26 (m, 3H, Ar-H), 5.93 (t, J = 10.0 Hz, 1H, H-2), 5.22 (dd, J =
9.8, 3.1 Hz, 1H, H-3), 4.95 (d, J = 10.1 Hz, 1H, H-1), 4.89 (dd, J = 3.1, 0.9 Hz, 1H, H-4),
4.33 (m, 2H, H-6a,b), 3.65 (q, J = 1.3 Hz, 1H, H-5), 1.16 (s, 9H, CH3-tBu-Si), 0.96 (s, 9H,
CH3-tBu-Si).

13

C NMR (126 MHz, Chloroform-d) δ 166.27, 165.58, 133.94, 133.37,

133.29, 132.60, 129.95, 129.93, 129.75, 129.59, 129.04, 128.53, 128.49, 127.94, 87.67,
75.61, 75.16, 70.61, 68.26, 67.27, 27.65, 27.60, 23.40, 20.86. MALDI-TOFMS: calcd for
C34H40O7SSi·Na+: 643.2156; found: m/z 643.2146.
(2) Synthesis of galactosyl acceptors

Scheme 3.9 Synthesis of propargyl 4,6-O-di-tert-butylsilanediyl-α-D-galactopyranoside
24.
Compound 1 (1.91 g, 8.76 mmol) was dissolved in dry DMF (20 mL) and cooled
to -40 °C. Di-tert-butylsilyl bis(trifluoromethanesulfonate) (2.70 mL, 8.32 mmol) was
added dropwise to the mixture, which was stirred for 30 min, followed by addition of
pyridine (2.1 mL). The reaction mixture was stirred for another 15 min, then diluted with
diethyl ether, washed by water (100 mL) and brine (100 mL) and dried over anhydrous
Na2SO4. The organic layer was concentrated in vacuo and purified by column
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chromatography (DCM/Acetone 40:1 to 20:1) to afford compound 24 (2.59 g, 82.6%) as
an amorphous white foam. Rf = 0.41 (9:1, DCM–Acetone). [α]D22 = 138.6 (c = 1.00,
CHCl3). 1H NMR (500 MHz, Chloroform-d) δ 5.13 (d, J = 3.9, 1H, H-1), 4.46 (dd, J =
3.5, 1.2 Hz, 1H), 4.30 – 4.27 (m, 3H), 4.18 (dd, J = 12.6, 1.7 Hz, 1H), 3.88 (dd, J = 9.8,
3.9 Hz, 1H), 3.80 (m, 1H), 3.72 (dd, J = 9.8, 3.4 Hz, 1H), 2.45 (t, J = 2.4 Hz, 1H), 1.05
(s, 9H), 1.03 (s, 9H).

13

C NMR (126 MHz, Chloroform-d) δ 98.18, 78.93, 75.12, 73.32,

71.29, 69.82, 67.95, 66.87, 55.50, 27.72, 27.34, 23.51, 20.84. HRMS ESI (m/z) (M+Na)+
calcd for C17H30O6SiNa+ 381.1709, found 381.1709.

Scheme 3.10 Synthesis of propargyl 3-O-benzoyl-4,6-O-di-tert-butylsilanediyl-α-Dgalactopyranoside

7

and propargyl

2-O-benzoyl-4,6-O-di-tert-butylsilanediyl-α-D-

galactopyranoside 8.
Compound 24 (1.69 g, 4.72 mmol) was dissolved in dry pyridine (20 mL),
followed by adding benzoyl chloride (0.58 mL, 4.96 mmol) at room temperature. The
reaction mixture was stirring for 1 hour, which was then quenched by EtOH (2 mL) and
concentrated in high vacuo. The residue was diluted by EtOAc (60 mL), washed with 1N
HCl (50 mL), sat. aq. NaHCO3 (60 mL) and brine (50 mL). The aqueous layer was
extracted with EtOAc (60 mL), and the combined organics were dried over anhydrous
Na2SO4. After concentration, the crude products were purified by silica gel
chromatography (10:1, hexane–EtOAc) to give 7 (1.02 g, 46.8%) and 8 (0.66 g, 30.3%)
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as amorphous white foam. 8: Rf = 0.47 (3:1, hexane–EtOAc). [α]D20 = +97.2 (c = 1.00,
CHCl3). 1H NMR (500 MHz, Chloroform-d) δ 8.12 (m, 2H, Ar-H), 7.56 (m, 1H, Ar-H),
7.44 (m, 2H, Ar-H), 5.39 (dd, J = 10.2, 3.7 Hz, 1H), 5.30 (d, J = 3.8 Hz, 1H, H-1), 4.54
(dd, J = 3.5, 1.3 Hz, 1H), 4.33 (dd, J = 12.7, 2.2 Hz, 1H), 4.26 (dd, J = 3.1, 2.4 Hz, 2H),
4.22 (dd, J = 12.6, 1.6 Hz, 1H), 4.11 (m, 1H), 3.90 (m, 1H), 2.58 (m, 1H), 2.33 (t, J = 2.4
Hz, 1H), 1.11 (s, 9H, CH3-tBu-Si), 1.07 (s, 9H, CH3-tBu-Si).

13

C NMR (126 MHz,

Chloroform-d) δ 166.86, 133.27, 130.06, 129.99, 128.46, 96.45, 79.02, 74.82, 73.78,
71.34, 68.52, 67.81, 66.80, 55.64, 27.68, 27.41, 23.52, 20.90. MALDI-TOFMS: calcd for
C24H34O7Si·Na+: 485.1972; found: m/z 485.1972. 7: Rf = 0.42 (3:1, hexane–EtOAc).
[α]D20 = +182.6 (c = 1.00, CHCl3). 1H NMR (500 MHz, Chloroform-d) δ 8.11 (m, 2H,
Ar-H), 7.57 (m, 1H, Ar-H), 7.45 (m, 2H, Ar-H), 5.23 (dd, J = 10.4, 3.2 Hz, 1H), 5.19 (d,
J = 3.9 Hz, 1H, H-1), 4.72 (m, 1H), 4.34 (m, 3H), 4.30 (dd, J = 12.6, 2.2 Hz, 1H), 4.21
(dd, J = 12.6, 1.7 Hz, 1H), 3.87 (m, 1H), 2.47 (t, J = 2.4 Hz, 1H), 2.04 (m, 1H), 1.07 (s,
9H, CH3-tBu-Si), 0.98 (s, 9H, CH3-tBu-Si).

13

C NMR (126 MHz, Chloroform-d) δ 166.91,

133.25, 130.29, 129.95, 128.50, 98.37, 78.85, 75.24, 73.83, 71.49, 68.00, 66.97, 66.85,
55.50, 27.69, 27.35, 23.43, 20.84. MALDI-TOFMS: calcd for C24H34O7Si·Na+:
485.1972; found: m/z 485.1972.

Scheme 3.11 Synthesis of propargyl 2,3,6-tri-O-benzoyl-α-D-galactopyranoside 9.
Benzoyl chloride (1.15 mL, 9.89 mmol) was added dropwise to a solution of 1
(0.52 g, 2.39 mmol) in pyridine (20 mL) at -30 °C. After stirring for 2 hrs, the reaction
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mixture was quenched by satd NaHCO3, extracted by DCM (100 mL), dried over
anhydrous Na2SO4 and concentrated. The crude product was purified by chromatography
column (20:15:3, Hex-DCM–EtOAc) to give 9 (0.61 g, 48.2%) as a glassy solid. m.p.
138 – 140 °C. [α]D21 = + 120.4 (c = 1.00, CHCl3). Rf = 0.30 (3:1, hexane–EtOAc). 1H
NMR (CDCl3, 500 MHz) δ 8.12 – 7.98 (m, 5H), 7.63 – 7.35 (m, 10H), 5.76 (m, 2H), 5.52
(d, J = 3.6 Hz, 1H), 4.69 (dd, J = 11.4, 6.2 Hz, 1H), 4.57 (dd, J = 11.4, 6.7 Hz, 1H), 4.44
(m, 2H), 4.34 (d, J = 2.4 Hz, 2H), 2.35 (t, J = 2.4 Hz, 1H). 13C NMR (CDCl3, 125 MHz)
δ 166.62, 166.20, 165.88, 133.84, 133.55, 133.44, 133.38 130.32, 129.99, 129.93, 129.86,
129.70, 129.48, 129.38, 128.60, 128.49, 95.70, 78.60, 75.23, 70.83, 68.54 (×2), 68.18,
63.22, 55.50. HRMS ESI (m/z) (M+Na)+ calcd for C30H26O9Na+ 553.1475, found
553.1475.

Scheme 3.12 Synthesis of propargyl 6-O-(tert-butyldimethylsilyl)-α-D-galactopyranoside
25.
To a cold solution of 1 (3.84 g, 17.61 mmol) in anhydrous pyridine (30 mL),
imidazole (2.40 g, 35.29 mmol) was added and reaction was stirred until all was
dissolved. Then, tert-butylchlorodimethylsilane (3.18 g, 21.10 mmol) was added, and the
mixture was stirred at room temperature for 24 h under nitrogen gas protection. The
mixture was poured into ice/water. The crystalline precipitate was thoroughly washed
with cold water and hexane to obtain the product 25 (3.78 g, 64.6%). 13C NMR (CD3OD,
75 MHz): δ: 97.13 (C-1), 78.53 (CH2−C≡CH), 74.65 (CH2−C≡CH), 71.39, 70.10, 69.30,
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68.54 (C-2 to C-5), 62.23 (C-6), 53.60 (CH2−C≡CH), 24.92 (C(CH3)3), 17.69 (C(CH3)3)), -6.59 (2) (-Si(CH3)2).

Scheme 3.13 Synthesis of propargyl 2,3,4-tri-O-benzoyl-6-O-(tert-butyldimethylsilyl)-αD-galactopyranoside

10.

To a solution of 25 (3.21 g, 9.67 mmol) in dry pyridine (40 mL), benzoyl chloride
(6.74 mL, 58.02 mmol) and a catalytic amount of DMAP was added. The mixture was
stirred at room temperature for overnight. EtOH (10 mL) was added to quench the
reaction and the solution was concentrated on high vacuum and diluted by DCM. It was
washed by 1M HCl (2 x 50 mL) and brine (2 x 60 mL), dried over anhydrous Na2SO4 to
get the organic layer, which was purified by silica gel chromatography (10:1, hexane–
EtOAc) to give 10 (3.93 g, 63.1%) as colorless syrup. Rf = 0.21 (10:1, hexane–EtOAc) 1H
NMR (CDCl3, 500 MHz): δ 8.09 (m, 2H), 8.00 (m, 2H), 7.81 (m, 2H), 7.61 (m, 1H), 7.50
(m, 3H), 7.42 (m, 1H), 7.37 (m, 2H), 7.24 (m, 2H), 6.00 (m, 2H), 5.69 (ddd, J = 11.8, 3.8,
1.6 Hz, 1H), 5.62 (d, J = 3.7 Hz, 1H, H-1), 4.37 (m, 3H), 3.78 (m, 2H), 2.37 (t, J = 2.4
Hz, 1H, CH2−C≡CH), 0.86 (s, 9H, -C(CH3)3), 0.01, -0.03 (2s, 2×3H, -Si(CH3)2).

13

C

NMR (CDCl3, 125 MHz): δ 166.20, 165.63, 165.53 (3×COPh), 133.42, 133.38, 133.12,
129.97, 129.92, 129.83, 129.75, 129.46, 129.42, 128.69, 128.48, 128.30, 95.30 (C-1),
78.54 (CH2−C≡CH), 75.19 (CH2−C≡CH), 70.19, 69.33, 69.04, 68.70 (C-2 to C-5), 61.28
(C-6), 55.30 (CH2−C≡CH), 25.87 (-C(CH3)3), 18.26 (-C(CH3)3)), -5.46, -5.51 (Si(CH3)2). MALDI-TOFMS: calcd for C36H40O9Si·Na+: 667.2334; found: m/z 667.2339.

118

Scheme 3.14 Synthesis of propargyl 2,3,4-tri-O-benzoyl-α-D-galactopyranoside 11.
A solution of 10 (3.78 g, 5.87 mmol) and glacial acetic acid (1.00 mL, 17.48
mmol) in dry THF (20 mL) was treated with 1 M TBAF (11.74 mL, 11.74 mmol) in THF
at room temperature for overnight. After concentration, the reaction mixture was
quenched by water, extracted by DCM (300 mL), dried over anhydrous Na2SO4 and
concentrated. The crude product was purified by chromatography column (30:1, DCM–
EtOAc) to give 11 (2.61 g, 83.8%) as an amorphous white foam. m.p. 59 – 61 °C. [α]D21
= + 264.3 (c = 1.00, CHCl3). Rf = 0.27 (2:1, hexane–EtOAc). 1H NMR (CDCl3, 500
MHz) δ 8.03 (m, 2H), 7.92 (m, 2H), 7.73 (m, 2H), 7.55 (ddt, J = 8.8, 7.2, 1.3 Hz, 1H),
7.42 (m, 3H), 7.32 (m, 2H), 7.17 (m, 2H), 5.90 (dd, J = 10.8, 3.4 Hz, 1H), 5.81 (dd, J =
3.5, 1.1 Hz, 1H), 5.70 (dd, J = 10.7, 3.8 Hz, 1H), 5.53 (d, J = 3.7 Hz, 1H), 4.34 (m, 1H),
4.28 (dd, J = 2.4, 1.3 Hz, 2H), 3.70 (dt, J = 11.8, 6.9 Hz, 1H), 3.57 (dt, J = 11.8, 6.8 Hz,
1H), 2.45 (t, J = 7.0 Hz, 1H), 2.31 (t, J = 2.4 Hz, 1H).

13

C NMR (CDCl3, 125 MHz) δ

166.87, 166.25, 165.57, 133.91, 133.50, 133.34, 130.16, 130.00, 129.81, 129.34, 129.24,
129.04, 128.82, 128.55, 128.42, 95.67, 78.56, 75.40, 70.10, 70.00, 69.22, 68.48, 60.88,
55.77.
(3) General glycosylation procedure.
Method A: The galactosyl donor 12 (1.2 equiv) and acceptor (1.0 equiv) were dissolved
in dry CH2Cl2 (25 mL), followed by adding pre-activated 4 Å molecular sieves powder
and stirring for 1 h under nitrogen at room temperature. Then the mixture was cooled to 0

119

°C and added NIS (2.0 equiv) and TfOH (0.2 equiv) which made a purple solution. After
the acceptor was completely consumed on TLC analysis, the mixture was filtered through
Celite, washed with CH2Cl2 for twice, and the combined filtrate was washed with satd
NaHCO3 aq., satd Na2S2O3 aq. and brine, dried over anhydrous Na2SO4 and concentrated
in vacuo.
Method B: A mixture of galactosyl acceptor (1.0 equiv) and activated 4Å molecular
sieves in CH2Cl2 (0.05 M) was stirred for 1 h under nitrogen at room temperature,
followed by cooled to -20 °C and the addition of NIS (2.0 equiv) and TfOH (0.2 equiv).
A solution of thiophenol donor 12 (1.2 equiv) in CH2Cl2 (0.25 M) was added dropwise to
the reaction mixture. After stirring for 30 min, the reaction mixture was warmed to room
temperature. When the acceptor was completely consumed on TLC analysis, the mixture
was filtered through Celite, washed with CH2Cl2 for twice, and the combined filtrate was
washed with satd NaHCO3 aq., satd Na2S2O3 aq. and brine, dried over anhydrous Na2SO4
and concentrated in vacuo.
(4) General procedure for di-tert-butylsilylidene group removal.
A solution of saccharide (1 equiv) and glacial acetic acid (7 equiv) in dry THF
(10.0 mL) was treated with 1 M tetrabutylammonium fluoride (TBAF) (10 equiv) in THF
at room temperature for overnight. After concentration, the reaction mixture was
quenched by water, extracted by DCM (100 mL), dried over anhydrous Na2SO4 and
concentrated.
(5) General procedure for debenzoylation.
Benzoylated saccharide was dissolved in dry MeOH (20 mL), followed by adding
NaOMe in small portion to afford pH 9. After overnight stirring, the solution was
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quenched by Amberlite® IR 120 (H+). The resin was filtered off and the solvent was
removed in vacuo.

Scheme 3.15 Synthesis of propargyl 3-O-benzoyl-4,6-di-O-tert-butylsilanediyl-2-O-(2,3di-O-benzoyl-4,6-di-O-tert-butylsilanediyl-α-D-galactopyranosyl)-α-D-galactopyranoside
13.
Compound 13 was synthesized according to the general glycosylation method B
above. The crude product was purified by silica gel chromatography (20:3:1, hexane–
CH2Cl2–EtOAc) to give 13 (238 mg, 58.3 %) as a white amorphous foam. Rf = 0.42
(10:3:1, hexane–CH2Cl2–EtOAc). [α]D21 = +190.9 (c = 1.00, CHCl3). 1H NMR (600
MHz, Chloroform-d) δ 8.06 (m, 4H, Ar-H), 7.96 (m, 2H, Ar-H), 7.59 (m, 1H, Ar-H), 7.54
– 7.47 (m, 4H, Ar-H), 7.42 – 7.34 (m, 4H, Ar-H), 5.65 (dd, J = 10.5, 3.6 Hz, 1H, H-2’),
5.50 (d, J = 3.8 Hz, 1H, H-1’), 5.48 (m, 1H, H-3’), 5.42 (dd, J = 10.3, 3.2 Hz, 1H, H-3),
5.12 (d, J = 3.6 Hz, 1H, H-1), 4.76 (dd, J = 3.3, 1.1 Hz, 1H, H-4), 4.64 (dd, J = 3.1, 1.1
Hz, 1H, H-4’), 4.43 (dd, J = 10.3, 3.6 Hz, 1H, H-2), 4.25 (dd, J = 12.7, 2.2 Hz, 1H, H6a/b), 4.14 (dd, J = 12.7, 1.7 Hz, 1H, H-6a/b), 4.05 (dd, J = 12.5, 1.5 Hz, 1H, H-6’a/b), 3.96
(q, J = 1.5 Hz, 1H, H-5’), 3.95 – 3.87 (m, 4H, H-5, H-6’a/b, CH2−C≡CH), 2.28 (t, J = 2.4
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Hz, 1H, CH2−C≡CH), 1.04, 1.02, 0.92, 0.87 (4s, 36H, 4 CH3-tBu-Si). 13C NMR (151 MHz,
Chloroform-d) δ 166.42, 166.22, 166.06 (3 C=OBz), 133.42, 133.30, 133.13, 130.54,
130.07, 129.78, 129.64, 129.62, 128.66, 128.57, 128.44, (Ar-C), 96.15 (C-1), 95.78 (C1’), 78.88 (CH2−C≡CH), 74.79 (CH2−C≡CH), 72.02 (C-3), 71.50 (C-2), 71.05 (C-4),
71.01 (C-3’), 70.92 (C-4’), 69.04 (C-2’), 67.40 (C-5), 67.27 (C-5’), 66.96 (C-6’), 66.82
(C-6), 55.32 (CH2−C≡CH), 27.59, 27.56, 27.35, 27.34 (4 CH3-tBu-Si), 23.36, 23.31, 20.80,
20.79 (4 Cq-tBu-Si). MALDI-TOFMS: calcd for C52H68O14Si2·Na+: 995.4040; found: m/z
995.4038.

Scheme 3.16 Synthesis of propargyl 2-O-(α-D-galactopyranosyl)-α-D-galactopyranoside
2.
The crude product was purified by silica gel chromatography (4:1, EtOAc–
MeOH) to give 2 as a white powdery solid (49 mg, 84.2 %). Rf = 0.44 (1:1, EtOAc–
MeOH). [α]D20 = 84.0 (c = 1.00, CH3OH). 1H NMR (600 MHz, Methanol-d4) δ 5.31 (d, J
= 3.7 Hz, 1H, H-1), 5.11 (d, J = 3.8 Hz, 1H, H-1’), 4.37 (t, J = 2.2 Hz, 2H, CH2−C≡CH),
4.18 (m, 1H, H-5’), 4.07 (dd, J = 10.1, 3.7 Hz, 1H, H-2), 4.00 (m, 1H, H-4), 3.96 (dd, J =
3.3, 1.2 Hz, 1H, H-4’), 3.93 (dd, J = 10.1, 3.4 Hz, 1H, H-3), 3.89 – 3.86 (m, 2H, H-5, H-
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3’), 3.83 – 3.74 (m, 5H, H-6a,b, H-2’, H-6’a,b) 2.92 (t, J = 2.4 Hz, 1H, CH2−C≡CH). 13C
NMR (151 MHz, Methanol-d4) δ 98.08 (C-1’), 96.13 (C-1), 80.00 (CH2−C≡CH), 76.28
(CH2−C≡CH), 74.25 (C-2), 72.76 (C-5), 72.53 (C-5’), 71.47 (C-3’), 71.17 (C-4’), 71.13
(C-4), 70.33 (C-2’), 69.76 (C-3), 62.90 (C-6’), 62.61 (C-6), 55.34 (CH2−C≡CH). HRMS
ESI (m/z) (M+Na)+ calcd for C15H24O11Na+ 403.1216, found 403.1218.

Scheme 3.17 Synthesis of propargyl 2-O-benzoyl-4,6-di-O-acetyl-3-O-(2,3-di-Obenzoyl-4,6-di-O-acetyl-α-D-galactopyranosyl)-α-D-galactopyranoside 26.
Compound 14 was synthesized according to the general glycosylation method B
above. After removal the di-tert-butylsilylidene group, the reaction mixture was dissolved
in dry pyridine (10 mL), followed by adding acetic anhydride (6 equiv) and a catalytic
amount of DMAP. The mixture was stirred at room temperature for overnight. Toluene
(3×25 mL) was added and the solution was concentrated, and it was extracted with
CH2Cl2 (150 mL) and satd NaHCO3 aq. The organic layer was then separated and washed
with brine, dried over anhydrous Na2SO4 and concentrated in vacuo. The crude product
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was purified by silica gel chromatography (3:1, hexane–EtOAc) to give 26 (621 mg, 79.4
%) as a white crystal. m.p. 148 – 150 °C. Rf = 0.36 (1.5:1, hexane–EtOAc). [α]D20 =
+234.6 (c = 1.00, CHCl3). 1H NMR (500 MHz, Chloroform-d) δ 8.12 (m, 2H), 7.97 (m,
2H), 7.78 (m, 2H), 7.62 (m, 1H), 7.51 – 7.27 (m, 8H), 5.61 (dd, J = 10.9, 3.5 Hz, 1H, H2’), 5.55 – 5.47 (m, 4H, H-2, H-4, H-1’, H-3’), 5.39 (d, J = 3.8 Hz, 1H, H-1), 5.24 (dd, J
= 3.4, 1.3 Hz, 1H, H-4’), 4.55 (dd, J = 10.7, 3.1 Hz, 1H, H-3), 4.44 (ddd, J = 7.7, 4.9, 1.4
Hz, 1H, H-5’), 4.25 (d, J = 2.5 Hz, 2H, CH2−C≡CH), 4.23 (m, 1H, H-5), 4.13 – 4.01 (m,
4H, H-6a,b, H-6’a,b), 2.32 (t, J = 2.3 Hz, 1H, CH2−C≡CH), 2.11, 2.08, 2.02, 1.36 (4s, 12H,
4×COCH3).

13

C NMR (126 MHz, Chloroform-d) δ 170.46, 170.45, 169.94, 169.92 (4

C=OAc), 166.02, 165.91, 165.12 (3 C=OBz), 133.74, 133.33, 133.27, 130.05, 129.77,
129.64, 129.61, 129.52, 129.23, 128.77, 128.45, 128.44 (Ar-C), 95.68 (C-1), 92.57 (C1’), 78.47 (CH2−C≡CH), 75.26 (CH2−C≡CH), 69.15 (C-2), 68.63 (C-3), 68.36 (C-4’),
67.86 (C-2’), 67.72 (C-3’), 67.23 (C-5), 67.20 (C-5’), 65.42 (C-4), 62.23 (C-6’), 61.69
(C-6), 55.67 (CH2−C≡CH), 20.87, 20.83, 20.66, 19.64 (4×COCH3). MALDI-TOFMS:
calcd for C44H44O18·Na+: 883.2420; found: m/z 883.2423.

Scheme 3.18 Synthesis of propargyl 3-O-(α-D-galactopyranosyl)-α-D-galactopyranoside
3.
The crude product was purified by silica gel chromatography (4:1, EtOAc–
MeOH) to give 3 as a white powdery solid (154 mg, 76.6 %). Rf = 0.48 (1:1, EtOAc–
124

MeOH). [α]D24 = 265.8 (c = 1.00, CH3OH). 1H NMR (600 MHz, Deuterium oxide) δ 5.18
(d, J = 3.6 Hz, 1H, H-1), 5.17 (d, J = 3.9 Hz, 1H, H-1’), 4.37 (m, 2H, CH2−C≡CH), 4.27
(m, 1H, H-4), 4.19 (m, 1H, H-5’), 4.04 – 3.95 (m, 5H, H-2, H-3, H-5, H-3’, H-4’), 3.88
(dd, J = 10.4, 3.9 Hz, 1H, H-2’), 3.79 – 3.75 (m, 4H, H-6a,b, H-6’a,b), 2.92 (t, J = 2.4 Hz,
1H, CH2−C≡CH).
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C NMR (126 MHz, Deuterium oxide) δ 97.16 (C-1), 94.94 (C-1’),

78.90 (CH2−C≡CH), 75.90 (CH2−C≡CH), 74.03 (C-2), 70.99 (C-3’), 70.82 (C-5’), 69.22
(C-3), 69.12 (C-4’), 68.13 (C-2’), 66.28 (C-5), 65.29 (C-4), 60.95 (C-6’), 60.89 (C-6),
54.71 (CH2−C≡CH). HRMS ESI (m/z) (M+Na)+ calcd for C15H24O11Na+ 403.1216,
found 403.1218.

Scheme 3.19 Synthesis of propargyl 2,3,6-tri-O-benzoyl-4-O-(2,3-di-O-benzoyl-4,6-Odi-tert-butyl-silanediyl-α-D-galactopyranosyl)-α-D-galactopyranoside 15.
Compound 15 was synthesized according to the general glycosylation method B
above. The crude product was purified by silica gel chromatography (10:1, hexane–
EtOAc) to give 15 (693 mg, 52.9 %) as a white amorphous foam. Rf = 0.46 (3:1, hexane–
EtOAc). [α]D21 = +207.4 (c = 1.00, CHCl3). 1H NMR (500 MHz, Chloroform-d) δ 8.06 –
7.98 (m, 8H), 7.87 – 7.85 (m, 2H), 7.56 – 7.49 (m, 4H), 7.42 – 7.35 (m, 9H), 7.30 (m,
2H), 5.91 (dd, J = 10.8, 3.6 Hz, 1H, H-2’), 5.78 (m, 2H, H-2, H-3), 5.75 (dd, J = 10.8, 3.0
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Hz, 1H, H-3’), 5.51 (d, J = 3.7 Hz, 1H, H-1’), 5.48 (d, J = 3.6 Hz, 1H, H-1), 4.94 (dd, J =
3.1, 1.1 Hz, 1H, H-4’), 4.68 (dd, J = 10.7, 6.3 Hz, 1H, H-6a), 4.48 (m, 1H, H-4), 4.38 (m,
1H, H-5), 4.34 – 4.31 (m, 4H, H-5’, H-6b, CH2−C≡CH), 3.84 (qd, J = 12.9, 1.9 Hz, 2H,
H-6’a,b), 2.35 (t, J = 2.4 Hz, 1H, CH2−C≡CH), 1.08 (s, 9H, CH3-tBu-Si), 0.93 (s, 9H, CH3tBu-Si).
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C NMR (126 MHz, Chloroform-d) δ 166.40, 166.27, 166.15, 166.05, 165.67 (5

C=OBz), 133.66, 133.45, 133.40, 133.25, 133.20, 130.07, 130.01, 129.99, 129.98, 129.85,
129.76, 129.52, 129.40, 129.34, 129.07, 128.75, 128.59, 128.49, 128.48 (×2) (Ar-C),
98.73 (C-1’), 95.84 (C-1), 78.58 (CH2−C≡CH), 76.54 (C-4), 75.27 (CH2−C≡CH), 71.37
(C-4’), 71.02 (C-3’), 70.19 (C-2), 69.11 (C-2’), 69.04 (C-5), 68.37 (C-3), 68.15 (C-5’),
66.74 (C-6’), 61.87 (C-6), 55.50 (CH2−C≡CH), 27.60, 27.36 (2 CH3-tBu-Si), 23.35 (CqtBuSi),

20.85 (Cq-tBuSi). MALDI-TOFMS: calcd for C58H60O16Si·Na+: 1063.3543; found:

m/z 1063.3543.

Scheme 3.20 Synthesis of propargyl 4-O-(α-D-galactopyranosyl)-α-D-galactopyranoside
4.
The crude product was purified by silica gel chromatography (4:1, EtOAc–
MeOH) to give 4 as a white powdery solid (163 mg, 84.0 %). Rf = 0.50 (1:1, EtOAc–
MeOH). [α]D20 = 183.9 (c = 1.00, CH3OH). 1H NMR (500 MHz, Methanol-d4) δ 5.06 (d,
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J = 3.7 Hz, 1H, H-1), 4.99 (d, J = 3.8 Hz, 1H, H-1’), 4.30 (dd, J = 2.5, 0.9 Hz, 2H,
CH2−C≡CH), 4.21 (ddd, J = 6.8, 5.1, 1.3 Hz, 1H, H-5’), 4.06 (m, 1H, H-4), 3.92 (m, 2H,
H-4’, H-5), 3.86 – 3.68 (m, 8H, H-2, H-3, H-6a,b, H-2’, H-3’, H-6’a,b), 2.88 (t, J = 2.4 Hz,
1H, CH2−C≡CH).
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C NMR (126 MHz, Methanol-d4) δ 102.75 (C-1’), 99.16 (C-1),

81.18 (C-4), 80.15 (CH2−C≡CH), 76.07 (CH2−C≡CH), 73.01 (C-5’), 72.39 (C-5), 71.18
(C-2’), 71.12 (C-2), 70.96 (C-4’), 70.49 (C-3), 70.30 (C-3’), 62.66 (C-6’), 61.40 (C-6),
55.66 (CH2−C≡CH). HRMS ESI (m/z) (M+Na)+ calcd for C15H24O11Na+ 403.1216,
found 403.1216.

Scheme 3.21 Synthesis of propargyl 2,3,4-tri-O-benzoyl-6-O-(2,3-di-O-benzoyl-4,6-Odi-tert-butyl-silanediyl-α-D-galactopyranosyl)-α-D-galactopyranoside 16.
Compound 16 was synthesized according to the general glycosylation method A
above. The crude product was purified by silica gel chromatography (16:3:1, hexane–
DCM–EtOAc) to give 16 (2.64 g, 64.0 %) as an amorphous white foam. Rf = 0.33 (4:1,
hexane–EtOAc). m.p. 106 – 108 °C. [α]D21 = +233.6 (c = 1.00, CHCl3). 1H NMR (500
MHz, Chloroform-d) δ 8.03 – 7.98 (m, 7H), 7.76 (dd, J = 8.3, 1.4 Hz, 2H), 7.60 (m, 1H),
7.52 – 7.36 (m, 13H), 7.22 (m, 2H), 5.94 (dd, J = 10.6, 3.4 Hz, 1H), 5.89 (dd, J = 3.4, 1.3
Hz, 1H), 5.78 (dd, J = 10.6, 3.6 Hz, 1H), 5.70 (dd, J = 10.7, 3.7 Hz, 1H), 5.60 (d, J = 3.7
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Hz, 1H), 5.58 (dd, J = 10.6, 3.1 Hz, 1H), 5.27 (d, J = 3.6 Hz, 1H), 4.90 (dd, J = 3.1, 1.1
Hz, 1H), 4.53 (ddd, J = 7.3, 4.6, 1.3 Hz, 1H), 4.39 – 4.31 (m, 3H), 4.27 (dd, J = 12.7, 1.7
Hz, 1H), 4.08 – 4.07 (m, 1H), 3.89 (dd, J = 10.7, 7.5 Hz, 1H), 3.69 (dd, J = 10.7, 4.4 Hz,
1H), 2.44 (t, J = 2.4 Hz, 1H), 1.12 (s, 9H), 0.98 (s, 9H).

13

C NMR (126 MHz,

Chloroform-d) δ 166.31, 166.22, 166.20, 165.54, 165.53 (5 C=OBz), 133.66, 133.47,
133.31, 133.22, 133.19, 130.05, 130.04, 130.01, 129.94, 129.85, 129.81, 129.62, 129.38,
129.30, 129.24, 128.75, 128.54, 128.53, 128.48, 128.34 (Ar-C), 97.08, 95.32 (C-1 and C1’), 78.47, 75.56, 71.34, 71.06, 69.63, 69.07, 68.74, 68.62, 68.49, 67.46, 67.14, 67.07,
55.52 (CH2−C≡CH), 27.68, 27.39 (2 CH3-tBu-Si), 23.45 (Cq-tBuSi), 20.87 (Cq-tBuSi).
MALDI-TOFMS: calcd for C58H60O16Si·Na+: 1063.3543; found: m/z 1063.3543.

Scheme 3.22 Synthesis of propargyl 2,3,4-tri-O-benzoyl-6-O-(2,3-di-O-benzoyl-α-Dgalactopyranosyl)-α-D-galactopyranoside 27.
The crude product was purified by chromatography column (5:1, DCM–EtOAc)
to give 27 (1.90 g, 91.5 %) as an amorphous white foam. m.p. 102 – 104 °C. [α]D21 = +
237.4 (c = 1.00, CHCl3). Rf = 0.36 (1:1.5, hexane–EtOAc). 1H NMR (500 MHz,
Chloroform-d) δ 8.02 – 7.94 (m, 7H), 7.75 (m, 2H), 7.59 (m, 1H), 7.52 – 7.32 (m, 13H),
7.22 (m, 2H), 5.94 (m, 2H), 5.73 – 5.65 (m, 3H), 5.60 (d, J = 3.7 Hz, 1H), 5.29 (d, J = 3.5
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Hz, 1H), 4.58 (ddd, J = 6.8, 5.5, 1.3 Hz, 1H), 4.49 (td, J = 2.7, 1.2 Hz, 1H), 4.41 – 4.31
(qd, J = 16.0, 2.4 Hz, 2H), 4.21 (td, J = 4.7, 1.4 Hz, 1H), 4.03 – 3.95 (m, 1H), 3.89 (dd, J
= 10.7, 7.0 Hz, 1H), 3.72 (dd, J = 10.7, 5.4 Hz, 1H), 3.11(d, J = 3.0 Hz, 1H), 2.55 (m,
1H), 2.49 (t, J = 2.4 Hz, 1H).

13

C NMR (126 MHz, Chloroform-d) δ 166.26, 166.18,

165.86, 165.65, 165.56 (5 C=OBz), 133.63, 133.46, 133.43, 133.31, 133.23, 130.03,
129.99, 129.94, 129.91, 129.80, 129.51, 129.44, 129.34, 129.26, 129.22, 128.74, 128.55,
128.51, 128.50, 128.32 (Ar-C), 97.31, 95.63 (C-1 and C-1’), 78.58, 77.41, 77.16, 76.91,
75.62, 71.11, 69.80, 69.79, 69.46, 69.05, 68.76, 68.61, 68.48, 67.23, 63.26,
55.77(CH2−C≡CH). MALDI-TOFMS: calcd for C50H44O16·Na+: 923.2522; found: m/z
923.2526.

Scheme 3.23 Synthesis of propargyl 6-O-(α-D-galactopyranosyl)-α-D-galactopyranoside
5.
The crude product was purified by chromatography column (4:1, EtOAc–MeOH)
to give 5 (543 mg, 80.4%) as a white powdery solid. Rf = 0.43 (1:1, EtOAc–MeOH).
[α]D20 = + 160.6 (c = 1.00, CH3OH). 1H NMR (500 MHz, Methanol-d4) δ 5.03 (d, J = 3.8
Hz, 1H, H-1), 4.87 (d, J = 3.7 Hz, 1H, H-1’), 4.29 (t, J = 2.4 Hz, 2H, CH2−C≡CH), 4.00
(m, 1H, H-5), 3.96 (dd, J = 3.3, 1.2 Hz, 1H, H-4), 3.91 – 3.85 (m, 3H, H-4’, H-5’, H-6a),
3.81 – 3.70 (m, 6H, H-2, H-2’, H-3, H-3’, H-6’a, H-6’b), 3.65 (dd, J = 10.1, 6.0 Hz, 1H,
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H-6b), 2.89 (t, J = 2.4 Hz, 1H, CH2−C≡CH).

13

C NMR (126 MHz, Methanol-d4) δ

100.33 (C-1’), 98.89 (C-1), 80.13 (CH2−C≡CH), 76.17 (CH2−C≡CH), 72.39 (C-5’),
71.51 (C-3’), 71.25 (C-2’), 71.09 (C-4’), 70.76 (C-4), 70.66 (C-5), 70.19 (C-3), 69.98 (C2), 67.62 (C-6), 62.71 (C-6’), 55.46 (CH2−C≡CH). HRMS ESI (m/z) (M+Na)+ calcd for
C15H24O11Na+ 403.1216, found 403.1216.

Scheme 3.24 Synthesis of propargyl 2,3,4-tri-O-acetyl-6-O-(2,3,4-tri-O-acetyl-6-O(2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside)-α-D-galactopyranosyl)-α-Dgalactopyranoside 19.25
Compound 19 was synthesized according to the general glycosylation method A
above. The crude product was purified by silica gel chromatography (4:1, hexane–
EtOAc). It was deprotected, acetylated, and purified again by silica gel chromatography
(1:1.5, hexane–EtOAc) to give 19 (153 mg, 42.8%) as colorless oil. Rf = 0.29 (1:1.5,
hexane–EtOAc). [α]D21 = 165.7 (c = 1.00, CHCl3). 1H NMR (600 MHz, Chloroform-d) δ
5.51 – 5.45 (m, 3H, H-3, H-4’’, H-4’), 5.34 (dd, J = 10.9, 3.3 Hz, 1H, H-3’), 5.28 (m, 1H,
H-3’’), 5.26 (d, J = 3.8 Hz, 1H, H-1), 5.16 (d, J = 3.5 Hz, 1H, H-1’), 5.14 – 5.12 (m, 2H,
H-4, H-2’’), 5.10 (dd, J = 10.9, 3.6 Hz, 1H, H-2’), 4.95 (d, J = 3.5 Hz, 1H, H-1’’), 4.89
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(dd, J = 10.3, 3.7 Hz, 1H, H-2), 4.31 – 4.25 (m, 4H, CH2−C≡CH, H-5’’, H-5’), 4.19 (dd,
J = 11.3, 5.6 Hz, 1H, H-6’’a/b), 4.07 – 4.01 (m, 2H, H-5, H-6’’a/b), 3.75 (dd, J = 11.5, 5.2
Hz, 1H, H-6a/b), 3.70 (dd, J = 10.1, 6.4 Hz, 1H, H-6’a/b), 3.58 (dd, J = 11.4, 2.3 Hz, 1H,
H-6a/b), 3.40 (dd, J = 10.1, 6.0 Hz, 1H, H-6’a/b), 2.57 (t, J = 2.4 Hz, 1H, CH2−C≡CH),
2.13 (×2), 2.11, 2.07 (×3), 2.05, 2.01, 1.97(×2) (10×COCH3).

13

C NMR (151 MHz,

Chloroform-d) δ 170.70, 170.65, 170.60, 170.31, 170.25, 170.22, 170.16, 169.97, 169.93,
169.65 (10× C=OAc), 96.36 (C-1’), 96.23 (C-1’’), 94.42 (C-1), 78.35 (CH2−C≡CH),
75.76 (CH2−C≡CH), 70.57 (C-2), 70.18 (C-3), 69.12 (C-5), 68.97 (C-4), 68.57 (C-4’),
68.34 (C-4’’), 68.23 (C-2’), 67.78 (C-3’), 67.75 (C-2’’), 67.48 (C-3’’), 67.32 (C-5’),
66.77 (C-5’’), 66.21 (C-6), 65.88 (C-6’), 62.11 (C-6’’), 55.45 (CH2−C≡CH), 20.96,
20.86 (×2), 20.82 (×3), 20.79, 20.77, 20.76, 20.74 (10×COCH3). MALDI-TOFMS: calcd
for C41H54O26·Na+: 985.2796; found: m/z 985.2798.

Scheme

3.25

Synthesis

of

propargyl

galactopyranosyl)-α-D-galactopyranoside 6.
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6-O-(6-O-α-D-galactopyranoside-α-D-

The crude product was purified by chromatography column (1:1, EtOAc–MeOH)
to give 6 (48 mg, 84.9%) as a white powdery solid. Rf = 0.5 (MeOH). [α]D21 = 154.2 (c =
1.00, CH3OH). 1H NMR (600 MHz, Deuterium Oxide) δ 5.13 (d, J = 3.8 Hz, 1H, H-1),
4.99 (2d, J = 3.6 Hz, 2H, H-1’, H-1’’), 4.37 (m, 2H, CH2−C≡CH), 4.19 (m, 1H, H-5’),
4.04 (m, 1H, H-4’), 4.01 – 3.98 (m, 3H, H-4, H-4’’, H-6a/b), 3.91 – 3.81 (m, 6H, H-3’, H3, H-6’a/b, H-3’’, H-2’, H-2’’), 3.75 – 3.67 (m, 5H, H-6’’a,b, H-6a/b, H-6’a/b, H-5), 3.62 (m,
1H, H-2), 3.53 (m, 1H, H-5’’), 2.92 (m, 1H, CH2−C≡CH).

13

C NMR (151 MHz,

Deuterium oxide) δ 97.92 (C-1’’, JC1’’-H1’’ = 170.55 Hz), 97.81 (C-1’, JC1’-H1’ = 169.56
Hz), 97.00 (C-1, JC1-H1 = 170.92 Hz), 78.73 (CH2−C≡CH), 76.00 (CH2−C≡CH), 73.16
(C-5), 70.89 (C-4), 70.83 (C-2), 70.56 (C-3), 69.41 (C-3’’), 69.38 (C-5’’), 69.33 (C-3’),
69.25 (C-4’), 69.14 (C-4’’), 68.68 (C-5’), 68.29 (C-2’’), 68.19 (C-2’), 66.36 (C-6’), 65.26
(C-6), 61.05 (C-6’’), 54.84 (CH2−C≡CH). HRMS ESI (m/z) (M+Na)+ calcd for
C21H34O16Na+ 565.1745, found 565.1748.
3.3 Conclusions
I have described straightforward syntheses of α-linked propargyl terminated
galactosides with various spatial presentations. Flexible and efficient regioselective
protection strategies were performed on propargyl galactoside to give the corresponding
glycosyl acceptors. The high α-stereoselective glycosylations were accomplished with the
usage of 4,6-di-tert-butylsilylene protected thiogalactoside donor. After mild deprotection
sequences, the desired galactoside ligands were obtained in satisfied yield, and their
structures were rigorously confirmed by using 1H NMR,
MALDI-TOF mass spectra.
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Chapter 4 Construction of an α-Galactosides Featured
Microarray and Evaluation of Its Lectin-Binding Properties

137

Abstract
A synthetic carbohydrate microarray with the immobilization of a collection of
diversely presented galactoside clusters was constructed to imitate featured carbohydrate
presentations on natural cell surface. The synthetic surface was interrogated by a
fluorescence-labeled lectin to quantitatively analyze their binding affinities and
dissociation constants. The lectin showed stronger binding affinities with disaccharides
that possess the non-reducing terminal Gal-α-(1,3)-Gal, Gal-α-(1,4)-Gal and Gal-α-(1,6)Gal aglycones. This study will add new dimensions to our understanding of the effects of
spatial arrangement of carbohydrate ligands in carbohydrate–lectin binding, and shed
light on elucidating the structure/affinity relationship of carbohydrates recognition with
receptors.
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4.1 Background
The glycocalyx, which is the thick layer of glycoconjugates covering both
eukaryotic and prokaryotic cell membrane surfaces, forms the basis for molecular
recognitions. Its interactions with lectins have been recognized to be critical in mediating
biological activities such as cell–cell communication and adhesion, host–pathogen
interactions and immune defense.1 However, understanding the mechanism of
carbohydrates–lectin interactions is arduous.2 A major impediment is the complex
structure of carbohydrates, which makes both chemical synthesis of the oligosaccharide
structures involved and biochemical analysis of their interactions with recognition
proteins highly challenging. Carbohydrate structures display tremendous diversity and
informational storage capacity because many permutations of size, composition,
connectivity, and spatial arrangement can be generated. Moreover, the multimeric
architecture of lectins allows simultaneous binding to multiple carbohydrate ligands to
generate multivalent binding types, while proper presentation of the carbohydrate ligands
with matched spacing and orientation is necessary.3, 4
In order to systematically investigate the molecular basis of carbohydrate–lectin
interactions, carbohydrate microarrays have been developed as an imitation of natural
glycosylated surfaces.5 Synthetic carbohydrate ligands, which can be acquired in
sufficient amount and high purity, are made and immobilized on solid supports with a
linker incorporated.6 Several carbohydrate microarrays have been constructed by
immobilizing homo or hetero glycoclusters,7 multiplexed glycoconjugates,8 sequence–
defined heteromultivalent glycooligomers,9 and glycoclusters with different valency,10 to
generate multivalent ligand landscapes that can create adequately affinity with lectins; 11

139

yet, less emphasis has been put on the integration of spatial and chemical patterning of
the synthetic glycan surface.12
Herein, I report a modular approach to constructing carbohydrate microarray by
immobilizing various α-linked galactoside clusters to investigate the influence of spatial
organization and site-specific ligand modifications on the recognition and binding with
lectin. The synthesized α-linked galactoside ligands 16 (Figure 3.1) were coupled with
the azido-PEG-biotin linker by click chemistry to afford the glycoconjugates G1–G6,
respectively, which were immobilized to an avidin-coated glass slide to afford the
carbohydrate microarray at defined densities. The synthetic carbohydrate landscape was
interrogated by using fluorescence imaging technique to assess the recognition with
Griffonia Simplicifolia Lectin I-isolectin B4 (GSL I-B4), a C-type lectin that shows high
affinity to α-D-galactosyl end groups.13–15 C-Type lectins are Ca2+-dependent glycanbinding proteins, and the binding occurs primarily through the coordination of the
calcium ion with the specific amino acid residues and the 3- and 4-hydroxyl groups on
the sugar.16 Because the protein and sugar are insulated by the calcium ion, recognition is
somewhat loose and primarily involves a single sugar unit. Sugars can be recognized in
alternative orientations, and structurally related sugars can be recognized.17, 18 Thus, how
strongly a particular biological surface is recognized depends heavily on presentation, the
subtleties of which the present work specifically seeks to explore.
4.2 Construction of Carbohydrate Microarray
The synthesized α-galactoside ligands 16 were used directly for the construction
of microarray. The choice of the linker structure is governed by a combination of factors,

140

Figure 4.1 Landscape of synthetic α-linked galactosides microarray and its
carbohydratelectin binding evaluations.
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primarily the geometry of the lectin multimers, the need for structures that have good
water solubility and resistance to non-specific protein adsorption, and the desire to use
readily available azide derivatives that can be incorporated readily into the modular
architecture. It is expected that substantially long length of linkers may be needed, as the
linear path between binding sites is not physically possible with a short linker, and some
added flexibility will be helpful in facilitating proper orientation of the terminal sugar
residues. Therefore, azido-PEG-biotin linker, derived from polyethylene glycol (PEG),
was synthesized19 and used, which is hydrophilic and highly flexible. It was coupled with
propargyl α-D-galactosides 1–6 by Cu-catalyzed azide–alkyne 1,3-dipolar cycloaddition
(CuAAC) “click chemistry”20 to synthesize the glycoconjugates G1–G6 (Scheme 4.1).

Scheme 4.1 Conjugation of propargyl terminated galactosides with azido-PEG-biotin
linker yielded glycoconjugates G1–G6 primed with a biotin group for immobilization on
avidin-coated slides. Reagents and conditions: (a) CuSO4, Sodium ascorbate, THTPA.
The resulting glycoconjugates were printed at 12 concentrations (1 M – 100 M,
by glycan) on avidin-coated glass slides using a robotic spotter to afford microarrays with
increasing glycoconjugates densities. Each concentration was spotted as four replicate
spots, and four replicate grids were printed for each glycocluster. The printing of multiple
142

grids allowed for the systematic modification of both sugar and protein concentrations.
The microarray slides were incubated overnight in a humid chamber at 55 °C to allow
biotin–avidin binding to proceed. After washing to remove unbound glycans, the
microarray slides were incubated with DyLight 594-labeled GSL I-B4 lectin, and
visualized using a fluorescence scanner (Figure 4.2a).
The binding curves (Figure 4.2b) were plotted from the surface bound
glycoconjugates G1–G6, showing the fluorescence resulting from the bound lectin as a
function of the concentration of GSL I-B4 lectin that was incubated with the slide.21 It
shows that the all of the arrayed glycoconjugates G1–G6 were recognized by the GSL IB4 lectin, while their affinities varied depending on the glycoconjugate structure. G3–G5
showed stronger bindings than G1, G2, and G6. The dissociation constants (Kd) of each
glycoconjugate were also determined to add more quantitative insights (Table 4.1). G3
and G5 exhibited lower Kd values (58.9 nM and 59.5 nM, respectively) and higher
binding affinities, which is followed by G4 (67.2 nM); while G1, G2 and G6 displayed
higher Kd values (82.5 nM, 83.6 nM and 100.3 nM, respctively) and lower binding
affinities. It indicated that the disaccharides showed generally better binding affinities
than the monosaccharide and the trisaccharide. I surmise that it may be due to the less
binding sites (hydroxyl groups) of monosaccharide than disaccharide, and the bulky size
of trisaccharide that limits lectin’s accessibility. G2 possessing an terminus Gal-α-(1,2)Gal disaccharide, unexpectedly, showed low binding affinity. A mechanistic explanation
of it is no doubt complicated, as many factors are possible and difficult to sort out.
Perhaps noteworthy is the downward orientation fact of the terminal α-Gal, which is to
some extent, concealing itself among the carbohydrate arrays.
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(a)

(b)

(c)
Figure 4.2 (a) Fluorescence scanning of carbohydrate microarray after DyLight 594labeled GSL I-B4 lectin incubation (Cglycan = 1 μM to 100 μM); (b) Binding curves
obtained from the surface bound glycoconjugates G1–G6 as a function of GSL I-B4 lectin
concentration; (c) Binding curves for the glycocluster G3 printed at different
concentrations.
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Table 4.1 Dissociation constants of G1–G6 determined by GSL I-B4 binding curves
F=

𝐹𝑚𝑎𝑥 [𝐿]
[𝐿] + 𝐾𝑑

Glycoconjugates

Kd (nM)

Error (%)

Glycoconjugates

Kd (nM)

Error (%)

G1

82.5

6.6

G4

67.2

8.2

G2

83.6

5.9

G5

59.5

8.9

G3

58.9

9.1

G6

100.3

3.5

Table 4.2 Relationship of different printing concentrations of G3 and the dissociation
constants (Kd), and the errors
Ligands Printing
concentration
(μM)

Kd
(nM)

Error (%)

Ligands Printing
concentration
(μM)

Kd
(nM)

Error (%)

100

58.9

9.1

10

61.6

4.2

80

72.9

6.5

5

104.4

7.7

40

65.0

4.1

2

217.4

18.6

20

61.7

1.6

1

173.5

10.5
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The binding curves of the glycocluster G3 at different concentrations were plotted
as well to further explore the relationship between ligand concentration with lectinbinding affinity (Figure 3(c)). Eight binding curves were plotted representing eight
printing concentrations of G3 (100 μM, 80 μM, 40 μM, 20 μM, 10 μM, 5 μM, 2 μM, 1
μM, respectively). When the printing concentrations of G3 were within 100 to 10 μM, the
Kd values obtained are narrowly distributed (mean Kd = 64 nM; SD = 5.4 nM; Table 4.2).
However, when the printing concentrations were below 10 μM, the Kd values increase
and the binding affinities decrease. This is probably due to the increased distance
between the ligands on the surface. If the distance between G3 ligands on the surface is
close enough, a multivalent binding type with GSL I-B4 lectin will form. However, if the
printing concentration is below 10 μM, the average distance between immobilized G3
ligand is too far for a multivalent interaction with the lectin.
4.3 Experimental Section
4.3.1 General procedure for glycoconjugates G1−G6 synthesis
Stock solutions were prepared as follows: six propargyl-terminated saccharides
1−6 in water (10 mM, respectively); azido-PEG-biotin linker in water (10 mM); CuSO4
in water (50 mM); sodium ascorbate in water (250 mM); THPTA (tris(3hydroxypropyltriazolylmethyl)amine) in PBS buffer (1 M, pH 7, 0.5 % DMSO).
Solutions were added to six Eppendorf tubes (respectively with six
glycoconjugates) in the following order (vortex after adding each solution): 850 μL PBS,
10 μL saccharide, 10 μL azido-PEG-biotin linker, 10 μL CuSO4, 110 μL THPTA, and 10
μL sodium ascorbate. All tubes were shaken at room temperature for overnight. The
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solutions were then diluted to 12 concentrations ranged from 1 μM to 100 μM, and
printed on to streptavidin-coated slides.
4.3.2 Preparation of microarrays
For microarray experiments, all water used was obtained from a Milli-Q water
purification system (Millipore). Six glycoclusters with biotin linkers in phosphatebuffered saline (PBS) buffer (1x PBS, pH 7.4 and 0.05% Tween-20) were immobilized at
12 concentrations (1 M – 100 M, by glycan) on streptavidin-coated glass (SuperAvidin
Microarray Substrates, ArrayIt®). Each concentration was spotted as four replicate spots,
and four replicate super grids were printed for each glycocluster. The printed slides were
incubated overnight in a humid chamber at 55 °C. The slides were rinsed with PBS buffer
(1XPBS, pH 7.4 and 0.05% Tween-20, 3 x 5 min), blocked in Superblock solution
(ArrayIt®) for 1 h on shaker, washed in PBS (3 x 5 min) again, and dried over a flow of
nitrogen.
4.3.3 Microarray–lectin binding assay
DyLight® 594 Griffonia Simplicifolia Lectin I (GSL I) – Isolectin B4 lectin
(DyLight® 594 GSL I – B4 Lectin, Vector Lab) was diluted to 2, 5, 10, 20, 50, and 80
g/mL, respectively, in PBS (1x PBS, 0.05% Tween-20, 0.15 M NaCl), and incubated
with six printed carbohydrate microarray slides, correspondingly. Slides were incubated
in a humid chamber for 3 h at room temperature, rinsed with PBS (1XPBS, pH 7.4 and
0.05% Tween-20, 3 x 5 min), water (3 x 5 min), and dried over a flow of nitrogen. The
slides were scanned with a GenePix 4300A microarray scanner (Molecular Devices,
Sunnyvale, CA, USA), and images were analyzed with the GenePix Pro 7 software
(Molecular Devices).
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(a)

(d)

(b)

(e)

(c)

(f)

Figure 4.3 Scanned images of GSI B4 lectin–incubated carbohydrate slides. Lectin
concentrations: (a) 2 g/mL, (b) 5 g/mL, (c) 10 g/mL, (d) 20 g/mL, (e) 50 g/mL, (f)
80 g/mL. The two columns on right side in (d) and (f) were not included in the Kd
calculation due to inconsistent printing.
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4.3.4 Calculation of Kd
Slides were scanned at 532 nm then at 635 nm with the microarray scanner.
Fluorescence intensities were obtained from the image analysis. Kd values were
determined from the surface bound glycoconjugates G1–G6 as a function of lectin
concentration [L] by the equation below. OriginPro 8 software was used to generate the
equation for nonlinear curve-fitting of each glycoconjugate and plotted binding curves.
4.4 Conclusion
I have successfully developed a microarray with controlled carbohydrate
presentations by immobilizing six synthetic α-linked glycoconjugates varied in linkage
and size to an avidin-coated glass slide to imitate featured carbohydrate presentations.
Quantitative evaluation of their binding properties toward fluorescence-labeled GSL I-B4
lectin was achieved by directly fluorescence scanning and determination of Kd values.
The lectin displayed stronger affinity with saccharides that possess the non-reducing
terminal disaccharide Gal-α-(1,3)-Gal, disaccharide Gal-α-(1,4)-Gal and Gal-α-(1,6)-Gal.
The insights gained will find applications in a wealth of biological recognition activities
and more importantly, it will have broad implications for the construction of analytical
platforms that display the complex arrangements of chemical epitopes commonly found
in natural systems.
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Chapter 5 Conclusions
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The fundamental role of oligosaccharides and glycoconjugates with 1,2-cis
glycosidic linkages in biological activities of living systems has been discussed, and
various strategies developed for the stereoselective construction of 1,2-cis-O-glycosidic
bond has been thoroughly reviewed in Chapter 1. Although considerable achievements
have been accomplished to access complex oligosaccharides, the development of general,
efficient, and flexible approaches to achieve the intrinsic organizational diversity of
carbohydrates is still urged in order to meet the substantial carbohydrates demand for
biological, medicinal, and therapeutic studies.
In this dissertation, a facile and general strategy for the direct construction of 1,2cis alkyl glycosides has been developed. Glycosylations between several unprotected
phenyl 1-thioglycosyl donors and various functionalized alcohols were performed under
the activation of NIS/TMSOTf. The reactions proceeded smoothly with satisfying yields
and 1,2-cis-selectivity. The optimization of the glycosylation condition was carried out
efficiently by an FIAESI-TOF-MS/1H NMR protocol, which enabled quantitative
evaluation of reaction yield and stereoselectivity. The synthetic procedures described
herein are anticipated to find application in the areas where 1,2-cis-linked glycosides is
required.
The development of synthetic glycoconjugate surfaces to imitate the natural
carbohydrate landscape on the cell surface was also presented in order to facilitate the
understanding of the structure–affinity relationships among carbohydrates in recognition
with protein receptors. Six α-linked propargyl terminated galactosides with various
spatial presentations were carefully designed for the construction of synthetic
carbohydrate microarrays. Combinatorial syntheses were performed to afford these
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glycan ligands from different combinations of glycosylation donor and acceptors. The
glycosyl acceptors were obtained via flexible and efficient regioselective protection
strategies, and they were glycosylated with 4,6-di-tert-butylsilylene protected
thiogalactoside donor to get the α-linked galactosides in exclusive stereoselective and
satisfying yield. A monosaccharide, α-linked 1→2, 1→3, 1→4 and 1→6 disaccharides,
and an α-linked galactose trisaccharide with propargyl terminus were synthesized and
coupled with the azido-PEG-biotin linker by click chemistry. The prepared
glycoconjugates were immobilized to an avidin-coated glass slide to afford the
carbohydrate microarrays. A fluorescent-labeled lectin, DyLight 594-labeled GSL I-B4
lectin, was employed with varied concentrations to determine the glycoarray recognitions
and analyze their binding affinities and dissociation constants. The lectin showed stronger
binding affinities with disaccharides that possess the non-reducing terminal Gal-α-(1,3)Gal, Gal-α-(1,4)-Gal and Gal-α-(1,6)-Gal aglycones. This study could add new
dimensions to our understanding of the effects of carbohydrate ligands density, avidity,
and spatial arrangement in carbohydrate–lectin binding process.
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Appendix
1

H NMR, 13C NMR, gCOSY NMR, gHSQC NMR and gHMBC
NMR Spectra of Synthesized Carbohydrates
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1

H NMR (500 MHz, CDCl3: Phenyl α-D-galactopyranosyl-(1,6)-1-thio-β-D-glucopyranoside (1dβ)

157

13

C NMR (125 MHz, CDCl3):Phenyl α-D-galactopyranosyl-(1,6)-1-thio-β-D-glucopyranoside(1dβ)

158

1

H NMR (500 MHz, CDCl3): Propargyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4a)

159

13

C NMR (125 MHz, CDCl3): Propargyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4a)

160

gCOSY NMR: Propargyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4a)

161

gHSQC NMR: Propargyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4a)

162

gHMBC NMR: Propargyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4a)

163

1

H NMR (500 MHz, CDCl3): Propargyl 2,3,4,6-tetra-O-(acetyl-d3)-α-D-galactopyranoside (4)

164

13

C NMR (125 MHz, CDCl3): Propargyl 2,3,4,6-tetra-O-(acetyl-d3)-α-D-galactopyranoside (4)

165

1

H NMR (500 MHz, CDCl3): 3-(Trimethylsilyl)propargyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4b)

166

13

C NMR (125 MHz, CDCl3): 3-(Trimethylsilyl)propargyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4b)

167

gCOSY NMR: 3-(Trimethylsilyl)propargyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4b)

168

gHSQC NMR: 3-(Trimethylsilyl)propargyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4b)

169

1

H NMR (500 MHz, CDCl3): Allyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4c)

170

13

C NMR (125 MHz, CDCl3): Allyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4c)

171

gCOSY NMR: Allyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4c)

172

gHSQC NMR: Allyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4c)

173

1

H NMR (500 MHz, CD3OD): 2-Nitroethyl α-D-galactopyranoside (4d)

174

13

C NMR (125 MHz, CD3OD): 2-Nitroethyl α-D-galactopyranoside (4d)

175

gCOSY NMR: 2-Nitroethyl α-D-galactopyranoside (4d)

176

gHSQC NMR: 2-Nitroethyl α-D-galactopyranoside (4d)

177

1

H NMR (500 MHz, CDCl3): 1,3-Dichloro-2-propyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4e)

178

13

C NMR (125 MHz, CDCl3): 1,3-Dichloro-2-propyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4e)

179

gCOSY NMR: 1,3-Dichloro-2-propyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4e)

180

gHSQC NMR: 1,3-Dichloro-2-propyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4e)

181

1

H NMR (500 MHz, CDCl3): 3-Bromopropyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4f)

182

13

C NMR (125 MHz, CDCl3): 3-Bromopropyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4f)

183

gCOSY NMR: 3-Bromopropyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4f)

184

gHSQC NMR: 3-Bromopropyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4f)

185

1

H NMR (500 MHz, CDCl3): 5-Hexynyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4g)

186

13

C NMR (125 MHz, CDCl3): 5-Hexynyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4g)

187

gCOSY NMR: 5-Hexynyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4g)

188

gHSQC NMR: 5-Hexynyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4g)

189

1

H NMR (500 MHz, CDCl3): Benzyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4h)

190

13

C NMR (125 MHz, CDCl3): Benzyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4h)

191

gCOSY NMR: Benzyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4h)

192

gHSQC NMR: Benzyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside (4h)

193

1

H NMR (500 MHz, CDCl3): Propargyl 2,3,4,6-tetra-O-acetyl-α-D-glucopyranoside (4i)

194

13

C NMR (125 MHz, CDCl3): Propargyl 2,3,4,6-tetra-O-acetyl-α-D-glucopyranoside (4i)

195

gCOSY NMR: Propargyl 2,3,4,6-tetra-O-acetyl-α-D-glucopyranoside (4i)

196

gHSQC NMR: Propargyl 2,3,4,6-tetra-O-acetyl-α-D-glucopyranoside (4i)

197

1

H NMR (500 MHz, CDCl3): Propargyl 2,3,4,6-tetra-O-acetyl-β-D-mannopyranoside (4j)

198

13

C NMR (125 MHz, CDCl3): Propargyl 2,3,4,6-tetra-O-acetyl-β-D-mannopyranoside (4j)

199

gCOSY NMR: Propargyl 2,3,4,6-tetra-O-acetyl-β-D-mannopyranoside (4j)

200

gHSQC NMR: Propargyl 2,3,4,6-tetra-O-acetyl-β-D-mannopyranoside (4j)

201

1

H NMR (500 MHz, CDCl3): Propargyl 6-O-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)-2,3,4-tri-O-acetyl-α-D-glucopyranoside
(4k)

202

13

C NMR (125 MHz, CDCl3): Propargyl 6-O-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)-2,3,4-tri-O-acetyl-α-D-glucopyranoside
(4k)

203

gCOSY NMR: Propargyl 6-O-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)-2,3,4-tri-O-acetyl-α-D-glucopyranoside (4k)

204

gHSQC NMR: Propargyl 6-O-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)-2,3,4-tri-O-acetyl-α-D-glucopyranoside (4k)

205

gHMBC NMR: Propargyl 6-O-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)-2,3,4-tri-O-acetyl-α-D-glucopyranoside (4k)

206

1

H NMR (500 MHz, CDCl3): Propargyl 4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-2,3,6-tri-O-acetyl-α-D-glucopyranoside
(4l)

207

13

C NMR (125 MHz, CDCl3): Propargyl 4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-2,3,6-tri-O-acetyl-α-D-glucopyranoside
(4l)

208

gCOSY NMR: Propargyl 4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-2,3,6-tri-O-acetyl-α-D-glucopyranoside (4l)

209

gHSQC NMR: Propargyl 4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-2,3,6-tri-O-acetyl-α-D-glucopyranoside (4l)

210

gHMBC NMR: Propargyl 4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-2,3,6-tri-O-acetyl-α-D-glucopyranoside (4l)

211

1

H NMR Phenyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-galactopyranoside (21)

212

13

C NMR Phenyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-galactopyranoside (21)

213

1

H NMR Phenyl 1-thio-β-D-galactopyranoside (22)

214

13

C NMR Phenyl 1-thio-β-D-galactopyranoside (22)

215

1

H NMR Phenyl 4,6-O-Di-tert-butylsilanediyl-1-thio-β-D-galactopyranoside (23)

216

13

C NMR Phenyl 4,6-O-Di-tert-butylsilanediyl-1-thio-β-D-galactopyranoside (23)

217

1

H NMR Phenyl 2,3-Di-O-benzoyl-4,6-O-di-tert-butylsilanediyl-1-thio-β-D-galactopyranoside (12)

218

13

C NMR Phenyl 2,3-Di-O-benzoyl-4,6-O-di-tert-butylsilanediyl-1-thio-β-D-galactopyranoside (12)

219

1

H NMR Propargyl 4,6-O-di-tert-butylsilanediyl-α-D-galactopyranoside (24)

220

13

C NMR Propargyl 4,6-O-di-tert-butylsilanediyl-α-D-galactopyranoside (24)

221

1

H NMR Propargyl 3-O-benzoyl-4,6-O-di-tert-butylsilanediyl-α-D-galactopyranoside (7)

222

13

C NMR Propargyl 3-O-benzoyl-4,6-O-di-tert-butylsilanediyl-α-D-galactopyranoside (7)

223

1

H NMR Propargyl 2-O-benzoyl-4,6-O-di-tert-butylsilanediyl-α-D-galactopyranoside (8)

224

13

C NMR Propargyl 2-O-benzoyl-4,6-O-di-tert-butylsilanediyl-α-D-galactopyranoside (8)

225

1

H NMR Propargyl 2,3,6-tri-O-benzoyl-α-D-galactopyranoside (9)

226

13

C NMR Propargyl 2,3,6-tri-O-benzoyl-α-D-galactopyranoside (9)

227

1

H NMR Propargyl 2,3,4-tri-O-benzoyl-6-O-(tert-butyldimethylsilyl)-α-D-galactopyranoside (10)

228

13

C NMR Propargyl 2,3,4-tri-O-benzoyl-6-O-(tert-butyldimethylsilyl)-α-D-galactopyranoside (10)

229

1

H NMR Propargyl 2,3,4-tri-O-benzoyl-α-D-galactopyranoside (11)

230

13

C NMR Propargyl 2,3,4-tri-O-benzoyl-α-D-galactopyranoside (11)

231

1

H NMR Propargyl 3-O-benzoyl-4,6-di-O-tert-butylsilanediyl-2-O-(2,3-di-O-benzoyl-4,6-di-O-tert-butylsilanediyl-α-Dgalactopyranosyl)-α-D-galactopyranoside (13)

232

13

C NMR Propargyl 3-O-benzoyl-4,6-di-O-tert-butylsilanediyl-2-O-(2,3-di-O-benzoyl-4,6-di-O-tert-butylsilanediyl-α-Dgalactopyranosyl)-α-D-galactopyranoside (13)

233

gCOSY NMR Propargyl 3-O-benzoyl-4,6-di-O-tert-butylsilanediyl-2-O-(2,3-di-O-benzoyl-4,6-di-O-tert-butylsilanediyl-α-Dgalactopyranosyl)-α-D-galactopyranoside (13)

234

gHSQC NMR Propargyl 3-O-benzoyl-4,6-di-O-tert-butylsilanediyl-2-O-(2,3-di-O-benzoyl-4,6-di-O-tert-butylsilanediyl-α-Dgalactopyranosyl)-α-D-galactopyranoside (13)

235

gHMBC NMR Propargyl 3-O-benzoyl-4,6-di-O-tert-butylsilanediyl-2-O-(2,3-di-O-benzoyl-4,6-di-O-tert-butylsilanediyl-α-Dgalactopyranosyl)-α-D-galactopyranoside (13)

236

1

H NMR Propargyl 2-O-(α-D-galactopyranosyl)-α-D-galactopyranoside (2)

237

13

C NMR Propargyl 2-O-(α-D-galactopyranosyl)-α-D-galactopyranoside (2)

238

gCOSY NMR Propargyl 2-O-(α-D-galactopyranosyl)-α-D-galactopyranoside (2)

239

gHSQC NMR Propargyl 2-O-(α-D-galactopyranosyl)-α-D-galactopyranoside (2)

240

gHMBC NMR Propargyl 2-O-(α-D-galactopyranosyl)-α-D-galactopyranoside (2)

241

1

H NMR Propargyl 2-O-benzoyl-4,6-di-O-acetyl-3-O-(2,3-di-O-benzoyl-4,6-di-O-acetyl-α-D-galactopyranosyl)-α-Dgalactopyranoside (26)

242

13

C NMR Propargyl 2-O-benzoyl-4,6-di-O-acetyl-3-O-(2,3-di-O-benzoyl-4,6-di-O-acetyl-α-D-galactopyranosyl)-α-Dgalactopyranoside (26)

243

gCOSY NMR Propargyl 2-O-benzoyl-4,6-di-O-acetyl-3-O-(2,3-di-O-benzoyl-4,6-di-O-acetyl-α-D-galactopyranosyl)-α-Dgalactopyranoside (26)

244

gHSQC NMR Propargyl 2-O-benzoyl-4,6-di-O-acetyl-3-O-(2,3-di-O-benzoyl-4,6-di-O-acetyl-α-D-galactopyranosyl)-α-Dgalactopyranoside (26)

245

gHMBC NMR Propargyl 2-O-benzoyl-4,6-di-O-acetyl-3-O-(2,3-di-O-benzoyl-4,6-di-O-acetyl-α-D-galactopyranosyl)-α-Dgalactopyranoside (26)

246

1

H NMR Propargyl 3-O-(α-D-galactopyranosyl)-α-D-galactopyranoside (3)

247

13

C NMR Propargyl 3-O-(α-D-galactopyranosyl)-α-D-galactopyranoside (3)

248

gCOSY NMR Propargyl 3-O-(α-D-galactopyranosyl)-α-D-galactopyranoside (3)

249

gHSQC NMR Propargyl 3-O-(α-D-galactopyranosyl)-α-D-galactopyranoside (3)

250

gHMBC NMR Propargyl 3-O-(α-D-galactopyranosyl)-α-D-galactopyranoside (3)

251

1

H NMR Propargyl 2,3,6-tri-O-benzoyl-4-O-(2,3-di-O-benzoyl-4,6-O-di-tert-butylsilanediyl-α-D-galactopyranosyl)-α-Dgalactopyranoside (15)

252

13

C NMR Propargyl 2,3,6-tri-O-benzoyl-4-O-(2,3-di-O-benzoyl-4,6-O-di-tert-butylsilanediyl-α-D-galactopyranosyl)-α-Dgalactopyranoside (15)

253

gCOSY Propargyl 2,3,6-tri-O-benzoyl-4-O-(2,3-di-O-benzoyl-4,6-O-di-tert-butylsilanediyl-α-D-galactopyranosyl)-α-Dgalactopyranoside (15)

254

gHSQC Propargyl 2,3,6-tri-O-benzoyl-4-O-(2,3-di-O-benzoyl-4,6-O-di-tert-butylsilanediyl-α-D-galactopyranosyl)-α-Dgalactopyranoside (15)

255

gHMBC Propargyl 2,3,6-tri-O-benzoyl-4-O-(2,3-di-O-benzoyl-4,6-O-di-tert-butylsilanediyl-α-D-galactopyranosyl)-α-Dgalactopyranoside (15)

256

1

H NMR Propargyl 4-O-(α-D-galactopyranosyl)-α-D-galactopyranoside (4)

257

13

C NMR Propargyl 4-O-(α-D-galactopyranosyl)-α-D-galactopyranoside (4)

258

gCOSY NMR Propargyl 4-O-(α-D-galactopyranosyl)-α-D-galactopyranoside (4)

259

gHSQC NMR Propargyl 4-O-(α-D-galactopyranosyl)-α-D-galactopyranoside (4)

260

gHMBC NMR Propargyl 4-O-(α-D-galactopyranosyl)-α-D-galactopyranoside (4)

261

1

H NMR Propargyl 2,3,4-tri-O-benzoyl-6-O-(2,3-di-O-benzoyl-4,6-O-di-tert-butylsilanediyl-α-D-galactopyranosyl)-α-Dgalactopyranoside (16)

262

13

C NMR Propargyl 2,3,4-tri-O-benzoyl-6-O-(2,3-di-O-benzoyl-4,6-O-di-tert-butylsilanediyl-α-D-galactopyranosyl)-α-Dgalactopyranoside (16)

263

1

H NMR Propargyl 2,3,4-tri-O-benzoyl-6-O-(2,3-di-O-benzoyl-α-D-galactopyranosyl)-α-D-galactopyranoside (27)

264

13

C NMR Propargyl 2,3,4-tri-O-benzoyl-6-O-(2,3-di-O-benzoyl-α-D-galactopyranosyl)-α-D-galactopyranoside (27)

265

1

H NMR Propargyl 6-O-(α-D-galactopyranosyl)-α-D-galactopyranoside (5)

266

13

C NMR Propargyl 6-O-(α-D-galactopyranosyl)-α-D-galactopyranoside (5)

267

gCOSY NMR Propargyl 6-O-(α-D-galactopyranosyl)-α-D-galactopyranoside (5)

268

gHSQC NMR Propargyl 6-O-(α-D-galactopyranosyl)-α-D-galactopyranoside (5)

269

gHMBC NMR Propargyl 6-O-(α-D-galactopyranosyl)-α-D-galactopyranoside (5)

270

1

H NMR Propargyl 2,3,4-tri-O-acetyl-6-O-(2,3,4-tri-O-acetyl-6-O-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside)-α-Dgalactopyranosyl)-α-D-galactopyranoside (19)

271

13

C NMR Propargyl 2,3,4-tri-O-acetyl-6-O-(2,3,4-tri-O-acetyl-6-O-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside)-α-Dgalactopyranosyl)-α-D-galactopyranoside (19)

272

gCOSY NMR Propargyl 2,3,4-tri-O-acetyl-6-O-(2,3,4-tri-O-acetyl-6-O-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside)-α-Dgalactopyranosyl)-α-D-galactopyranoside (19)

273

gHSQC NMR Propargyl 2,3,4-tri-O-acetyl-6-O-(2,3,4-tri-O-acetyl-6-O-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside)-α-Dgalactopyranosyl)-α-D-galactopyranoside (19)

274

gHMBC NMR Propargyl 2,3,4-tri-O-acetyl-6-O-(2,3,4-tri-O-acetyl-6-O-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside)-α-Dgalactopyranosyl)-α-D-galactopyranoside (19)

275

1

H NMR Propargyl 6-O-(6-O-α-D-galactopyranoside-α-D-galactopyranosyl)-α-D-galactopyranoside (6)

276

13

C NMR Propargyl 6-O-(6-O-α-D-galactopyranoside-α-D-galactopyranosyl)-α-D-galactopyranoside (6)

277

gCOSY NMR Propargyl 6-O-(6-O-α-D-galactopyranoside-α-D-galactopyranosyl)-α-D-galactopyranoside (6)

278

gHSQC NMR Propargyl 6-O-(6-O-α-D-galactopyranoside-α-D-galactopyranosyl)-α-D-galactopyranoside (6)

279

gHMBC NMR Propargyl 6-O-(6-O-α-D-galactopyranoside-α-D-galactopyranosyl)-α-D-galactopyranoside (6)
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